
<!DOCTYPE html>
<html>
<head>
<!-- Required meta tags -->
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<!-- Check Browser, as well as Hostname and set JS, CSS, Favicon path based on that-->

<!-- Favicon --><!-- cpcommit -->
<!-- <link rel="shortcut icon" type="image/x-icon" href="https://www.sec.gov/favicon.ico"> -->

<script>
	(function() {
		var hostName = window.location.hostname;

		var browserAccepted = function() {

			var ua = window.navigator.userAgent;
			var trident = ua.indexOf('Trident/'); //IE 11;
			var msie = ua.indexOf('MSIE '); // IE 10 or older
			if (msie > 0) {
				return false;
			}
			return true;
		}();

		var pathToLibs = 'https://www.sec.gov/js';
		var pathToError = '/';
		if (hostName === 'www-test.sec.gov' || hostName === 'www.sec.gov') {
			pathToLibs = 'https://www.sec.gov/ixviewer/js';
			pathToError = '/ixviewer/';
		}
		if (browserAccepted) {

			// css
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/custom-bootstrap.css>');
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/lib/fontawesome/css/all.min.css>');
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/app.css>');

			// js
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/jquery-3.3.1.slim.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/popper.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/bootstrap.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/moment.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/vanilla-picker.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/he.js"><\/script>');

			var date = new Date();
			var todaysDate = date.getDate() + '-' + (date.getMonth() + 1) + '-'
					+ date.getFullYear();
			document.write('<script type = "text/javascript" defer=true src="'
					+ pathToLibs + '/production.min.js?d=' + todaysDate
					+ '"><\/script>');
		} else {
			// user us on a browser that we do not support
			var currentUrl = window.location.href.split('?')[0];
			var browserError = currentUrl.substring(0, currentUrl
					.lastIndexOf('/'));
			browserError += pathToError + 'browser-error.html?url='
					+ encodeURIComponent(window.location.href);
			window.location.href = browserError;
		}
	})();
</script><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/css/custom-bootstrap.css"><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/lib/fontawesome/css/all.min.css"><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/css/app.css"><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/jquery-3.3.1.slim.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/popper.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/bootstrap.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/moment.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/vanilla-picker.min.js"></script><style>.picker_wrapper.no_alpha .picker_alpha{display:none}.picker_wrapper.no_editor .picker_editor{position:absolute;z-index:-1;opacity:0}.picker_wrapper.no_cancel .picker_cancel{display:none}.layout_default.picker_wrapper{display:-webkit-box;display:flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;flex-flow:row wrap;-webkit-box-pack:justify;justify-content:space-between;-webkit-box-align:stretch;align-items:stretch;font-size:10px;width:25em;padding:.5em}.layout_default.picker_wrapper input,.layout_default.picker_wrapper button{font-size:1rem}.layout_default.picker_wrapper>*{margin:.5em}.layout_default.picker_wrapper::before{content:'';display:block;width:100%;height:0;-webkit-box-ordinal-group:2;order:1}.layout_default .picker_slider,.layout_default .picker_selector{padding:1em}.layout_default .picker_hue{width:100%}.layout_default .picker_sl{-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_sl::before{content:'';display:block;padding-bottom:100%}.layout_default .picker_editor{-webkit-box-ordinal-group:2;order:1;width:6.5rem}.layout_default .picker_editor input{width:100%;height:100%}.layout_default .picker_sample{-webkit-box-ordinal-group:2;order:1;-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_done,.layout_default .picker_cancel{-webkit-box-ordinal-group:2;order:1}.picker_wrapper{box-sizing:border-box;background:#f2f2f2;box-shadow:0 0 0 1px silver;cursor:default;font-family:sans-serif;color:#444;pointer-events:auto}.picker_wrapper:focus{outline:none}.picker_wrapper button,.picker_wrapper input{box-sizing:border-box;border:none;box-shadow:0 0 0 1px silver;outline:none}.picker_wrapper button:focus,.picker_wrapper button:active,.picker_wrapper input:focus,.picker_wrapper input:active{box-shadow:0 0 2px 1px dodgerblue}.picker_wrapper button{padding:.4em .6em;cursor:pointer;background-color:whitesmoke;background-image:-webkit-gradient(linear, left bottom, left top, from(gainsboro), to(transparent));background-image:-webkit-linear-gradient(bottom, gainsboro, transparent);background-image:linear-gradient(0deg, gainsboro, transparent)}.picker_wrapper button:active{background-image:-webkit-gradient(linear, left bottom, left top, from(transparent), to(gainsboro));background-image:-webkit-linear-gradient(bottom, transparent, gainsboro);background-image:linear-gradient(0deg, transparent, gainsboro)}.picker_wrapper button:hover{background-color:white}.picker_selector{position:absolute;z-index:1;display:block;-webkit-transform:translate(-50%, -50%);transform:translate(-50%, -50%);border:2px solid white;border-radius:100%;box-shadow:0 0 3px 1px #67b9ff;background:currentColor;cursor:pointer}.picker_slider .picker_selector{border-radius:2px}.picker_hue{position:relative;background-image:-webkit-gradient(linear, left top, right top, from(red), color-stop(yellow), color-stop(lime), color-stop(cyan), color-stop(blue), color-stop(magenta), to(red));background-image:-webkit-linear-gradient(left, red, yellow, lime, cyan, blue, magenta, red);background-image:linear-gradient(90deg, red, yellow, lime, cyan, blue, magenta, red);box-shadow:0 0 0 1px silver}.picker_sl{position:relative;box-shadow:0 0 0 1px silver;background-image:-webkit-gradient(linear, left top, left bottom, from(white), color-stop(50%, rgba(255,255,255,0))),-webkit-gradient(linear, left bottom, left top, from(black), color-stop(50%, rgba(0,0,0,0))),-webkit-gradient(linear, left top, right top, from(gray), to(rgba(128,128,128,0)));background-image:-webkit-linear-gradient(top, white, rgba(255,255,255,0) 50%),-webkit-linear-gradient(bottom, black, rgba(0,0,0,0) 50%),-webkit-linear-gradient(left, gray, rgba(128,128,128,0));background-image:linear-gradient(180deg, white, rgba(255,255,255,0) 50%),linear-gradient(0deg, black, rgba(0,0,0,0) 50%),linear-gradient(90deg, gray, rgba(128,128,128,0))}.picker_alpha,.picker_sample{position:relative;background:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E") left top/contain white;box-shadow:0 0 0 1px silver}.picker_alpha .picker_selector,.picker_sample .picker_selector{background:none}.picker_editor input{font-family:monospace;padding:.2em .4em}.picker_sample::before{content:'';position:absolute;display:block;width:100%;height:100%;background:currentColor}.picker_arrow{position:absolute;z-index:-1}.picker_wrapper.popup{position:absolute;z-index:2;margin:1.5em}.picker_wrapper.popup,.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{background:#f2f2f2;box-shadow:0 0 10px 1px rgba(0,0,0,0.4)}.picker_wrapper.popup .picker_arrow{width:3em;height:3em;margin:0}.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{content:"";display:block;position:absolute;top:0;left:0;z-index:-99}.picker_wrapper.popup .picker_arrow::before{width:100%;height:100%;-webkit-transform:skew(45deg);transform:skew(45deg);-webkit-transform-origin:0 100%;transform-origin:0 100%}.picker_wrapper.popup .picker_arrow::after{width:150%;height:150%;box-shadow:none}.popup.popup_top{bottom:100%;left:0}.popup.popup_top .picker_arrow{bottom:0;left:0;-webkit-transform:rotate(-90deg);transform:rotate(-90deg)}.popup.popup_bottom{top:100%;left:0}.popup.popup_bottom .picker_arrow{top:0;left:0;-webkit-transform:rotate(90deg) scale(1, -1);transform:rotate(90deg) scale(1, -1)}.popup.popup_left{top:0;right:100%}.popup.popup_left .picker_arrow{top:0;right:0;-webkit-transform:scale(-1, 1);transform:scale(-1, 1)}.popup.popup_right{top:0;left:100%}.popup.popup_right .picker_arrow{top:0;left:0}</style><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/he.js"></script><script type="text/javascript" defer="true" src="https://www.sec.gov/ixviewer/js/production.min.js?d=20-4-2022"></script>
<title>Inline XBRL Viewer</title>
<style type="text/css" id="customized-styles"> #dynamic-xbrl-form [enabled-taxonomy="true"][continued-taxonomy="false"]{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;display:inline;} #dynamic-xbrl-form [enabled-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;} #dynamic-xbrl-form [enabled-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;border-top:none;border-bottom:none;} #dynamic-xbrl-form [highlight-taxonomy="true"]{background-color:#FFD700 !important;} #dynamic-xbrl-form [highlight-taxonomy="true"] > *{background-color:#FFD700 !important;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-taxonomy="false"]{border:3px solid #003768 !important;display:inline;} #dynamic-xbrl-form [hover-taxonomy="true"]{background-color:rgba(255,0,0,0.3);} .tagged-data-example-1{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;} .search-results-example-1{background-color:#FFD700;} .tag-shading-exmple-1:hover{background-color:rgba(255,0,0,0.3);} .selected-fact-example-1{border:3px solid #003768 !important;}</style></head>
<body style="overflow:auto">
<!--?xml version="1.0" encoding="utf-8"?-->


     <title></title>
<meta http-equiv="Content-Type" content="text/html">

<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_alsa_alsa_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20210311_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001865111 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_073_XDX_alphastaracq__10k.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->

<div style="display: none">
<ix:header>
 <ix:hidden>
  <span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityCentralIndexKey" inside-table="false" id="fact-identifier-0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">0001865111</ix:nonnumeric></span>
  <span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag" inside-table="false" id="fact-identifier-1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">false</ix:nonnumeric></span>
  <span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:DocumentFiscalYearFocus" inside-table="false" id="fact-identifier-2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">2021</ix:nonnumeric></span>
  <span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:DocumentFiscalPeriodFocus" inside-table="false" id="fact-identifier-3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">FY</ix:nonnumeric></span>
  <ix:nonfraction id="xdx2ixbrl0105" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0125" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0137" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0138" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0139" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0140" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0142" unitref="Shares" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0146" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0153" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0158" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0160" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0163" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0165" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0170" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0177" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0182" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0184" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0192" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0193" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0198" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0246" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0513" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction id="xdx2ixbrl0515" unitref="USD" xs:nil="true"></ix:nonfraction>
  </ix:hidden>
 <ix:references>
  <link:schemaref xlink:href="alsa-20211231.xsd" xlink:type="simple">
  </link:schemaref></ix:references>
 <ix:resources>
    <xbrli:context id="From2021-03-11to2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_OrdinarySharesParValue0.001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">alsa:OrdinarySharesParValue0.001PerShareMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">alsa:RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">alsa:RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">alsa:UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-10_custom_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">alsa:OrdinarySharesMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-10_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-10_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">alsa:OrdinarySharesMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">alsa:OrdinarySharesMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-012021-12-15_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-12-01</xbrli:startdate>
        <xbrli:enddate>2021-12-15</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-012021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">alsa:UnderwritersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-12-01</xbrli:startdate>
        <xbrli:enddate>2021-12-15</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-15_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-012021-12-15_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-12-01</xbrli:startdate>
        <xbrli:enddate>2021-12-15</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-15_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_NonRedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">alsa:NonRedeemableSharesMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_RedeemableSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">alsa:RedeemableSharesMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">alsa:UnderwritersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-04-06_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">alsa:SponsorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-04-01</xbrli:startdate>
        <xbrli:enddate>2021-04-06</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-04-06_custom_FounderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">alsa:FounderMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-04-01</xbrli:startdate>
        <xbrli:enddate>2021-04-06</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">alsa:SponsorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-26_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">alsa:SponsorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">alsa:PublicWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">alsa:PublicWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">alsa:PrivateWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-12-31_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">alsa:PrivateWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-03-11</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_WarrantRedemptionExercisePricePercentageOneMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="alsa:WarrantRedemptionExercisePricePercentageAxis">alsa:WarrantRedemptionExercisePricePercentageOneMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">alsa:PublicWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_WarrantRedemptionExercisePricePercentageTwoMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="alsa:WarrantRedemptionExercisePricePercentageAxis">alsa:WarrantRedemptionExercisePricePercentageTwoMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">alsa:PublicWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865111</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitnumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitnumerator>
        <xbrli:unitdenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitdenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&nbsp;</div></div><!-- Field: /Rule-Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED



STATES</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES



AND EXCHANGE COMMISSION</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,



D.C. 20549</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM&nbsp;<span id="xdx_90C_edei--DocumentType_c20210311__20211231_z0wz30mFR58f"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:DocumentType" inside-table="false" id="fact-identifier-4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10-K</ix:nonnumeric></span></span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--DocumentAnnualReport_c20210311__20211231_ziwroWZzlKAh"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport" inside-table="false" id="fact-identifier-5" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☒</ix:nonnumeric></span></span> <b>ANNUAL



REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For



the fiscal year ended <span id="xdx_909_edei--DocumentPeriodEndDate_c20210311__20211231_zAW9rbiZYvC3"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" inside-table="false" id="fact-identifier-6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span id="xdx_90D_edei--CurrentFiscalYearEndDate_c20210311__20211231_zeKeGfmJeAe"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" inside-table="false" id="fact-identifier-7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">December 31</ix:nonnumeric></span></span>, 2021</ix:nonnumeric></span></span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--DocumentTransitionReport_c20210311__20211231_zOMsiWyXujch"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport" inside-table="false" id="fact-identifier-8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☐</ix:nonnumeric></span></span> <b>TRANSITION



REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For



the transition period from __________ to __________</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission



File No.&nbsp;<span id="xdx_907_edei--EntityFileNumber_c20210311__20211231_zBpXflRVbPp8"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityFileNumber" inside-table="false" id="fact-identifier-9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">001-41153</ix:nonnumeric></span></span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityRegistrantName_c20210311__20211231_zSVWzwDU49x4"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityRegistrantName" inside-table="false" id="fact-identifier-10" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">ALPHA STAR ACQUISITION CORPORATION</ix:nonnumeric></span></span></span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact



Name of Registrant as Specified in Its Charter)</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20210311__20211231_zQwo4V3wkTj9"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" inside-table="true" id="fact-identifier-11" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Cayman Islands</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>n/a

    <span id="xdx_901_edei--EntityTaxIdentificationNumber_c20210311__20211231_z6nuPLDXjtIh" style="display: none"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityTaxIdentificationNumber" inside-table="true" id="fact-identifier-12" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">00-0000000</ix:nonnumeric></span></span></b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State



    or other jurisdiction of<br>



    incorporation or organization)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.



    Employer<br>



    Identification No.)</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20210311__20211231_zqodEoB2Xlw5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityAddressAddressLine1" inside-table="false" id="fact-identifier-13" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">80 Broad Street</ix:nonnumeric></span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20210311__20211231_zLdAklqXqTO2"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityAddressAddressLine2" inside-table="false" id="fact-identifier-14" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">5<sup>th </sup>Floor</ix:nonnumeric></span></span></span></b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br>

<span id="xdx_90E_edei--EntityAddressCityOrTown_c20210311__20211231_zxImrE1eMfLg"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityAddressCityOrTown" inside-table="false" id="fact-identifier-15" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">New York</ix:nonnumeric></span></span></span></b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,

<span id="xdx_903_edei--EntityAddressStateOrProvince_c20210311__20211231_zQMHwLg0hTD6"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityAddressStateOrProvince" inside-table="false" id="fact-identifier-16" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">NY</ix:nonnumeric></span></span></span></b><b> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20210311__20211231_zyhWOUyvCnt1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityAddressPostalZipCode" inside-table="false" id="fact-identifier-17" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10004</ix:nonnumeric></span></span></b></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address



of principal executive offices) (Zip Code)</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issuer’s



telephone number, including area code (<span id="xdx_901_edei--CityAreaCode_c20210311__20211231_zpAF4hcEmTM5"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:CityAreaCode" inside-table="false" id="fact-identifier-18" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">212</ix:nonnumeric></span></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20210311__20211231_zRCP4ftEhYJ9"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:LocalPhoneNumber" inside-table="false" id="fact-identifier-19" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">837 7977</ix:nonnumeric></span></span></span></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities



registered pursuant to Section&nbsp;12(b)&nbsp;of the Exchange Act</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title



    of Each Class</b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading



    Symbol</b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name



    of Each Exchange on&nbsp;Which&nbsp;Registered</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--Security12bTitle_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesParValue0.001PerShareMember_zXUUSMhyzHvk"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_OrdinarySharesParValue0.001PerShareMember" name="dei:Security12bTitle" inside-table="true" id="fact-identifier-20" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Ordinary



    Shares, Par Value $0.001 Per Share</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--TradingSymbol_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesParValue0.001PerShareMember_zd1VdS0CiIB5"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_OrdinarySharesParValue0.001PerShareMember" name="dei:TradingSymbol" inside-table="true" id="fact-identifier-21" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">ALSA</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The



    <span id="xdx_90D_edei--SecurityExchangeName_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesParValue0.001PerShareMember_zMmorWgJrFu"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_OrdinarySharesParValue0.001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" inside-table="true" id="fact-identifier-22" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Nasdaq</ix:nonnumeric></span></span> Stock Market, LLC</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--Security12bTitle_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember_z7HYqT8N7fB1"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember" name="dei:Security12bTitle" inside-table="true" id="fact-identifier-23" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Rights



    Entitling the Holder to Receive One-Seventh (1/7) of one Ordinary Share</ix:nonnumeric></span></span> </b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--TradingSymbol_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember_z8aodCA2EsM5"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember" name="dei:TradingSymbol" inside-table="true" id="fact-identifier-24" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">ALSAR</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The <span id="xdx_905_edei--SecurityExchangeName_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember_z33xH9ANVqo2"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_RightsEntitlingTheHolderToReceiveOneSeventh17OfOneOrdinaryShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" inside-table="true" id="fact-identifier-25" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Nasdaq</ix:nonnumeric></span></span> Stock Market, LLC</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--Security12bTitle_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember_zoXDkOcggkmh"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember" name="dei:Security12bTitle" inside-table="true" id="fact-identifier-26" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Redeemable Warrant Entitling the Holder to Purchase One-half (1/2) of One Ordinary Share</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--TradingSymbol_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember_ziWvC8FXA9T9"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember" name="dei:TradingSymbol" inside-table="true" id="fact-identifier-27" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">ALSAW</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The



    <span id="xdx_901_edei--SecurityExchangeName_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember_zP9xZoUmWAB4"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_RedeemableWarrantEntitlingTheHolderToPurchaseOneHalf12OfOneOrdinaryShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" inside-table="true" id="fact-identifier-28" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Nasdaq</ix:nonnumeric></span></span> Stock Market, LLC</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--Security12bTitle_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember_zNOfO4BP7bVg"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember" name="dei:Security12bTitle" inside-table="true" id="fact-identifier-29" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Units,



    Each Consisting of One Ordinary Share, One Right and One Warrant</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--TradingSymbol_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember_zPB53Ms2IYj6"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember" name="dei:TradingSymbol" inside-table="true" id="fact-identifier-30" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">ALSAU</ix:nonnumeric></span></span></b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The



    <span id="xdx_904_edei--SecurityExchangeName_c20210311__20211231__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember_zpoLtNT6Ub43"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" inside-table="true" id="fact-identifier-31" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Nasdaq</ix:nonnumeric></span></span> Stock Market, LLC</b></span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities



registered pursuant to Section&nbsp;12(g)&nbsp;of the Securities Exchange Act: NONE</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&nbsp;405 of the Securities Act.&nbsp;Yes



☐&nbsp;&nbsp;&nbsp;<span id="xdx_90F_edei--EntityWellKnownSeasonedIssuer_c20210311__20211231_ztaUXe1rweA"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer" inside-table="false" id="fact-identifier-32" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">No</ix:nonnumeric></span></span> ☒</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or 15 (d)&nbsp;of the Securities Exchange



Act.&nbsp;Yes&nbsp;☐&nbsp;&nbsp;&nbsp;<span id="xdx_907_edei--EntityVoluntaryFilers_c20210311__20211231_zeizkK22SHZ3"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityVoluntaryFilers" inside-table="false" id="fact-identifier-33" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">No</ix:nonnumeric></span></span>&nbsp;☒</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d)&nbsp;of the Securities



Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has



been subject to such filing requirements for the past 90 days.&nbsp;<span id="xdx_909_edei--EntityCurrentReportingStatus_c20210311__20211231_zcQjyRgMbfr4"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityCurrentReportingStatus" inside-table="false" id="fact-identifier-34" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Yes</ix:nonnumeric></span></span> ☒&nbsp;&nbsp;&nbsp;No ☐</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted&nbsp;pursuant



to Rule&nbsp;405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the



registrant was required to submit such files).&nbsp;<span id="xdx_90F_edei--EntityInteractiveDataCurrent_c20210311__20211231_zJamI3lQQY55"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:EntityInteractiveDataCurrent" inside-table="false" id="fact-identifier-35" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Yes</ix:nonnumeric></span></span> ☒&nbsp;&nbsp;&nbsp;No ☐</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (ss.229.405 of this chapter) is not contained



herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated



by reference in Part&nbsp;III of this Form&nbsp;10-K or any amendment to this Form&nbsp;10-K.&nbsp;<span id="xdx_90F_edei--IcfrAuditorAttestationFlag_c20210311__20211231_zjqmB1nhnEFc"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleanfalse" name="dei:IcfrAuditorAttestationFlag" inside-table="false" id="fact-identifier-36" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☐</ix:nonnumeric></span></span></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting



company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”



“smaller reporting company,” and “emerging growth company” in Rule&nbsp;12b-2 of the Exchange Act. (Check one):</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif">



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 10%"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">☐</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 10%; text-align: justify"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">☐</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 18%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityFilerCategory_c20210311__20211231_zPVla2z6YwBk"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" inside-table="true" id="fact-identifier-37" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Non-accelerated filer</ix:nonnumeric></span></span> </span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 10%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">☒</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 14%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntitySmallBusiness_c20210311__20211231_z5X8RX538E12"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness" inside-table="true" id="fact-identifier-38" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☒</ix:nonnumeric></span></span></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif">



    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20210311__20211231_zbtPLduZ45bi"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany" inside-table="true" id="fact-identifier-39" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☒</ix:nonnumeric></span></span></span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying



with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a)&nbsp;of the Exchange Act. <span id="xdx_90D_edei--EntityExTransitionPeriod_c20210311__20211231_zyWzlzaNJHFh"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod" inside-table="false" id="fact-identifier-40" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☐</ix:nonnumeric></span></span></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of the Exchange Act). <span id="xdx_902_edei--EntityShellCompany_c20210311__20211231_zEWwLLzRwkff"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" format="ixt:booleantrue" name="dei:EntityShellCompany" inside-table="false" id="fact-identifier-41" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Yes</ix:nonnumeric></span></span>



☒&nbsp;&nbsp;&nbsp;No ☐</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



of December&nbsp;31, 2021, the aggregate market value of the shares of common stock (ordinary shares) of the registrant held by non-affiliates



of the registrant (11,500,000 ordinary shares) was $ <span id="xdx_905_edei--EntityPublicFloat_iI_c20211231_zKNm5rpvxeQ4"><span><ix:nonfraction name="dei:EntityPublicFloat" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-42" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">113,045,000</ix:nonfraction></span> </span>(based upon a per share closing price of $9.83).</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPLICABLE



ONLY TO CORPORATE REGISTRANTS</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate



the number of shares outstanding of each of the registrant’s classes of common stock (ordinary shares), as of the latest practicable



date: On March 18, 2022, there were <span id="xdx_90A_edei--EntityCommonStockSharesOutstanding_iI_c20220318_zCHSDGWBbMyf"><span><ix:nonfraction name="dei:EntityCommonStockSharesOutstanding" contextref="AsOf2022-03-18" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-43" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">14,675,000</ix:nonfraction></span></span> ordinary shares outstanding of the registrant.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS



INCORPORATED BY REFERENCE</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<div id="xdx_986_edei--DocumentsIncorporatedByReferenceTextBlock_c20210311__20211231_z1QADVftJiJd"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="dei:DocumentsIncorporatedByReferenceTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-44" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">List



hereunder the following documents if incorporated by reference and the Part&nbsp;of the Form&nbsp;10-K (e.g., Part&nbsp;I, Part&nbsp;II,&nbsp;etc.)



into which the document is incorporated:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>



</ix:nonnumeric></span></div>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&nbsp;</div></div><!-- Field: /Rule-Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>















<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>















<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">TABLE



OF CONTENTS</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td>&nbsp;</td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAGE</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: center"><a href="#aaxa_001" tabindex="18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART&nbsp;I</b></span></a></td>



    <td style="width: 1%">&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center">1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001" tabindex="18">Item 1. Business</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002" tabindex="18">Item 1A. Risk Factors</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003" tabindex="18">Item 1B. Unresolved Staff Comments</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004" tabindex="18">Item 2. Properties</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005" tabindex="18">Item 3. Legal Proceedings</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006" tabindex="18">Item 4. Submission of Matters to a Vote of Security Holders</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#a_007" tabindex="18">PART&nbsp;II</a></b></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008" tabindex="18">Item 5. Market for the Registrant’s Common Equity, and Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009" tabindex="18">Item 6. Reserved</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010" tabindex="18">Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011" tabindex="18">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012" tabindex="18">Item 8. Financial Statements and Supplementary Data</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013" tabindex="18">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014" tabindex="18">Item 9A. Controls and Procedures</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015" tabindex="18">Item 9B. Other Information</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">

    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><a href="#item9c" tabindex="18">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></p></td>

    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>

    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">45</td></tr>

  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#a_016" tabindex="18">PART&nbsp;III</a></b></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017" tabindex="18">Item 10. Directors and Executive Officers of the Registrant</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018" tabindex="18">Item 11. Executive Compensation</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019" tabindex="18">Item 12. Security Ownership of Certain Beneficial Owners and Management</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020" tabindex="18">Item 13. Certain Relationships and Related Transactions</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021" tabindex="18">Item 14. Principal Accountant Fees and Services</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#a_022" tabindex="18">PART&nbsp;IV</a></b></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023" tabindex="18">Item 15. Exhibits and Financial Statement Schedules</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>



    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#a_024" tabindex="18">Item 16. Form 10-K Summary</a></td>

    <td>&nbsp;</td>

    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">53</td></tr>

</tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</p>















<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORWARD



LOOKING STATEMENTS</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This



Annual Report on Form&nbsp;10-K contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933,



or the “Securities Act,” and Section&nbsp;21E of the Securities Exchange Act of 1934, or the Exchange Act. The statements



contained in this report that are not purely historical are forward-looking statements. Our forward-looking statements include, but are



not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the



future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances,



including any underlying assumptions, are forward-looking statements. The words “anticipates,” “believe,” “continue,”



“could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,”



“possible,” “potential,” “predicts,” “project,” “should,” “would”



and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not



forward-looking. Forward-looking statements in this Form&nbsp;10-K may include, for example, statements about our:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ability



to complete our initial business combination;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">success



in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">officers



and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving



our initial business combination, as a result of which they would then receive expense reimbursements;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential



ability to obtain additional financing to complete a business combination;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pool



of prospective target businesses;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ability



of our officers and directors to generate a number of potential investment opportunities;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential



change in control if we acquire one or more target businesses for shares or other forms of equity;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">public



securities’ potential liquidity and trading;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the



lack of a market for our securities;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expectations



regarding the time during which we will be an “emerging growth company” under the JOBS Act;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">use



of proceeds not held in the trust account or available to us from interest income on the trust account balance; or</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial



performance following our business combination, if we compete a business combination.</span></td>



</tr></tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



forward-looking statements contained in this Form&nbsp;10-K are based on our current expectations and beliefs concerning future developments



and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated.



These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions



that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.



Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may



vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any



forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable



securities laws.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 3; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aaxa_001"></span>PART
I</b>&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>Item



1. BUSINESS</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Company



Profile</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Alpha



Star Acquisition Corporation is a blank check company incorporated on March 11, 2021 as a Cayman Islands exempted company and incorporated



for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination



with one or more businesses.</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on December 13,



2021. We completed our initial public offering on December 15, 2021. In our initial public offering, we sold units at an offering price



of $10.00 and consisting of one ordinary share, one right to receive one-seventh (1/7) of an ordinary share upon the consummation of



an initial business combination and one redeemable warrant. Each warrant entitles the holder thereof to purchase one-half of one ordinary



share.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



connection with our initial public offering, we sold 11,500,000 units, generating gross proceeds of $115,000,000. Simultaneously with



the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement by and between the Company and our sponsor, A-Star



Management Corporation, a British Virgin Islands company, the Company completed the private sale of an aggregate of 330,000 units (the



“<span style="text-decoration: underline">Private Placement Units</span>”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross



proceeds to the Company of $3,300,000. The Private Placement Units are identical to the Units in the IPO, except that the Sponsor has



agreed not to transfer, assign or sell any of the Private Placement Units (except to certain permitted transferees) until 30 days after



the completion of the Company’s initial business combination. No underwriting discounts or commissions were paid with respect to



such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section&nbsp;4(a)(2)&nbsp;of



the Securities Act of 1933, as amended.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction



costs amounted to $5,669,696, consisting of $2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees and $494,696 of



other offering costs. A total of $115,000,000, comprised of $112,700,000 of the proceeds from the IPO (which amount includes up to $2,875,000



of the underwriter’s deferred discount) and $2,300,000 of the proceeds of the sale of the Private Placement Units, was placed in



a U.S.-based trust account, established by VStock Transfer LLC, our transfer agent and maintained at Wilmington Trust, National Association,



acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay



its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i)&nbsp;the completion



of the Company’s initial business combination, (ii)&nbsp;the redemption of any of the Company’s public shares properly tendered



in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A)&nbsp;modify



the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business



combination within 9 months from the closing of the IPO (or up to 21 months from the closing of the IPO if we extend the period of time



to consummate a business combination), or (B)&nbsp;with respect to any other provision relating to shareholders’ rights or pre-business



combination activity, and (iii)&nbsp;the redemption of the Company’s public shares if it is unable to complete its initial business



combination within 9 months from the closing of the IPO (or up to 21 months from the closing of the IPO if we extend the period of time



to consummate a business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At

December&nbsp;31, 2021, the Company had working capital of $477,051, which exclude amount of $115,000,744 for marketable security

held in trust account in current asset, and amount of $2,875,000 for deferred underwriting commission in current

liability.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company’s units are listed on The Nasdaq Global Market (“Nasdaq”) and commenced trading under the ticker symbol “ALSAU”



on December 13, 2021. Each unit consists of one ordinary share, one right to receive one-seventh (1/7) of an ordinary share upon the



consummation of an initial business combination, and one redeemable warrant. Each warrant entitles the holder thereof to purchase one-half



of one ordinary share of the Company at a price of $11.50 per whole share. The units began separate trading on January 18, 2022



and the ordinary shares, rights and warrants commenced trading on Nasdaq under the symbols “ALSA,” “ALSAR,” and



“ALSAW,” respectively.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since



our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates and engaging in non-binding



discussions with potential target entities. To date we have not entered into any binding agreement with any target entity. We presently



have no revenue and have had losses since inception from incurring formation and operating costs since completion of our IPO.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acquisition



Strategy and Management Business Combination Experience</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



efforts in identifying prospective target businesses will not be limited to a particular geographic region, although we intend to focus



on businesses that have a connection to the Asian market. However, we shall not consider or undertake a business combination with an



entity or business with its principal or a majority of its business operations (either directly or through any subsidiaries) in the People’s



Republic of China (including Hong Kong and Macau). We believe that we will add value to these businesses primarily by providing them



with access to the U.S. capital markets.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will seek to capitalize on the strength of our management team. Our team consists of experienced professionals and senior operating executives.



Collectively, our officers and directors have decades of experience in mergers and acquisitions, and operating companies. We believe



we will benefit from their accomplishments, and specifically their current and recent activities with companies that have a connection



to the Asian market, in identifying attractive acquisition opportunities. However, there is no assurance that we will complete a business



combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment



Criteria</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



management team intends to focus on creating shareholder value by leveraging its experience in the management, operation and financing



of businesses to improve the efficiency of operations while implementing strategies to scale revenue organically and/or through acquisitions.



We have identified the following general criteria and guidelines, which we believe are important in evaluating prospective target businesses.



While we intend to use these criteria and guidelines in evaluating prospective businesses, we may deviate from these criteria and guidelines



should we see justification to do so.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Middle-Market



Growth Business. </i></b>We will primarily seek to acquire one or more growth businesses with a total enterprise value of between $300,000,000



and $600,000,000. We believe that there are a substantial number of potential target businesses within this valuation range that can



benefit from new capital for scalable operations to yield significant revenue and earnings growth. We currently do not intend to acquire



either a start-up company (a company that has not yet established commercial operations) or a company with negative cash flow.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Companies



in Business Segments that are Strategically Significant to the Asian Markets. </i></b>We will seek to acquire those businesses that are



currently strategically significant in the Asian markets. Such sectors include clean energy, internet and high technology, financial



technology, health care, consumer and retail, energy and resources, manufacturing and education.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business



with Revenue and Earnings Growth Potential. </i></b>We will seek to acquire one or more businesses that have the potential for significant



revenue and earnings growth through a combination of both existing and new product development, increased production capacity, expense



reduction and synergistic follow-on acquisitions resulting in increased operating leverage.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>●</i></b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Companies



with Potential for Strong Free Cash Flow Generation. </i></b>We will seek to acquire one or more businesses that have the potential to



generate strong, stable and increasing free cash flow. We intend to focus on one or more businesses that have predictable revenue streams



and definable low working capital and capital expenditure requirements. We may also seek to prudently leverage this cash flow in order



to enhance shareholder value.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>●</i></b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Benefit



from Being a Public Company. </i></b>We intend to only acquire a business or businesses that will benefit from being publicly traded



and which can effectively utilize access to broader sources of capital and a public profile that are associated with being a publicly



traded company.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These



criteria are not intended to be exhaustive or exclusive. Any evaluation relating to the merits of a particular business combination may



be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our sponsor



and management team may deem relevant. In the event that we decide to enter into an business combination with a target business that



does not meet the above criteria and guidelines, we will disclose that the target business does not meet the above criteria in our shareholder



communications related to our business combination, which, as discussed in this prospectus, would be in the form of proxy solicitation



or tender offer materials, as applicable, that we would file with the United States Securities and Exchange Commission, or the SEC. In



evaluating a prospective target business, we expect to conduct a due diligence review which may encompass, among other things, meetings



with incumbent ownership, management and employees, document reviews, interviews of customers and suppliers, inspections of facilities,



as well as reviewing financial and other information which will be made available to us.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



management team continues to actively source target candidates where they believe will be attractive candidates for acquisition, utilizing



their deal-making track record, professional relationships, and capital markets expertise to enhance the growth potential and value of



a target business and provide opportunities for an attractive return to our stockholders.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 5; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sourcing



of Potential Business Combination Targets</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



management team has developed a broad network of contacts and corporate relationships. We believe that the network of contacts and relationships



of our management team and our sponsor will provide us with an important source of business combination opportunities. In addition, we



anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment banking



firms, private equity firms, consultants, accounting firms and business enterprises. We are not prohibited from pursuing an initial business



combination with a company that is affiliated with our sponsor, officers or directors, or completing the business combination through



a joint venture or other form of shared ownership with our sponsor, officers or directors.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity



to which he or she has then-existing fiduciary or contractual obligations, he or she may be required to present such business combination



opportunity to such entity prior to presenting such business combination opportunity to us.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless



we complete our initial business combination with an affiliated entity, or our Board of Directors cannot independently determine the



fair market value of the target business or businesses, we are not required to obtain an opinion from an independent investment banking



firm, another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or from an



independent accounting firm that the price we are paying for a target is fair to our company from a financial point of view. If no opinion



is obtained, our shareholders will be relying on the business judgment of our Board of Directors, which will have significant discretion



in choosing the standard used to establish the fair market value of the target or targets, and different methods of valuation may vary



greatly in outcome from one another. Such standards used will be disclosed in our tender offer documents or proxy solicitation materials,



as applicable, related to our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members



of our management team may directly or indirectly own our ordinary shares and/or private placement units following our initial public



offering, and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business



with which to effectuate our initial business combination. Further, each of our officers and directors may have a conflict of interest



with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included



by a target business as a condition to any agreement with respect to our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each



of our directors and officers presently has, and in the future any of our directors and our officers may have additional, fiduciary or



contractual obligations to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities



to such entity. Accordingly, subject to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes



aware of an acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations,



he or she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such entity,



and only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association will



provide that, subject to his or her fiduciary duties under Cayman Islands law, we renounce our interest in any corporate opportunity



offered to any officer or director unless such opportunity is expressly offered to such person solely in his or her capacity as a director



or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be



reasonable for us to pursue. We do not believe, however, that any fiduciary duties or contractual obligations of our directors or officers



would materially undermine our ability to complete our business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



officers and directors are not prohibited from becoming an officer or director of another special purpose acquisition company with a



class of securities registered under the Securities Exchange Act of 1934, as amended.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 6; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In

identifying, evaluating and selecting a target business for our initial business combination, we may encounter intense competition

from other entities having a business objective similar to ours, including other blank check companies, private equity groups and

leveraged buyout funds, and operating businesses seeking strategic acquisitions. Many of these entities are well established and

have extensive experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these

competitors possess greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses

will be limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition

of a target business. Furthermore, our obligation to pay cash in connection with our public shareholders who exercise their

redemption rights may reduce the resources available to us for our initial business combination and our outstanding rights and

warrants, and the future dilution they potentially represent, may not be viewed favorably by certain target businesses. Either of

these factors may place us at a competitive disadvantage in successfully negotiating an initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



believe our structure will make us an attractive business combination partner to target businesses. As an existing public company, we



offer a target business an alternative to the traditional initial public offering through a merger or other business combination. In



this situation, the owners of the target business would exchange their shares of stock in the target business for our shares or for a



combination of our shares and cash, allowing us to tailor the consideration to the specific needs of the sellers. Although there are



various costs and obligations associated with being a public company, we believe target businesses will find this method a more certain



and cost effective method to becoming a public company than the typical initial public offering. In a typical initial public offering,



there are additional expenses incurred in marketing, road show and public reporting efforts that may not be present to the same extent



in connection with a business combination with us.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,



once a proposed business combination is completed, the target business will have effectively become public, whereas an initial public



offering is always subject to the underwriters’ ability to complete the offering, as well as general market conditions, which could



delay or prevent the offering from occurring. Once public, we believe the target business would then have greater access to capital and



an additional means of providing management incentives consistent with shareholders’ interests. It can offer further benefits by



augmenting a company’s profile among potential new customers and vendors and aid in attracting talented employees.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While



we believe that our structure and our management team’s backgrounds will make us an attractive business partner, some potential



target businesses may have a negative view of us since we are a blank check company, without an operating history, and there is uncertainty



relating to our ability to obtain shareholder approval of our proposed initial business combination and retain sufficient funds in our



trust account in connection therewith.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial



Business Combination Timeframe and Nasdaq Rules</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will have until 9 months from December 15, 2021 (the closing of our IPO) to consummate our initial business combination. However, if we



anticipate that we may not be able to consummate our initial business combination within 9 months, we may, by resolution of our board



if requested by our sponsor, extend the period of time to consummate a business combination up to twelve times, each by an additional month



(for a total of up to 21 months to complete a business combination), subject to the sponsor depositing additional funds into the trust



account as set out below. Pursuant to the terms of our memorandum and articles of association and the trust agreement entered into between



us and Wilmington Trust, National Association and Vstock Transfer LLC in connection with our IPO, in order for the time available for



us to consummate our initial business combination to be extended, our sponsor or its affiliates or designees, upon five days advance



notice prior to the applicable deadline, must deposit into the trust account $383,332, ($0.033 per public share), up to an aggregate



of $4,600,000, or $0.40 per public share, on or prior to the date of the applicable deadline, for each monthly extension. In the event



that we receive notice from our sponsor five days prior to the applicable deadline of its wish for us to effect an extension, we intend



to issue a press release announcing such intention at least three days prior to the applicable deadline. In addition, we intend to issue



a press release the day after the applicable deadline announcing whether or not the funds had been timely deposited. Our sponsor and



its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination.



If we are unable to consummate our initial business combination within the applicable time period, we will, as promptly as reasonably



possible but not more than ten business days thereafter, redeem the public shares for a pro rata portion of the funds held in the trust



account and as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our



board of directors, dissolve and liquidate, subject in each case to our obligations under Cayman Islands law to provide for claims of



creditors and the requirements of other applicable law. In such event, the rights and warrants will be worthless.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 7; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



NASDAQ rules&nbsp;require that our initial business combination must be with one or more target businesses that together have an aggregate



fair market value equal to at least 80% of the balance in the trust account (less any deferred underwriting commissions and taxes payable



on interest earned) at the time of our signing a definitive agreement in connection with our initial business combination. If our Board



of Directors is not able to independently determine the fair market value of the target business or businesses, we will obtain an opinion



from an independent investment banking firm or another independent firm that commonly renders valuation opinions for the type of company



we are seeking to acquire or an independent accounting firm. We do not intend to purchase multiple businesses in unrelated industries



in conjunction with our initial business combination. Additionally, pursuant to NASDAQ rules, any initial business combination must be



approved by a majority of our independent directors.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



anticipate structuring our initial business combination so that the post-transaction company in which our public shareholders own shares



will own or acquire 100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial



business combination such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target



business in order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete



such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target



or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company



under the Investment Company Act of 1940, as amended, or the Investment Company Act. Even if the post-transaction company owns or acquires



50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively own a minority



interest in the post-transaction company, depending on valuations ascribed to the target and us in the business combination transaction.



For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding



capital stock of a target. In this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance



of a substantial number of new shares, our shareholders immediately prior to our initial business combination could own less than a majority



of our outstanding shares subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target



business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned



or acquired is what will be valued for purposes of the 80% of net assets test. If our initial business combination involves more than



one target business, the 80% of net assets test will be based on the aggregate value of all of the target businesses.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary



Information Related to Our Securities, Redemption Rights and Liquidation</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are a Cayman Islands exempted company (company number 373150) and our affairs are governed by our amended and restated memorandum and



articles of association, the Companies Law and common law of the Cayman Islands. Pursuant to our amended and restated memorandum and



articles of association which will be adopted upon the consummation of our initial public offering, we will be authorized to issue 50,000,000



ordinary shares, $0.001 par value each. The information provided below is a summary only and we refer you to our prospectus dated as



of December 14, 2021, our amended and restated memorandum and articles of association and our warrant agreement with Vstock Transfer



LLC Company as warrant agent for additional important and material information.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



our initial public offering, we sold units at an offering price of $10.00 and consisting of one ordinary share, one right to receive



one-seventh (1/7) of an ordinary share upon the consummation of an initial business combination and one redeemable warrant. Each warrant



entitles the holder thereof to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise



of the warrants. As a result, a warrant holder must exercise warrants in multiples of two warrants, at a price of $11.50 per full share,



subject to adjustment. Each warrant will become exercisable on the later of the completion of an initial business combination and 9 months



from December 15, 2021 and will expire five years after the completion of an initial business combination, or earlier upon redemption.



Effective January 18, 2022, the component parts of the units began trading separately.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



of December 31, 2021, there were 14,705,000 ordinary shares issued and outstanding. Ordinary shareholders of record are entitled to one



vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law.



Unless specified in the Companies Law, our amended and restated memorandum and articles of association or applicable stock exchange rules,



the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter voted on by our shareholders.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 8; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



of December 31, 2021, there are warrants outstanding to acquire and aggregate of 5,750,000 ordinary shares. We will not be obligated



to deliver any ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless



a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a



prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration. No warrant



will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise



their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state



of the exercising holder, or an exemption is available. In the event that the conditions in the two immediately preceding sentences are



not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may



have no value and expire worthless. In the event that a registration statement is not effective for the exercised warrants, the purchaser



of a unit containing such warrant will have paid the full purchase price for the unit solely for the ordinary share underlying such unit.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Once the warrants become exercisable, we may call
the warrants for redemption (including the private placement warrants but including any outstanding warrants issued upon exercise of the
unit purchase option issued to the underwriters or their designees):</p>








<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in



whole and not in part;</span></td>



</tr></tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at



a price of $0.01 per warrant;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon



not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder;



and</span></td>



</tr></tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,



and only if, the reported last sale price of the ordinary shares equal or exceed $18.00 per share (as adjusted for share splits, share



capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading



day period ending on the third trading day prior to the date we send to the notice of redemption to the warrant holders.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will provide our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon the completion of



our initial business combination either (i)&nbsp;in connection with a shareholder meeting called to approve the business combination



or (ii)&nbsp;by means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed business combination



or conduct a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing



of the transaction, whether the terms of the transaction would require us to seek shareholder approval under the law or stock exchange



listing requirement or whether we were deemed to be a foreign private issuer (which would require that we conduct a tender offer under



SEC rules&nbsp;rather than seeking shareholder approval). Under NASDAQ rules, asset acquisitions and stock purchases would not typically



require shareholder approval while direct mergers with our company where we do not survive and any transactions where we issue more than



20% of our issued and outstanding ordinary shares (unless we are deemed to be a foreign private issuer at such time) or seek to amend



our amended and restated memorandum and articles of association would require shareholder approval. We intend to conduct redemptions



without a shareholder vote pursuant to the tender offer rules&nbsp;of the SEC unless shareholder approval is required by law or stock



exchange listing requirement or we choose to seek shareholder approval for business or other legal reasons. So long as we obtain and



maintain a listing for our securities on the NASDAQ, we will be required to comply with NASDAQ rules.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will provide our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon the completion of



our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account



as of two business days prior to the consummation of the initial business combination, including interest (which interest shall be net



of taxes payable) divided by the number of then issued and outstanding public shares, subject to the limitations described herein. The



amount in the trust account is initially anticipated to be approximately $10.00 per public share (subject to increase of up to an additional



$0.40 per public share in the event that our sponsor elects to extend the period of time to consummate a business combination). The per-share



amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions



we will pay to the underwriters. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which



they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and any public shares



they may hold in connection with the completion of our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 9; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



amended and restated memorandum and articles of association provides that in no event will we redeem our public shares in an amount that



would cause our net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of our initial business



combination (so that we are not subject to the SEC’s “penny stock” rules). Redemptions of our public shares may also



be subject to a higher net tangible asset test or cash requirement pursuant to an agreement relating to our initial business combination.



For example, the proposed business combination may require: (i)&nbsp;cash consideration to be paid to the target or its owners, (ii)&nbsp;cash



to be transferred to the target for working capital or other general corporate purposes or (iii)&nbsp;the retention of cash to satisfy



other conditions in accordance with the terms of the proposed business combination. In the event the aggregate cash consideration we



would be required to pay for all ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions



pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete



the business combination or redeem any shares, and all ordinary shares submitted for redemption will be returned to the holders thereof.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our

sponsor, officers and directors have agreed that we will have only 9 months from the closing of our initial public offering

(December 15, 2021) (or up to 21 months from the closing of our initial public offering if we extend the period of time to

consummate a business combination,) to complete our initial business combination. If we are unable to complete our initial business

combination within such 9-month (or up to 21-month) time period, we will: (i)&nbsp;cease all operations except for the purpose of

winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,

at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less

up to $50,000 of interest to pay dissolution expenses (which interest shall be net of taxes payable) divided by the number of then

issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders

(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)&nbsp;as promptly as

reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board of Directors,

liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the

requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our rights and

warrants, which will expire worthless if we fail to complete our initial business combination within the 9-month (or up to 21-

month) time period.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate



Information</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are an “emerging growth company,” as defined in Section&nbsp;2(a)&nbsp;of the Securities Act of 1933, as amended, or the



Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As such, we are eligible to take advantage



of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging



growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section&nbsp;404



of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our



periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation



and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive



as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



addition, Section&nbsp;107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended



transition period provided in Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act for complying with new or revised accounting standards.



In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards



would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will remain an emerging growth company until the earlier of (1)&nbsp;the last day of the fiscal year following the fifth anniversary



of the completion of our IPO, (b)&nbsp;in which we have total annual gross revenue of at least $1.07 billion, or (c)&nbsp;in which we



are deemed to be a large accelerated filer, which means the market value of our ordinary shares that is held by non-affiliates exceeds



$700 million as of the prior June&nbsp;30<sup>th</sup>, and (2)&nbsp;the date on which we have issued more than $1.0 billion in non-convertible



debt securities during the prior three-year period. References herein to “emerging growth company” shall have the meaning



associated with it in the JOBS Act.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,



we are a “smaller reporting company” as defined in Rule&nbsp;10(f)(1)&nbsp;of Regulation S-K. Smaller reporting companies



may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial



statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1)&nbsp;the market value of our



ordinary shares held by non-affiliates exceeds $250 million as of the prior June&nbsp;30th, or (2)&nbsp;our annual revenues exceed $100



million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates exceeds $700 million as



of the prior June&nbsp;30.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are a Cayman Islands exempted company incorporated on March&nbsp;11, 2021. Our executive offices are located at 80 Broad Street, 5<sup>th



</sup>Floor, New York, NY, 10004, and our telephone number is (212) 837 7977.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 10; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>Item



1A. RISK FACTORS</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



a smaller reporting company, we are not required to include risk factors in this Annual Report. However, below is a partial list of material



risks, uncertainties and other factors that could have a material effect on the Company and its operations:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve



our business objective.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are a blank check company established under the laws of the Cayman Islands with no operating results, and we commenced operations



 only after the closing of our initial public offering. Because we lack an operating history, you have no basis upon which to evaluate



our ability to achieve our business objective of completing our initial business combination with one or more target businesses. We have



no plans, arrangements or understandings with any prospective target business concerning a business combination and may be unable to



complete our initial business combination. If we fail to complete our initial business combination, we will never generate any operating



revenues.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>COVID-19



and its impact on businesses and financial markets could have a material adverse effect on our search for a business combination and



any target business with which we ultimately consummate a business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



COVID-19 coronavirus pandemic has resulted in a widespread health crisis that has adversely impacted the economies and financial markets



worldwide, business operations and the conduct of commerce generally. There is no way of being certain how long these adverse impacts



will last. The coronavirus, or other disease outbreaks, could have a material adverse effect on the business of any potential target



business with which we consummate a business combination. Furthermore, we may be unable to complete a business combination if concerns



relating to the coronavirus pandemic continue to restrict travel, limit the ability to have meetings with potential investors or the



target company’s personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely



manner. The extent to which the coronavirus pandemic impacts our search for a business combination will depend on future developments,



which are highly uncertain and cannot be predicted, including new information which may emerge concerning the coronavirus pandemic and



the actions to contain it or treat its impact, among others. If the disruptions posed by the coronavirus or other matters of global concern



continue for an extensive period of time, it could have a material adverse effect on our ability to consummate a business combination,



or the operations of a target business with which we ultimately consummate a business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



addition, our ability to consummate a business combination may be dependent on the ability to raise equity and debt financing and the



coronavirus pandemic and other related events could have a material adverse effect on our ability to raise adequate financing, including



as a result of increased market volatility, decreased market liquidity and third-party financing being unavailable on terms acceptable



to us or at all.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



addition, our ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted



by COVID-19 and other events, including as a result of increased market volatility and decreased market liquidity and third-party financing



being unavailable on terms acceptable to us or at all.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



occurrence of natural disasters may adversely affect our business, financial condition and results of operations following our business



combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



occurrence of natural disasters, including hurricanes, floods, earthquakes, tornadoes, fires and pandemic disease may adversely affect



our business, financial condition or results of operations following our business combination. The potential impact of a natural disaster



on our results of operations and financial position is speculative, and would depend on numerous factors. The extent and severity of



these natural disasters will determine their effect on a given economy. Although the long term effect of diseases such as the H5N1 “avian



flu,” or H1N1, the swine flu, cannot currently be predicted, previous occurrences of avian flu and swine flu had an adverse effect



on the economies of those countries in which they were most prevalent. An outbreak of a communicable disease could adversely affect our



business, financial condition and results of operations following our business combination. We cannot assure you that natural disasters



will not occur in the future or that its business, financial condition and results of operations will not be adversely affected.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 11; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>U.S.



laws in the future may restrict or eliminate our ability to complete a business combination with certain companies.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future



developments in U.S. laws may restrict our ability or willingness to complete certain business combinations with companies. For instance,



the federal government has recently proposed legislation that would restrict our ability to consummate a business combination with a



target business unless that business met certain standards of the Public Company Accounting Oversight Board (United States), or PCAOB,



and would require delisting of a company from national securities exchanges if it failed to retain an accounting firm that the PCAOB



has inspected to the satisfaction of the SEC. Such proposed legislation would also require public companies to disclose whether they



are owned or controlled by a foreign government, specifically those based in China. We may not be able to consummate a business combination



with a favored target business due to these laws. Furthermore, the documentation we may be required to submit to the SEC proving certain



beneficial ownership requirements and establishing that we are not owned or controlled by a foreign government in the event that we use



a foreign public accounting firm not subject to inspection by the PCAOB or where the PCAOB is unable to completely inspect or investigate



our accounting practices or financial statements because of a position taken by an authority in the foreign jurisdiction could be onerous



and time consuming to prepare.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



public shareholders may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our



initial business combination even though a majority of our public shareholders does not support such a combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



may not hold a shareholder vote to approve our initial business combination unless the business combination would require shareholder



approval under applicable Cayman Islands law or the rules&nbsp;of the NASDAQ or if we decide to hold a shareholder vote for business



or other reasons. Examples of transactions that would not ordinarily require shareholder approval include asset acquisitions and share



purchases, while transactions such as direct mergers with our company or transactions where we issue more than 20% of our outstanding



shares would require shareholder’s approval. For instance, the NASDAQ rules&nbsp;currently allow us to engage in a tender offer in lieu of a shareholder



meeting but would still require us to obtain shareholder approval if we were seeking to issue more than 20% of our outstanding shares



to a target business as consideration in any business combination. Therefore, if we were structuring a business combination that required



us to issue more than 20% of our outstanding shares, we would seek shareholder approval of such business combination. Except as required



by law or NASDAQ rules, the decision as to whether we will seek shareholder approval of a proposed business combination or will allow



shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety



of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek shareholder



approval. Accordingly, we may consummate our initial business combination even if holders of a majority of the issued and outstanding



ordinary shares do not approve of the business combination we consummate.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



we seek shareholder approval of our initial business combination, our sponsor, officers and directors have agreed to vote in favor of



such initial business combination, regardless of how our public shareholders vote.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike



other blank check companies in which the initial shareholders agree to vote their founder shares in accordance with the majority of the



votes cast by the public shareholders in connection with an initial business combination, our sponsor, officers and directors have agreed



(and their permitted transferees will agree), pursuant to the terms of a letter agreement entered into with us, to vote any founder shares



and private placement shares held by them, as well as any public shares purchased during or after this offering, in favor of our initial



business combination. We expect that our sponsor and its permitted transferees will own approximately 21.88% of our issued and outstanding



ordinary shares at the time of any such shareholder vote (assuming it does not purchase units in this offering, and taking into account



ownership of the private placement units). As a result, in addition to our initial shareholder’s founder shares, we would need



only 4,147,501 or approximately 36.06% of the 11,500,000 public shares sold in this offering to be voted in favor of a transaction (assuming



all outstanding shares are voted) in order to have our initial business combination approved (assuming the over-allotment option is not



exercised). Accordingly, if we seek shareholder approval of our initial business combination, it is more likely that the necessary shareholder



approval will be received than would be the case if such persons agreed to vote their founder shares in accordance with the majority



of the votes cast by our public shareholders.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 12; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholders’



only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your



right to redeem your shares from us for cash, unless we seek shareholder approval of the business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At



the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of one or more



target businesses. Since our Board of Directors may complete a business combination without seeking shareholder approval, public shareholders



may not have the right or opportunity to vote on the business combination, unless we seek such shareholder approval. Accordingly, if



we do not seek shareholder approval, shareholders only opportunity to affect the investment decision regarding a potential business combination



may be limited to exercising your redemption rights within the period of time (which will be at least 20 business days) set forth in



our tender offer documents mailed to our public shareholders in which we describe our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business



combination targets, which may make it difficult for us to enter into a business combination with a target.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



may seek to enter into a business combination transaction agreement with a prospective target that requires as a closing condition that



we have a minimum net worth or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not



be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Furthermore, in



no event will we redeem our public shares in an amount that would cause our net tangible assets, after payment of the deferred underwriting



commissions, to be less than $5,000,001 either immediately prior to or upon consummation of our initial business combination (so that



we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may



be contained in the agreement relating to our initial business combination. Consequently, if accepting all properly submitted redemption



requests would cause our net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of our initial



business combination or such greater amount necessary to satisfy a closing condition as described above, we would not proceed with such



redemption and the related business combination and may instead search for an alternate business combination. Prospective targets will



be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete



the most desirable business combination or optimize our capital structure.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At



the time we enter into an agreement for our initial business combination, we will not know how many shareholders may exercise their redemption



rights, and therefore we will need to structure the transaction based on our expectations as to the number of shares that will be submitted



for redemption. If our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the



purchase price, or requires us to have a minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust



account to meet such requirements, or arrange for third party financing. In addition, if a larger number of shares are submitted for



redemption than we initially expected, we may need to restructure the transaction to reserve a greater portion of the cash in the trust



account or arrange for third party financing. Raising additional third party financing may involve dilutive equity issuances or the incurrence



of indebtedness at higher than desirable levels. The above considerations may limit our ability to complete the most desirable business



combination available to us or optimize our capital structure.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability



that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or



requires us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful



is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account until



we liquidate the trust account. If you are in need of immediate liquidity, you could attempt to sell your shares in the open market;



however, at such time our shares may trade at a discount to the pro rata amount per share in the trust account. In either situation,



you may suffer a material loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate



or you are able to sell your shares in the open market.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 13; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage



over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business combination



targets as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms



that would produce value for our shareholders.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any



potential target business with which we enter into negotiations concerning a business combination will be aware that we must complete



our initial business combination within 9 months from the closing of our initial public offering (or up to 21 months from the closing



of our initial public offering if we extend the period of time to consummate a business combination). Consequently, such target business



may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial business combination



with that particular target business, we may be unable to complete our initial business combination with any target business. This risk



will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence and may



enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We

may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all

operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public

shareholders may only receive $10.00 per share, or less than such amount in certain circumstances, and our rights and warrants will

expire worthless.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our

sponsor, officers and directors have agreed that we must complete our initial business combination within 9 months from the closing

of our initial public offering (or up to 21 months from the closing of our initial public offering if we extend the period of time

to consummate a business combination,). We may not be able to find a suitable target business and complete our initial business

combination within such time period. If we have not completed our initial business combination within such time period, we will:

(i)&nbsp;cease all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than

ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on

deposit in the trust account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest

to pay dissolution expenses) divided by the number of then issued and outstanding public shares, which redemption will completely

extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if

any), subject to applicable law, and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the

approval of our remaining shareholders and our Board of Directors, liquidate and dissolve, subject in each case to our obligations

under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such case, our public

shareholders may only receive $10.00 per share, and our rights and warrants will expire worthless. In certain circumstances, our

public shareholders may receive less than $10.00 per share on the redemption of their shares.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our

sponsor may decide not to extend the term we have to consummate our initial business combination, in which case we would cease all

operations except for the purpose of winding up and we would redeem our public shares and liquidate, and the rights and warrants

will be worthless.</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will have until 9 months from the closing of our initial public offering to consummate our initial business combination. However, if



we anticipate that we may not be able to consummate our initial business combination within 9 months, we may, by resolution of our board



if requested by our sponsor, extend the period of time to consummate a business combination up to twelve times, each by an additional



month (for a total of up to 21 months to complete a business combination), subject to the sponsor depositing additional funds into the



trust account as set out below. In order for the time available for us to consummate our initial business combination to be extended,



our sponsor or its affiliates or designees must deposit into the trust account $383,332 ($0.033 per public share), up to an aggregate



of $4,600,000, or $0.40 per public share, on or prior to the date of the applicable deadline, for each monthly extension. Any such payments



would be made in the form of a loan. The terms of the promissory note to be issued in connection with any such loans have not yet been



negotiated.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our

sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our

initial business combination. If we are unable to consummate our initial business combination within the applicable time period, we

will, as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares for a pro rata

portion of the funds held in the trust account and as promptly as reasonably possible following such redemption, subject to the

approval of our remaining shareholders and our board of directors, dissolve and liquidate, subject in each case to our obligations

under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such event, the rights

and warrants will be worthless.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 14; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



we seek shareholder approval of our initial business combination, our sponsor, directors, officers, advisors and their affiliates may



elect to purchase shares from public shareholders, which may influence a vote on a proposed business combination and reduce the public



“float” of our ordinary shares.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business



combination pursuant to the tender offer rules, our sponsor, directors, officers, advisors or their affiliates may purchase shares in



privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination,



although they are under no obligation to do so. Please see “Proposed Business — Permitted purchases of our securities”



for a description of how such persons will determine which shareholders to seek to acquire shares from. Such a purchase may include a



contractual acknowledgement that such shareholder, although still the record holder of our shares is no longer the beneficial owner thereof



and therefore agrees not to exercise its redemption rights. In the event that our sponsor, directors, officers, advisors or their affiliates



purchase shares in privately negotiated transactions from public shareholders who have already elected to exercise their redemption rights,



such selling shareholders would be required to revoke their prior elections to redeem their shares. The price per share paid in any such



transaction may be different from the amount per share a public shareholder would receive if it elected to redeem its shares in connection



with our initial business combination. The purpose of such purchases could be to vote such shares in favor of the business combination



and thereby increase the likelihood of obtaining shareholder approval of the business combination or to satisfy a closing condition in



an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our Initial business



combination, where it appears that such requirement would otherwise not be met. This may result in the completion of our initial business



combination that may not otherwise have been possible.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



addition, if such purchases are made, the public “float” of our ordinary shares and the number of beneficial holders of our



securities may be reduced, possibly making it difficult to maintain or obtain the quotation, listing or trading of our securities on



a national securities exchange.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or



fails to comply with the procedures for tendering its shares, such shares may not be redeemed.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will comply with the tender offer rules&nbsp;or proxy rules, as applicable, when conducting redemptions in connection with our initial



business combination. Despite our compliance with these rules, if a shareholder fails to receive our tender offer or proxy materials,



as applicable, such shareholder may not become aware of the opportunity to redeem its shares. In addition, the tender offer documents



or proxy materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination



will describe the various procedures that must be complied with in order to validly tender or redeem public shares. In the event that



a shareholder fails to comply with these procedures, its shares may not be redeemed.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You



will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your



investment, therefore, you may be forced to sell your public shares, rights or warrants, potentially at a loss.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



public shareholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i)&nbsp;the completion



of our initial business combination, (ii)&nbsp;the redemption of any public shares properly tendered in connection with a shareholder



vote to amend our amended and restated memorandum and articles of association to (A)&nbsp;modify the substance or timing of our obligation



to redeem 100% of our public shares if we do not complete our initial business combination within 9 months from the closing of our initial



public offering (or up to 21 months from the closing of our initial public offering if we extend the period of time to consummate a business



combination,) or (B)&nbsp;with respect to any other provision relating to shareholders’ rights or pre-business combination activity



and (iii)&nbsp;the redemption of all of our public shares if we are unable to complete our initial business combination within 9 months



from the closing of our initial public offering (or up to 21 months from the closing of our initial public offering if we extend the



period of time to consummate a business combination), subject to applicable law and as further described herein. In no other circumstances



will a public shareholder have any right or interest of any kind in the trust account. Accordingly, to liquidate your investment, you



may be forced to sell your public shares, rights or warrants, potentially at a loss.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 15; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>NASDAQ



may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities



and subject us to additional trading restrictions.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



units, ordinary shares, rights and warrants are listed on the NASDAQ. We cannot guarantee that our securities will continue to be, listed on



NASDAQ in the future or prior to our initial business combination. In order to continue listing our securities on NASDAQ prior to our



initial business combination, we must maintain certain financial, distribution and stock price levels. Generally, we must maintain a



minimum market value of listed securities of $50 million, a minimum market value of public held shares of $15 million, and a minimum



number of holders of our securities (generally 400 public holders).</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



NASDAQ delists our securities from trading on its exchange and we are not able to list our securities on another national securities



exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material



adverse consequences, including:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a



limited availability of market quotations for our securities;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced



liquidity for our securities;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a



determination that our ordinary shares is a “penny stock” which will require brokers trading in our ordinary shares to adhere



to more stringent rules&nbsp;and possibly result in a reduced level of trading activity in the secondary trading market for our securities;</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a



limited amount of news and analyst coverage; and</span></td>



</tr></tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a



decreased ability to issue additional securities or obtain additional financing in the future.</span></td>



</tr></tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The

National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the

sale of certain securities, which are referred to as “covered securities.” Because our units, ordinary shares, rights

and warrants are listed on NASDAQ, our units, ordinary shares, rights and warrants are covered securities. Although the states are

preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is

a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered

securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of

securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check

companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check

companies in their states. Further, if we were no longer listed on NASDAQ, our securities would not be covered securities and we

would be subject to regulation in each state in which we offer our securities, including in connection with our initial business

combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>If



we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules,



and if you or a “group” of shareholders are deemed to hold in excess of 15% of the ordinary shares sold in our initial public



offering, you will lose the ability to redeem all such shares in excess of 15% of our ordinary shares sold in our initial public offering.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">If



we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business



combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association will provide that a public



shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as



a “group” (as defined under Section&nbsp;13 of the Exchange Act), will be restricted from seeking redemption rights with



respect to more than an aggregate of 15% of the shares sold in our initial public offering, which we refer to throughout this Form&nbsp;10-K



as the “Excess Shares.” However, we would not be restricting our shareholders’ ability to vote all of their shares



(including Excess Shares) for or against our initial business combination. Your inability to redeem the Excess Shares will reduce your



influence over our ability to complete our initial business combination and you could suffer a material loss on your investment in us



if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the



Excess Shares if we complete our initial business combination. And as a result, you will continue to hold that number of shares exceeding



15% and, in order to dispose of such shares, would be required to sell your shares in open market transactions, potentially at a loss.</span></p>











<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>















<!-- Field: Page; Sequence: 16; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because

of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to

complete our initial business combination. If we are unable to complete our initial business combination, our public shareholders

may receive only approximately $10.00 per share, or less in certain circumstances, on our redemption, and our rights and warrants

will expire worthless.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We

expect to encounter intense competition from other entities having a business objective similar to ours, including private investors

(which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international,

competing for the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have

extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing

services to various industries. Many of these competitors possess greater technical, human and other resources or more local

industry knowledge than we do and our financial resources will be relatively limited when contrasted with those of many of these

competitors. While we believe there are numerous target business, we could potentially acquire with the net proceeds of our initial

public offering and the sale of the private placement units, our ability to compete with respect to the acquisition of certain

target businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation gives

others an advantage in pursuing the acquisition of certain target businesses. Furthermore, if we are obligated to pay cash for the

ordinary shares redeemed and, in the event we seek shareholder approval of our initial business combination, we make purchases of

our ordinary shares, potentially reducing the resources available to us for our initial business combination. Any of these

obligations may place us at a competitive disadvantage in successfully negotiating a business combination. If we are unable to

complete our initial business combination, our public shareholders may receive only approximately $10.00 per share (or less in

certain circumstances) on the liquidation of our trust account and our rights and warrants will expire worthless. In certain

circumstances, our public shareholders may receive less than $10.00 per share on the redemption of their shares.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



the net proceeds of our initial public offering not being held in the trust account are insufficient to allow us to operate for at least



9 months (or up to 21 months from the closing of our initial public offering if we extend the period of time to consummate a business



combination,), we may be unable to complete our initial business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



funds available to us outside of the trust account may not be sufficient to allow us to operate for at least 9 months (or up to 21 months



from the closing of our initial public offering if we extend the period of time to consummate a business combination,), assuming that



our initial business combination is not completed during that time. We expect to incur significant costs in pursuit of our acquisition



plans. However, our affiliates are not obligated to make loans to us in the future, and we may not be able to raise additional financing



from unaffiliated parties necessary to fund our expenses. Any such event in the future may negatively impact the analysis regarding our



ability to continue as a going concern at such time.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We

believe that, upon the closing of our initial public offering, the funds available to us outside of the trust account, will be

sufficient to allow us to operate for at least 9 months (or up to 21 months from the closing of our initial public offering if we

extend the period of time to consummate a business combination,); however, we cannot assure you that our estimate is accurate. Of

the funds available to us, we could use a portion of the funds available to us to pay fees to consultants to assist us with our

search for a target business. We could also use a portion of the funds as a down payment or to fund a “no-shop”

provision (a provision in letters of intent designed to keep target businesses from “shopping” around for transactions

with other companies on terms more favorable to such target businesses) with respect to a particular proposed business combination,

although we do not have any current intention to do so. If we entered into a letter of intent where we paid for the right to receive

exclusivity from a target business and were subsequently required to forfeit such funds (whether as a result of our breach or

otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a target

business. If we are unable to complete our initial business combination, our public shareholders may receive only approximately

$10.00 per share (or less in certain circumstances) on the liquidation of our trust account and our rights and warrants will expire

worthless. In such case, our public shareholders may only receive $10.00 per share, and our rights and warrants will expire

worthless. In certain circumstances, our public shareholders may receive less than $10.00 per share on the redemption of their

shares.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our working capital position and the requirement that

we consummate an initial business combination within 21 months after the closing of our IPO give rise to substantial doubt about

our ability to continue as a going concern.</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">At December 31, 2021, we had
approximately $387,858 in cash. We have incurred and we expect to continue to incur significant costs in pursuit of a business combination.
Further, we have until September 15, 2022 or September 15, 2023 with extension to consummate a business combination, and it is uncertain
that we will be able to consummate a business combination by that date. If a business combination is not consummated by that date, we
will commence a mandatory liquidation and subsequent dissolution. These conditions raise substantial doubt about our ability to continue
as a going concern for a period of time within one year after the date of our financial statements included in this report. Our financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</p>






<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>















<!-- Field: Page; Sequence: 17; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



the net proceeds of our initial public offering and the sale of the private placement units not being held in the trust account are insufficient,



it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination



and we will depend on loans from our sponsor or management team to fund our search, to pay our taxes and to complete our initial business



combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of

the net proceeds of our initial public offering and the sale of the private placement units, only $682,254 was available to us

initially outside the trust account to fund our working capital requirements.  If

we are required to seek additional capital, we would need to borrow funds from our sponsor, management team or other third parties

to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor any of their affiliates is under

any obligation to advance funds to us in such circumstances. Any such advances would be repaid only from funds held outside the

trust account or from funds released to us upon completion of our initial business combination. If we are unable to complete our

initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and

liquidate the trust account. Consequently, our public shareholders may only receive approximately $10.00 per share (or less in

certain circumstances) on our redemption of our public shares, and our rights and warrants will expire worthless. In such case, our

public shareholders may only receive $10.00 per share, and our rights and warrants will expire worthless. In certain circumstances,

our public shareholders may receive less than $10.00 per share on the redemption of their shares.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subsequent



to the completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment



or other charges that could have a significant negative effect on our financial condition, results of operations and our share price,



which could cause you to lose some or all of your investment.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even



if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will surface



all material issues that may be present inside a particular target business, that it would be possible to uncover all material issues



through a customary amount of due diligence, or that factors outside of the target business and outside of our control will not later



arise. As a result of these factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment



or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected



risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though



these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature



could contribute to negative market perceptions about our securities or us. In addition, charges of this nature may cause us to violate



net worth or other covenants to which we may be subject as a result of assuming pre-existing debt held by a target business or by virtue



of our obtaining post-combination debt financing. Accordingly, any shareholders who choose to remain shareholders following the business



combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction



in value.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received



by shareholders may be less than $10.00 per share.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have all



vendors, service providers (other than our independent auditors), prospective target businesses or other entities with which we do business



execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for



the benefit of our public shareholders, such parties may not execute such agreements, or even if they execute such agreements they may



not be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary



responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain



advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute



an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives



available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such



third party’s engagement would be significantly more beneficial to us than any alternative.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Examples



of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant



whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would



agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition,



there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,



any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption



of our public shares, if we are unable to complete our initial business combination within the prescribed timeframe, or upon the exercise



of a redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors



that were not waived that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount



received by public shareholders could be less than the $10.00 per share initially held in the trust account, due to claims of such creditors.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 18; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



sponsor has agreed that it will be liable to us if and to the extent any claims by a vendor (other than our independent auditors) for



services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement,



reduce the amount of funds in the trust account to below (i)&nbsp;$10.00 per public share or (ii)&nbsp;such lesser amount per public



share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets,



in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver



of any and all rights to seek access to the trust account and except as to any claims under our indemnity of the underwriters of our



initial public offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed



waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such



third party claims. We have not independently verified whether our sponsor has sufficient funds to satisfy their indemnity obligations



and believe that our sponsor’s only assets are securities of our company. Our sponsor may not have sufficient funds available to



satisfy those obligations. We have not asked our sponsor to reserve for such obligations, and therefore, no funds are currently set aside



to cover any such obligations. As a result, if any such claims were successfully made against the trust account, the funds available



for our initial business combination and redemptions could be reduced to less than $10.00 per public share. In such event, we may not



be able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption



of your public shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation,



claims by vendors and prospective target businesses.</span></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in



the trust account available for distribution to our public shareholders.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



the event that the proceeds in the trust account are reduced below the lesser of (i)&nbsp;$10.00 per public share or (ii)&nbsp;such lesser



amount per share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the



trust assets, in each case net of the interest which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy



its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine



whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent



directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible



that our independent directors in exercising their business judgment may choose not to do so in any particular instance. If our independent



directors choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution



to our public shareholders may be reduced below $10.00 per share.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If,



after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy



petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and the members of our Board



of Directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our Board of Directors



and us to claims of punitive damages.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,



after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy



petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor



and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy



court could seek to recover all amounts received by our shareholders. In addition, our Board of Directors may be viewed as having breached



its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by



paying public shareholders from the trust account prior to addressing the claims of creditors.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If,



before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy



petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our



shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be



reduced.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,



before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy



petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy



law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders.



To the extent any bankruptcy claims deplete the trust account, the per-share amount that would otherwise be received by our shareholders



in connection with our liquidation may be reduced.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 19; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements



and our activities may be restricted, which may make it difficult for us to complete our initial business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions



    on the nature of our investments; and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions



    on the issuance of securities;</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each



of which may make it difficult for us to complete our initial business combination. In addition, we may have imposed upon us burdensome



requirements, including:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">registration



    as an investment company;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adoption



    of a specific form of corporate structure; and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting,



    record keeping, voting, proxy and disclosure requirements and other rules&nbsp;and regulations.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



do not believe that our anticipated principal activities will subject us to the Investment Company Act. The proceeds held in the trust



account may be invested by the trustee only in United States government treasury bills with a maturity of 180 days or less or in money



market funds investing solely in United States Treasuries and meeting certain conditions under Rule&nbsp;2a-7 under the Investment Company



Act. Because the investment of the proceeds will be restricted to these instruments, we believe we will meet the requirements for the



exemption provided in Rule&nbsp;3a-1 promulgated under the Investment Company Act. If we were deemed to be subject to the Investment



Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds



and may hinder our ability to complete a business combination. If we are unable to complete our initial business combination, our public



shareholders may receive only approximately $10.00 per share, or less in certain circumstances, on the liquidation of our trust account



and our rights and warrants will expire worthless.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes



in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and results



of operations.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are subject to laws and regulations enacted by national, regional and local governments. In particular, we will be required to comply



with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult,



time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and



those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to



comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business and results



of operations.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



we are unable to consummate our initial business combination within the initial 9 months (or up to 21 months from the closing of our



initial public offering if we extend the period of time to consummate a business combination) of the closing of our initial public offering,



our public shareholders may be forced to wait beyond such 9 months (or up to 21 months) before redemption from our trust account.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we are unable to consummate our initial business combination within the initial 9 months (or up to 21 months from the closing of our



initial public offering if we extend the period of time to consummate a business combination,), we will distribute the aggregate amount



then on deposit in the trust account (less up to $50,000 of the net interest earned thereon to pay dissolution expenses), pro rata to



our public shareholders by way of redemption and cease all operations except for the purposes of winding up of our affairs, as further



described herein. Any redemption of public shareholders from the trust account shall be effected automatically by function of our amended



and restated memorandum and articles of association prior to any voluntary winding up. If we are required to windup, liquidate the trust



account and distribute such amount therein, pro rata, to our public shareholders, as part of any liquidation process, such winding up,



liquidation and distribution must comply with the applicable provisions of the Companies Law. In that case, investors may be forced to



wait beyond the initial 9 months (or up to 21 months) before the redemption proceeds of our trust account become available to them and



they receive the return of their pro rata portion of the proceeds from our trust account. We have no obligation to return funds to investors



prior to the date of our redemption or liquidation unless we consummate our initial business combination prior thereto and only then



in cases where investors have sought to redeem their ordinary shares. Only upon our redemption or any liquidation will public shareholders



be entitled to distributions if we are unable to complete our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 20; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption



of their shares.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment



if it was proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall



due in the ordinary course of business. As a result, a liquidator could seek to recover all amounts received by our shareholders. Furthermore,



our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, and



thereby exposing themselves and our company to claims, by paying public shareholders from the trust account prior to addressing the claims



of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our directors and officers who



knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were unable to



pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable to fines and to imprisonment for five years in the Cayman Islands.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may not hold an annual meeting of shareholders until after the consummation of our initial business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



accordance with NASDAQ corporate governance requirements, we are required to hold an annual meeting no later than one year after our



first fiscal year end following our listing on NASDAQ, unless we continue to be a foreign private issuer. There is no requirement under



the Cayman Islands’ Companies Law for us to hold annual or general meetings or elect directors. Until we hold an annual meeting



of shareholders, public shareholders may not be afforded the opportunity to discuss company affairs with management.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



are not registering the ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws



at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor



from being able to exercise its warrants except on a cashless basis and potentially causing such warrants to expire worthless.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are not registering the ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws



at this time. However, under the terms of the warrant agreement, we have agreed that as soon as practicable, but in no event later than



15 business days after the closing of our initial business combination, we will use our best efforts to file, and within 60 business



days following our initial business combination to have declared effective, a registration statement covering such shares and maintain



a current prospectus relating to the ordinary shares issuable upon exercise of the warrants, until the expiration of the warrants in



accordance with the provisions of the warrant agreement. We cannot assure you that we will be able to do so if, for example, any facts



or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial



statements contained or incorporated by reference therein are not current or correct or the SEC issues a stop order. If the shares issuable



upon exercise of the warrants are not registered under the Securities Act, we will be required to permit holders to exercise their warrants



on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any



shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified



under the securities laws of the state of the exercising holder, or an exemption is available.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding



the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective within



a specified period following the consummation of our initial business combination, warrant holders may, until such time as there is an



effective registration statement and during any period when we shall have failed to maintain an effective registration statement, exercise



warrants on a cashless basis pursuant to the exemption provided by Section&nbsp;3(a)(9)&nbsp;of the Securities Act, provided that such



exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants



on a cashless basis. We will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption



is not available. In no event will we be required to net cash settle any warrant, or issue securities or other compensation in exchange



for the warrants in the event that we are unable to register or qualify the shares underlying the warrants under applicable state securities



laws and no exemption is available. If the issuance of the shares upon exercise of the warrants is not so registered or qualified or



exempt from registration or qualification, the holder of such warrant shall not be entitled to exercise such warrant and such warrant



may have no value and expire worthless. In such event, holders who acquired their warrants as part of a purchase of units will have paid



the full unit purchase price solely for the ordinary shares included in the units. If and when the warrants become redeemable by us,



we may not exercise our redemption right if the issuance of shares upon exercise of the warrants is not exempt from registration or qualification



under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best efforts to register



or qualify such shares under the blue sky laws of the state of residence in those states in which the warrants were offered by us in



our initial public offering.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 21; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



grant of registration rights to our sponsor and holders of our private placement units may make it more difficult to complete our initial



business combination, and the future exercise of such rights may adversely affect the market price of our ordinary shares.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant

to an agreement to be entered into concurrently with the issuance and sale of the securities in our initial public offering, our

sponsor and its permitted transferees can demand that we register their founder shares. In addition, holders of our private

placement units and their permitted transferees can demand that we register the private placement units and their underlying

securities, holders of the shares, and the shares underlying the rights and warrants, can demand that we register such securities, and holders of units that may

be issued upon conversion of working capital loans, may demand that we register such units and their underlying securities. We will

bear the cost of registering these securities. The registration and availability of such a significant number of securities for

trading in the public market may have an adverse effect on the market price of our ordinary shares. In addition, the existence of

the registration rights may make our initial business combination more costly or difficult to conclude. This is because the

shareholders of the target business may increase the equity stake they seek in the combined entity or ask for more cash

consideration to offset the negative impact on the market price of our ordinary shares that is expected when the ordinary shares

owned by our sponsor, holders of our private placement units or holders of our working capital loans or their respective permitted

transferees are registered.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because



we are not limited to a particular industry or any specific target businesses with which to pursue our initial business combination,



you will be unable to ascertain the merits or risks of any particular target business’s operations.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



may seek to complete a business combination with an operating company in any industry or sector. However, we will not, under our amended



and restated memorandum and articles of association, be permitted to effectuate our initial business combination with another blank check



company or similar company with nominal operations. Because we have not yet identified or approached any specific target business with



respect to a business combination, there is no basis to evaluate the possible merits or risks of any particular target business’s



operations, results of operations, cash flows, liquidity, financial condition or prospects. To the extent we complete our initial business



combination, we may be affected by numerous risks inherent in the business operations with which we combine. For example, if we combine



with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks



inherent in the business and operations of a financially unstable entity. Although our officers and directors will endeavor to evaluate



the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all of the significant



risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control



and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business. We also cannot



assure you that an investment in our units will ultimately prove to be more favorable to investors than a direct investment, if such



opportunity were available, in a business combination target. Accordingly, any shareholders who choose to remain shareholders following



the business combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such



reduction in value.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Past



performance by our management team and their respective affiliates may not be indicative of future performance of an investment in us.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information



regarding performance by, or businesses associated with, our management team and their affiliates is presented for informational purposes



only. Past performance by our management team, including their affiliates’ past performance, is not a guarantee either (i)&nbsp;of



success with respect to any business combination we may consummate or (ii)&nbsp;that we will be able to locate a suitable candidate for



our initial business combination. You should not rely on the historical record of our management team and their affiliates as indicative



of our future performance. Additionally, in the course of their respective careers, members of our management team have been involved



in businesses and deals that were unsuccessful.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may seek acquisition opportunities in industries or sectors that may be outside of our management’s areas of expertise.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



will consider a business combination outside of our management’s areas of expertise if a business combination candidate is presented



to us and we determine that such candidate offers an attractive acquisition opportunity for our company. In the event we elect to pursue



an acquisition outside of the areas of our management’s expertise, our management’s expertise may not be directly applicable



to its evaluation or operations. As a result, our management may not be able to adequately ascertain or assess all of the significant



risk factors. Accordingly, any shareholders who choose to remain shareholders following our initial business combination could suffer



a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction in value.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 22; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Although



we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may



enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target



business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria



and guidelines.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although



we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business



with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial



business combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a



combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business



combination with a target that does not meet our general criteria and guidelines, a greater number of shareholders may exercise their



redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to have a



minimum net worth or a certain amount of cash. In addition, if we are no longer a foreign private issuer and shareholder approval of



the transaction is required by law, or we decide to obtain shareholder approval for business or other legal reasons, it may be more difficult



for us to attain shareholder approval of our initial business combination if the target business does not meet our general criteria and



guidelines. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $10.00



per share on the liquidation of our trust account and our rights and warrants will expire worthless.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may seek acquisition opportunities with a financially unstable business or an entity lacking an established record of revenue or earnings.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To



the extent we complete our initial business combination with a financially unstable business or an entity lacking an established record



of sales or earnings, we may be affected by numerous risks inherent in the operations of the business with which we combine. These risks



include volatile revenues or earnings and difficulties in obtaining and retaining key personnel. Although our officers and directors



will endeavor to evaluate the risks inherent in a particular target business, we may not be able to properly ascertain or assess all



of the significant risk factors and we may not have adequate time to complete due diligence.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,



some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will



adversely impact a target business.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



are not required to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and consequently,



you may have no assurance from an independent source that the price we are paying for the business is fair to our company from a financial



point of view.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless



we complete our initial business combination with an affiliated entity, or our Board of Directors cannot independently determine the



fair market value of the target business or businesses, we are not required to obtain an opinion from an independent investment banking



firm, another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or from an



independent accounting firm that the price we are paying for a target is fair to our company from a financial point of view. If no opinion



is obtained, our shareholders will be relying on the business judgment of our Board of Directors, which will have significant discretion



in choosing the standard used to establish the fair market value of the target or targets, and different methods of valuation may vary



greatly in outcome from one another. Such standards used will be disclosed in our tender offer documents or proxy solicitation materials,



as applicable, related to our initial business combination. However, if our Board of Directors is unable to determine the fair value



of an entity with which we seek to complete an initial business combination based on such standards, we will be required to obtain an



opinion as described above.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may issue additional ordinary or preference shares to complete our initial business combination or under an employee incentive plan after



completion of our initial business combination. Any such issuances would dilute the interest of our shareholders and likely present other



risks.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our

amended and restated memorandum and articles of association will authorize the issuance of up to 50,000,000 ordinary

shares, par value $0.001 per share. There are 35,295,000 authorized but unissued ordinary shares available for issuance  and there is no preference shares issued and outstanding.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 23; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



may issue a substantial number of additional ordinary shares, and may issue preference shares, in order to complete our initial business



combination or under an employee incentive plan after completion of our initial business combination. However, our amended and restated



memorandum and articles of association will provide, among other things, that prior to our initial business combination, we may not issue



additional ordinary shares that would entitle the holders thereof to (i)&nbsp;receive funds from the trust account or (ii)&nbsp;vote



on any initial business combination. The issuance of additional ordinary shares or preference shares:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may



    significantly dilute the equity interest of investors in our initial public offering;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may



    subordinate the rights of holders of ordinary shares if preference shares are issued with rights senior to those afforded our ordinary



    shares;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">could



    cause a change in control if a substantial number of ordinary shares are issued, which may affect, among other things, our ability



    to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and



    directors; and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may



    adversely affect prevailing market prices for our units, ordinary shares, rights and/or warrants.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may be a passive foreign investment company, or “PFIC,” which could result in adverse U.S. federal income tax consequences



to U.S. investors.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If

we are a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S. Holder (as defined in the

section of this prospectus captioned “Income Tax Considerations — Certain U.S. Federal Income Tax Considerations —

U.S. Holders”) of our ordinary shares, rights or warrants, the U.S. Holder may be subject to adverse U.S. federal income tax

consequences and may be subject to additional reporting requirements. Our PFIC status for our current and subsequent taxable years

may depend on whether we qualify for the PFIC start-up exception (see the section of this prospectus captioned “Income Tax

Considerations — Certain U.S. Federal Income Tax Considerations — U.S. Holders — Passive Foreign Investment

Company Rules”). Depending on the particular circumstances the application of the start-up exception may be subject to

uncertainty, and there cannot be any assurance that we will qualify for the start-up exception. Accordingly, there can be no

assurances with respect to our status as a PFIC for our current taxable year or any subsequent taxable year. Our actual PFIC status

for any taxable year, however, will not be determinable until after the end of such taxable year. Moreover, if we determine we are a

PFIC for any taxable year, we will endeavor to provide to a U.S. Holder such information as the Internal Revenue Service

(“IRS”) may require, including a PFIC annual information statement, in order to enable the U.S. Holder to make and

maintain a “qualified electing fund” election, but there can be no assurance that we will timely provide such required

information, and such election would be unavailable with respect to our ordinary shares, rights and warrants in all cases. We urge

U.S. Holders to consult their own tax advisors regarding the possible application of the PFIC rules&nbsp;to holders of our ordinary

shares, rights and warrants.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may reincorporate in another jurisdiction in connection with our initial business combination and such reincorporation may result in



taxes imposed on shareholders.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



may, in connection with our initial business combination and subject to requisite shareholder approval under the Companies Law, reincorporate



in the jurisdiction in which the target company or business is located. The transaction may require a shareholder to recognize taxable



income in the jurisdiction in which the shareholder is a tax resident or in which its members are resident if it is a tax transparent



entity. We do not intend to make any cash distributions to shareholders to pay such taxes. Shareholders may be subject to withholding



taxes or other taxes with respect to their ownership of us after the reincorporation.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Resources



could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate



and acquire or merge with another business. If we are unable to complete our initial business combination, our public shareholders may



receive only approximately $10.00 per share, or less than such amount in certain circumstances, on the liquidation of our trust account



and our rights and warrants will expire worthless.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We

anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant

agreements, disclosure documents and other instruments will require substantial management time and attention and substantial costs

for accountants, attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up

to that point for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a

specific target business, we may fail to complete our initial business combination for any number of reasons including those beyond

our control. Any such event will result in a loss to us of the related costs incurred which could materially adversely affect

subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business

combination, our public shareholders may receive only approximately $10.00 per share on the liquidation of our trust account and our

rights and warrants will expire worthless.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 24; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



are dependent upon our officers and directors and their departure could adversely affect our ability to operate.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



operations are dependent upon a relatively small group of individuals and, in particular, our officers and directors. We believe that



our success depends on the continued service of our officers and directors, at least until we have completed our initial business combination.



In addition, our officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will



have conflicts of interest in allocating management time among various business activities, including identifying potential business



combinations and monitoring the related due diligence. We do not have an employment agreement with, or key-man insurance on the life



of, any of our directors or officers. The unexpected loss of the services of one or more of our directors or officers could have a detrimental



effect on us.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



ability to successfully effect our initial business combination and to be successful thereafter will be totally dependent upon the efforts



of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively



impact the operations and profitability of our post-combination business.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



ability to successfully effect our initial business combination is dependent upon the efforts of our key personnel. The role of our key



personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may remain with the target



business in senior management or advisory positions following our initial business combination, it is likely that some or all of the



management of the target business will remain in place. While we intend to closely scrutinize any individuals we engage after our initial



business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be



unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources



helping them become familiar with such requirements.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination.



These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them



to have conflicts of interest in determining whether a particular business combination is the most advantageous.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



key personnel may be able to remain with the company after the completion of our initial business combination only if they are able to



negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously



with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments



and/or our securities for services they would render to us after the completion of the business combination. The personal and financial



interests of such individuals may influence their motivation in identifying and selecting a target business, subject to his or her fiduciary



duties under Cayman Islands law. However, we believe the ability of such individuals to remain with us after the completion of our initial



business combination will not be the determining factor in our decision as to whether or not we will proceed with any potential business



combination. There is no certainty, however, that any of our key personnel will remain with us after the completion of our initial business



combination. We cannot assure you that any of our key personnel will remain in senior management or advisory positions with us. The determination



as to whether any of our key personnel will remain with us will be made at the time of our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may have a limited ability to assess the management of a prospective target business and, as a result, may effect our initial business



combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When



evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the



target business’s management may be limited due to a lack of time, resources or information. Our assessment of the capabilities



of the target’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities



we suspected. Should the target’s management not possess the skills, qualifications or abilities necessary to manage a public company,



the operations and profitability of the post-combination business may be negatively impacted. Accordingly, any shareholders who choose



to remain shareholders following the business combination could suffer a reduction in the value of their shares. Such shareholders are



unlikely to have a remedy for such reduction in value.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The departure of a



business combination target’s key personnel could negatively impact the operations and profitability of our post-combination business.



The role of an acquisition candidate’s key personnel upon the completion of our initial business combination cannot be ascertained



at this time. Although we contemplate that certain members of an acquisition candidate’s management team will remain associated



with the acquisition candidate following our initial business combination, it is possible that members of the management of an acquisition



candidate will not wish to remain in place.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 25; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to



how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial



business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest



in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend



to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged in several



other business endeavors for which he or she may be entitled to substantial compensation and our officers are not obligated to contribute



any specific number of hours per week to our affairs. Our independent directors also serve as officers and board members for other entities.



If our officers’ and directors’ other business affairs require them to devote substantial amounts of time to such affairs



in excess of their current commitment levels, it could limit their ability to devote time to our affairs which may have a negative impact



on our ability to complete our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain



of our officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities



similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in determining to which entity a particular



business opportunity should be presented.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following



the completion of our initial public offering and until we consummate our initial business combination, we intend to engage in the business



of identifying and combining with one or more businesses. Our sponsor and officers and directors are, or may in the future become, affiliated



with other blank check companies like ours or other entities (such as operating companies or investment vehicles) that are engaged in



making and managing investments in a similar business.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



officers and directors also may become aware of business opportunities which may be appropriate for presentation to us and the other



entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have conflicts of interest in determining to



which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential



target business may be presented to other entities prior to its presentation to us, subject to his or her fiduciary duties under Cayman



Islands law.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our



interests.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



have not adopted a policy that expressly prohibits our directors, officers, security holders or affiliates from having a direct or indirect



pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or



have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, our directors



or officers, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for



their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between



their interests and ours.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated



with our sponsor, officers, directors or existing holders which may raise potential conflicts of interest.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



light of the involvement of our sponsor, officers and directors with other entities, we may decide to acquire one or more businesses



affiliated with our sponsor, officers and directors. Our officers and directors also serve as officers and board members for other entities.



Such entities may compete with us for business combination opportunities. Our sponsor, officers and directors are not currently aware



of any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and



there have been no preliminary discussions concerning a business combination with any such entity or entities. Although we will not be



specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined



that such affiliated entity met our criteria for a business combination and such transaction was approved by a majority of our disinterested



directors. Despite our agreement to obtain an opinion from an independent investment banking firm or another independent firm that commonly



renders valuation opinions for the type of company we are seeking to acquire or an independent accounting firm, regarding the fairness



to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated



with our officers, directors or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the



business combination may not be as advantageous to our public shareholders as they would be absent any conflicts of interest.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 26; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Since



our sponsor, officers and directors will lose their entire investment in us if our initial business combination is not completed, a conflict



of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On



March 26,&nbsp;2021, our sponsor purchased an aggregate of 2,875,000 founder shares for an aggregate purchase price of $25,000, or approximately



$0.01 per share. Prior to the initial investment in the company of $25,000 by our sponsor, the company had no assets, tangible or intangible.



As such, our sponsor owns approximately 21.88% of our issued and outstanding shares after our initial public offering (assuming it does



not purchase units in our initial public offering and taking into account ownership of the private placement units). The founder shares



will be worthless if we do not complete an initial business combination. In addition, our sponsor has purchased an aggregate of 330,000



private placement units, for a purchase price of $3,300,000 in the aggregate, or $10.00 per unit, that will also be worthless if we do



not complete a business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each



private placement unit consists of one private placement share, one private placement warrant and one private placement right. Each private placement right will be converted to one seventh (1/7) of one ordinary share upon the closing of the business combination transaction. Each private placement warrant may



be exercised for one-half of one ordinary share at a price of $11.50 per whole share, subject to adjustment as provided herein.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



founder shares are identical to the ordinary shares included in the units being sold in our initial public offering except that (i)&nbsp;the



founder shares are subject to certain transfer restrictions and (ii)&nbsp;our sponsor, officers and directors have entered into a letter



agreement with us, pursuant to which they have agreed (A)&nbsp;to waive their redemption rights with respect to their founder shares,



private placement shares and public shares in connection with the completion of our initial business combination, (B)&nbsp;to waive their



redemption rights with respect to any founder shares, private placement shares and public shares held by them in connection with a stockholder



vote to approve an amendment to our amended and restated memorandum and articles of association (x)&nbsp;to modify the substance or timing



of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem



100% of our public shares if we have not consummated our initial business combination within the timeframe set forth therein or with



respect to any other provision relating to stockholders’ rights or pre-initial business combination activity and (C)&nbsp;to waive



their rights to liquidating distributions from the trust account with respect to their founder shares and private placement shares if



we fail to complete our initial business combination within 9 months from the closing of our initial public offering (or up to 21 months



from the closing of our initial public offering if we extend the period of time to consummate a business combination, as described in



more detail in this prospectus) (although they will be entitled to liquidating distributions from the trust account with respect to any



public shares they hold if we fail to complete our initial business combination within the prescribed time frame).</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



personal and financial interests of our officers and directors may influence their motivation in identifying and selecting a target business



combination, completing an initial business combination and influencing the operation of the business following the initial business



combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Since



our sponsor, officers and directors may not be eligible to be reimbursed for their out-of-pocket expenses if our initial business combination



is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for



our initial business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At



the closing of our initial business combination, our sponsor, officers and directors, or any of their respective affiliates, will be



reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses



and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses



incurred in connection with activities on our behalf. These financial interests of our sponsor, officers and directors may influence



their motivation in identifying and selecting a target business combination and completing an initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely



affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although



we have no commitments as of the date of this prospectus to issue any notes or other debt securities, or to otherwise incur outstanding



debt following our initial public offering, we may choose to incur substantial debt to complete our initial business combination. We



have agreed that we will not incur any indebtedness unless we have obtained from the lender a waiver of any right, title, interest or



claim of any kind in or to the monies held in the trust account. As such, no issuance of debt will affect the per-share amount available



for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 27; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">default



    and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt



    obligations;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceleration



    of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants



    that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such



    financing while the debt security is outstanding;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    inability to pay dividends on our ordinary shares;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">using



    a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends



    on our ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations



    on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased



    vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;



    and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations



    on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution



    of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may only be able to complete one business combination with the proceeds of our initial public offering and the sale of the private placement



units, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This



lack of diversification may negatively impact our operations and profitability.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of



the net proceeds from our initial public offering and the sale of the private placement units, $115,000,000 was available to complete



our business combination and pay related fees and expenses (which includes up to approximately $2,875,000 for the payment of deferred



underwriting commissions).</span></p>















<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



may effectuate our initial business combination with a single target business or multiple target businesses simultaneously or within



a short period of time. However, we may not be able to effectuate our initial business combination with more than one target business



because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma



financial statements with the SEC that present operating results and the financial condition of several target businesses as if they



had been operated on a combined basis. By completing our initial business combination with only a single entity our lack of diversification



may subject us to numerous economic, competitive and regulatory risks. Further, we would not be able to diversify our operations or benefit



from the possible spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete several



business combinations in different industries or different areas of a single industry.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,



the prospects for our success may be:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">solely



    dependent upon the performance of a single business, property or asset; or</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dependent



    upon the development or market acceptance of a single or limited number of products, processes or services.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This



lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial



adverse impact upon the particular industry in which we may operate subsequent to our initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 28; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete



our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers



to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make



it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we



could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence



investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations



and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks,



it could negatively impact our profitability and results of operations.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may attempt to complete our initial business combination with a private company about which little information is available, which may



result in a business combination with a company that is not as profitable as we suspected, if at all.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



pursuing our acquisition strategy, we may seek to effectuate our initial business combination with a privately held company. Very little



public information generally exists about private companies, and we could be required to make our decision on whether to pursue a potential



initial business combination on the basis of limited information, which may result in a business combination with a company that is not



as profitable as we suspected, if at all.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance



that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably



operate such business.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



may structure a business combination so that the post-transaction company in which our public shareholders own shares will own less than



100% of the equity interests or assets of a target business, but we will only complete such business combination if the post-transaction



company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest



in the target sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not



consider any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities



of the target, our shareholders prior to the business combination may collectively own a minority interest in the post business combination



company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue



a transaction in which we issue a substantial number of new ordinary shares in exchange for all of the outstanding capital stock of a



target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number of



new ordinary shares, our shareholders immediately prior to such transaction could own less than a majority of our issued and outstanding



ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently combine their holdings resulting



in a single person or group obtaining a larger share of the company’s stock than we initially acquired. Accordingly, this may make



it more likely that our management will not be able to maintain our control of the target business.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete



a business combination with which a substantial majority of our shareholders do not agree.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



amended and restated memorandum and articles of association will not provide a specified maximum redemption threshold, except that in



no event will we redeem our public shares in an amount that would cause our net tangible assets, after payment of the deferred underwriting



commissions, to be less than $5,000,001 either immediately prior to or upon consummation of our initial business combination (such that



we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may



be contained in the agreement relating to our initial business combination. As a result, we may be able to complete our initial business



combination even though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares



or, if we are no longer a foreign private issuer and we seek shareholder approval of our initial business combination and do not conduct



redemptions in connection with our initial business combination pursuant to the tender offer rules, have entered into privately negotiated



agreements to sell their shares to our sponsor, officers, directors, advisors or their affiliates. In the event the aggregate cash consideration



we would be required to pay for all ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash



conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not



complete the business combination or redeem any shares, all ordinary shares submitted for redemption will be returned to the holders



thereof, and we instead may search for an alternate business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 29; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investors



may view our units as less attractive than those of other blank check companies.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike



other blank check companies that sell units comprised of shares and warrants each to purchase one full share in their initial public



offerings, we are selling units each of which is comprised of one ordinary share, one right to receive one-seventh (1/7) of an ordinary



share upon the consummation of an initial business combination and one redeemable warrant. Each warrant entitles the holder thereof to



purchase one-half of one ordinary share. The rights and warrants will not have any voting rights and will expire and be worthless if



we do not consummate an initial business combination. Furthermore, no fractional shares will be issued upon exercises of the warrants.



As a result, unless you acquire at least two warrants, you will not be able to receive a share upon exercise of your warrants. Accordingly,



investors in our initial public offering will not be issued the same securities as part of their investment as they may have in other



blank check company offerings, which may have the effect of limiting the potential upside value of your investment in our company.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In



order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their



charters and modified governing instruments. We cannot assure you that we will not seek to amend our amended and restated memorandum



and articles of association or governing instruments in a manner that will make it easier for us to complete our initial business combination



that our shareholders may not support.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



order to effectuate a business combination, blank check companies have, in the past, amended various provisions of their charters and



modified governing instruments. For example, blank check companies have amended the definition of business combination, increased redemption



thresholds and extended the period of time in which it had to consummate a business combination. We cannot assure you that we will not



seek to amend our amended and restated memorandum and articles of association or governing instruments or extend the time in which we



have to consummate a business combination through amending our amended and restated memorandum and articles of association will require



a special resolution of our shareholders as a matter of Cayman Islands law.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



provisions of our amended and restated memorandum and articles of association that relate to our pre-initial business combination activity



(and corresponding provisions of the agreement governing the release of funds from our trust account), including an amendment to permit



us to withdraw funds from the trust account such that the per share amount investors will receive upon any redemption or liquidation



is substantially reduced or eliminated, may be amended with the approval of holders of at least two-thirds of our ordinary shares who



attend and vote in a general meeting, which is a lower amendment threshold than that of some other blank check companies. It may be easier



for us, therefore, to amend our amended and restated memorandum and articles of association and the trust agreement to facilitate the



completion of an initial business combination that some of our shareholders may not support.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some



other blank check companies have a provision in their charter which prohibits the amendment of certain of its provisions, including those



which relate to a company’s pre-initial business combination activity, without approval by a certain percentage of the company’s



shareholders. In those companies, amendment of these provisions requires approval by between 90% and 100% of the company’s public



shareholders. Our amended and restated memorandum and articles of association will provide that any of its provisions, including those



related to pre-initial business combination activity (including the requirement to deposit proceeds of our initial public offering and



the private placement of warrants into the trust account and not release such amounts except in specified circumstances, and to provide



redemption rights to public shareholders as described herein and in our amended and restated memorandum and articles of association or



an amendment to permit us to withdraw funds from the trust account such that the per share amount investors will receive upon any redemption



or liquidation is substantially reduced or eliminated), but excluding the provision of the articles relating to the appointment of directors,



may be amended if approved by holders of at least two-thirds of our ordinary shares who attend and vote in a general meeting, and corresponding



provisions of the trust agreement governing the release of funds from our trust account may be amended if approved by holders of 65%



of our ordinary shares. We may not issue additional securities that can vote on amendments to our amended and restated memorandum and



articles of association. Our sponsor, which will beneficially own approximately 21.88% of our ordinary shares upon the closing of our



initial public offering (assuming it does not purchase units in our initial public offering and taking into account ownership of the



private placement units), will participate in any vote to amend our amended and restated memorandum and articles of association and/or



trust agreement and will have the discretion to vote in any manner it chooses. As a result, we may be able to amend the provisions of



our amended and restated memorandum and articles of association which govern our pre-business combination behavior more easily than some



other blank check companies, and this may increase our ability to complete a business combination with which you do not agree. Our shareholders



may pursue remedies against us for any breach of our amended and restated memorandum and articles of association.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 30; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain



agreements related to our initial public offering may be amended without shareholder approval.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain



agreements, including the underwriting agreement relating to our initial public offering, the investment management trust agreement between



us and Wilmington Trust, National Association and Vstock Transfer LLC, the letter agreement among us and our sponsor, officers, directors



and director nominees, the registration rights agreement among us and our sponsor and the administrative services agreement between us



and our sponsor, may be amended without shareholder approval. These agreements contain various provisions that our public shareholders



might deem to be material. For example, the underwriting agreement related to our initial public offering contains a covenant that the



target company that we acquire must have a fair market value equal to at least 80% of the balance in the trust account at the time of



signing the definitive agreement for the transaction with such target business (excluding the deferred underwriting commissions and taxes



payable on the income earned on the trust account) so long as we obtain and maintain a listing for our securities on the NASDAQ. While



we do not expect our board to approve any amendment to any of these agreements prior to our initial business combination, it may be possible



that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to



any such agreement in connection with the consummation of our initial business combination. Any such amendment may have an adverse effect



on the value of an investment in our securities.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target



business, which could compel us to restructure or abandon a particular business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although

we believe that the net proceeds of our initial public offering and the sale of the private placement units will be sufficient to

allow us to complete our initial business combination, because we have not yet identified any prospective target business we cannot

ascertain the capital requirements for any particular transaction. If the net proceeds of our initial public offering and the sale

of the private placement units prove to be insufficient, either because of the size of our initial business combination, the

depletion of the available net proceeds in search of a target business, the obligation to redeem for cash a significant number of

shares from shareholders who elect redemption in connection with our initial business combination or the terms of negotiated

transactions to purchase shares in connection with our initial business combination, we may be required to seek additional financing

or to abandon the proposed business combination. We cannot assure you that such financing will be available on acceptable terms, if

at all. To the extent that additional financing proves to be unavailable when needed to complete our initial business combination,

we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative

target business candidate. In addition, even if we do not need additional financing to complete our initial business combination, we

may require such financing to fund the operations or growth of the target business. The failure to secure additional financing could

have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or

shareholders is required to provide any financing to us in connection with or after our initial business combination. If we are

unable to complete our initial business combination, our public shareholders may only receive approximately $10.00 per share on the

liquidation of our trust account, and our rights and warrants will expire worthless. In certain circumstances, our public

shareholders may receive less than $10.00 per share on the redemption of their shares.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of



a majority of the then issued and outstanding warrants.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



warrants will be issued in registered form under a warrant agreement between Vstock Transfer LLC, as warrant agent, and us. The warrant



agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any



defective provision, but requires the approval by the holders of a majority of the then issued and outstanding warrants (including private



warrants) to make any change that adversely affects the interests of the registered holders of warrants. Accordingly, we may amend the



terms of the warrants in a manner adverse to a holder if holders of a majority of the then issued and outstanding warrants (including



private warrants) approve of such amendment. Although our ability to amend the terms of the public warrants with the consent of a majority



of the then issued and outstanding warrants is unlimited, examples of such amendments could be amendments to, among other things, increase



the exercise price of the warrants, shorten the exercise period or decrease the number of ordinary shares purchasable upon exercise of



a warrant.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 31; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of



$0.01 per warrant, provided that the last reported sales price of our ordinary shares equal or exceed $18.00 per share (as adjusted for



share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading



days within a 30 trading-day period ending on the third trading day prior to the date we send the notice of redemption to the warrant



holders. If and when the warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares upon exercise



of the warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such



registration or qualification. We will use our best efforts to register or qualify such shares under the blue sky laws of the state of



residence in those states in which the warrants were offered by us in our initial public offering. Redemption of the outstanding warrants



could force you (i)&nbsp;to exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you



to do so, (ii)&nbsp;to sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii)&nbsp;to



accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially



less than the market value of your warrants. None of the private placement warrants will be redeemable by us so long as they are held



by our sponsor or its permitted transferees.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



management’s ability to require holders of our warrants to exercise such warrants on a cashless basis will cause holders to receive



fewer ordinary shares upon their exercise of the warrants than they would have received had they been able to exercise their warrants



for cash.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we call our public warrants for redemption after the redemption criteria described elsewhere in this prospectus have been satisfied,



our management will have the option to require any holder that wishes to exercise his warrant (including any warrants held by our sponsor,



officers or directors, other purchasers of our founders’ units, or their permitted transferees) to do so on a “cashless basis.”



If our management chooses to require holders to exercise their warrants on a cashless basis, the number of ordinary shares received by



a holder upon exercise will be fewer than it would have been had such holder exercised his warrant for cash. This will have the effect



of reducing the potential “upside” of the holder’s investment in our company.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our



warrants and founder shares may have an adverse effect on the market price of our ordinary shares and make it more difficult to effectuate



our initial business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We

have issued, as part of the units offered in our IPO and, simultaneously with the closing of our initial public offering, an

aggregate of 11,830,000 public and private placement units. In each case, the warrants are exercisable to purchase one-half

of one ordinary share at a price of $11.50 per whole share, subject to adjustment as provided herein. Prior to our initial

public offering, our sponsor purchased an aggregate of 2,875,000 founder shares in a private placement. In addition, if our

sponsor makes any working capital loans, up to $1,500,000 of such loans may be converted into units, at the price of $10.00

per unit (which, for example, would result in the holders being issued 150,000 ordinary shares if $1,500,000 of notes were so

converted, as well as 150,000 warrants to purchase 75,000 shares) at the option of the lender and 150,000 rights. Such units

would be identical to the private placement units. To the extent we issue ordinary shares to effectuate a business

transaction, the potential for the issuance of a substantial number of additional ordinary shares upon exercise of these

warrants could make us a less attractive acquisition vehicle to a target business. Any such issuance will increase the number

of issued and outstanding ordinary shares and reduce the value of the ordinary shares issued to complete the business

transaction. Therefore, our warrants and founder shares may make it more difficult to effectuate a business combination or

increase the cost of acquiring the target business. The private placement units are identical to the units sold in our

initial public.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 32; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A



provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike



some other blank check companies, if</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we



    issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial



    business combination at a Newly Issued Price of less than $9.20 per share;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the



    aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available



    for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions),



    and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the



    Market Value is below $9.20 per share,</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">then



the exercise price of the warrants will be adjusted to be equal to 115% of the higher of the Market Value and the Newly Issued Price,



and the $18 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market



Value and the Newly Issued Price. This may make it more difficult for us to consummate an initial business combination with a target



business.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The



determination of the offering price of our units and the size of our initial public offering is more arbitrary than the pricing of securities



and size of an offering of an operating company in a particular industry. You may have less assurance, therefore, that the offering price



of our units properly reflects the value of such units than you would have in a typical offering of an operating company.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior



to our initial public offering there has been no public market for any of our securities. The public offering price of the units and



the terms of the warrants were negotiated between the underwriters and us. In determining the size of our initial public offering, management



held customary organizational meetings with representatives of the underwriters, both prior to our inception and thereafter, with respect



to the state of capital markets, generally, and the amount the underwriters believed they reasonably could raise on our behalf. Factors



considered in determining the size of our initial public offering, prices and terms of the units, including the ordinary shares and warrants



underlying the units, include:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the



    history and prospects of companies whose principal business is the acquisition of other companies;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior



    offerings of those companies;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    prospects for acquiring an operating business at attractive values;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a



    review of debt to equity ratios in leveraged transactions;</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    capital structure;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an



    assessment of our management and their experience in identifying operating companies;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general



    conditions of the securities markets at the time of our initial public offering; and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other



    factors as were deemed relevant.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although



these factors were considered, the determination of our offering price is more arbitrary than the pricing of securities of an operating



company in a particular industry since we have no historical operations or financial results.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 33; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because



we must furnish our shareholders with target business financial statements, we may lose the ability to complete an otherwise advantageous



initial business combination with some prospective target businesses.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



federal proxy rules&nbsp;require that a proxy statement with respect to a vote on a business combination meeting certain financial significance



tests include historical and/or pro forma financial statement disclosure in periodic reports. We will include the same financial statement



disclosure in connection with our tender offer documents, whether or not they are required under the tender offer rules. These financial



statements may be required to be prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United



States of America, or U.S. GAAP, or international financing reporting standards as issued by the International Accounting Standards Board,



or IFRS, depending on the circumstances and the historical financial statements may be required to be audited in accordance with the



standards of the PCAOB. These financial statement requirements may limit the pool of potential target businesses we may acquire because



some targets may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules&nbsp;and



complete our initial business combination within the prescribed time frame.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We



are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of



certain exemptions from disclosure requirements available to emerging growth companies and smaller reporting companies, this could make



our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage



of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth



companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&nbsp;404 of



the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,



and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any



golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may



deem important. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status



earlier, including if the market value of our ordinary shares held by non-affiliates exceeds $700 million as of any June&nbsp;30 before



that time, in which case we would no longer be an emerging growth company as of the following December&nbsp;31. We cannot predict whether



investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less



attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would



be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,



Section&nbsp;102(b)(1)&nbsp;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial



accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective



or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting



standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements



that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such



extended transition period which means that when a standard is issued or revised and it has different application dates for public or



private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new



or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth



company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of



the potential differences in accountant standards used.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,



we are a “smaller reporting company” as defined in Rule&nbsp;10(f)(1)&nbsp;of Regulation S-K. Smaller reporting companies



may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial



statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1)&nbsp;the market value of our



ordinary shares held by non-affiliates exceeds $250 million as of the end of the prior June&nbsp;30<sup>th</sup>, or (2)&nbsp;our annual



revenues exceeded $100 million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates exceeds



$700 million as of the prior June&nbsp;30<sup>th</sup>. To the extent we take advantage of such reduced disclosure obligations, it may



also make comparison of our financial statements with other public companies difficult or impossible.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 34; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compliance



obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require substantial



financial and management resources, and increase the time and costs of completing an acquisition.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;404



of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report on



Form&nbsp;10-K for the year ending December&nbsp;31, 2022. Only in the event we are deemed to be a large accelerated filer or an accelerated



filer will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control



over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required to comply with the independent



registered public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank



check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public



companies because a target company with which we seek to complete our initial business combination may not be in compliance with the



provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such



entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because



we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to



protect your rights through the U.S. Federal courts may be limited.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are an exempted company incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service



of process within the United States upon our directors or officers, or enforce judgments obtained in the United States courts against



our directors or officers.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



corporate affairs are governed by our amended and restated memorandum and articles of association, the Companies Law (as the same may



be supplemented or amended from time to time) and the common law of the Cayman Islands. The rights of shareholders to take action against



the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are



to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively



limited judicial precedent in the Cayman Islands as well as from English common law, the decisions of whose courts are of persuasive



authority, but are not binding on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of



our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions



in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to the United States, and



certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate law. In addition, Cayman



Islands companies may not have standing to initiate a shareholders derivative action in a Federal court of the United States.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



have been advised by our Cayman Islands legal counsel that the courts of the Cayman Islands are unlikely (i)&nbsp;to recognize or enforce



against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of



the United States or any state; and (ii)&nbsp;in original actions brought in the Cayman Islands, to impose liabilities against us predicated



upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed



by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of



judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign



court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes



upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign



judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in



respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the



grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy



of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court



may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken



by management, members of the Board of Directors or controlling shareholders than they would as public shareholders of a United States



company.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 35; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provisions



in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors



might be willing to pay in the future for our ordinary shares and could entrench management.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



amended and restated memorandum and articles of association will contain provisions that may discourage unsolicited takeover proposals



that shareholders may consider to be in their best interests. These provisions include two-year director terms and the ability of the



Board of Directors to designate the terms of and issue new series of preference shares, which may make more difficult the removal of



management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>After



our initial business combination, it is possible that a majority of our directors and officers will live outside the United States and



all of our assets will be located outside the United States; therefore investors may not be able to enforce federal securities laws or



their other legal rights.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It



is possible that after our initial business combination, a majority of our directors and officers will reside outside of the United States



and all of our assets will be located outside of the United States. As a result, it may be difficult, or in some cases not possible,



for investors in the United States to enforce their legal rights, to effect service of process upon all of our directors or officers



or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties on our directors and officers



under United States laws.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 36; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks



Associated with Acquiring and Operating a Business Outside of the United States</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



we effect our initial business combination with a company located outside of the United States, we would be subject to a variety of additional



risks that may negatively impact our operations.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we effect our initial business combination with a company located outside of the United States, we would be subject to any special considerations



or risks associated with companies operating in the target business’ home jurisdiction, including any of the following:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rules&nbsp;and



    regulations or currency redemption or corporate withholding taxes on individuals;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws



    governing the manner in which future business combinations may be effected;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tariffs



    and trade barriers;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulations



    related to customs and import/export matters;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">longer



    payment cycles;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax



    issues, such as tax law changes and variations in tax laws as compared to the United States;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency



    fluctuations and exchange controls;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rates



    of inflation;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges



    in collecting accounts receivable;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cultural



    and language differences;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">employment



    regulations;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">crime,



    strikes, riots, civil disturbances, terrorist attacks and wars; and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">deterioration



    of political relations with the United States which could result in any number of difficulties, both normal course such as above



    or extraordinary such as sanctions being imposed. We may not be able to adequately address these additional risks. If we were unable



    to do so, our operations might suffer.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



our management following our initial business combination is unfamiliar with United States securities laws, they may have to expend time



and resources becoming familiar with such laws, which could lead to various regulatory issues.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following



our initial business combination, any or all of our management could resign from their positions as officers of the Company, and the



management of the target business at the time of the business combination will remain in place. Management of the target business may



not be familiar with United States securities laws. If new management is unfamiliar with United States securities laws, they may have



to expend time and resources becoming familiar with such laws. This could be expensive and time-consuming and could lead to various regulatory



issues which may adversely affect our operations.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If



we effect a business combination with a company located outside of the United States, the laws applicable to such company will likely



govern all of our material agreements and we may not be able to enforce our legal rights.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If



we effect a business combination with a company located outside of the United States, the laws of the country in which such company operates



will govern almost all of the material agreements relating to its operations. We cannot assure you that the target business will be able



to enforce any of its material agreements or that remedies will be available in this new jurisdiction. The system of laws and the enforcement



of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability



to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities



or capital. Additionally, if we acquire a company located outside of the United States, it is likely that substantially all of our assets



would be located outside of the United States and some of our officers and directors might reside outside of the United States. As a



result, it may not be possible for investors in the United States to enforce their legal rights, to effect service of process upon our



directors or officers or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties of our



directors and officers under Federal securities laws.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 37; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because



of the costs and difficulties inherent in managing cross-border business operations after we acquire it, our results of operations may



be negatively impacted following a business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
a business, operations, personnel or assets in another country is challenging and costly. Management of the target business that we
may hire (whether based abroad or in the U.S.) may be inexperienced in cross-border business practices and unaware of significant
differences in accounting rules, legal regimes and labor practices. Even with a seasoned and experienced management team, the costs
and difficulties inherent in managing cross-border business operations, personnel and assets can be significant (and much higher
than in a purely domestic business) and may negatively impact our financial and operational performance.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Many



countries, and especially those in emerging markets, have difficult and unpredictable legal systems and underdeveloped laws and regulations



that are unclear and subject to corruption and inexperience, which may adversely impact our results of operations and financial condition.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



ability to seek and enforce legal protections, including with respect to intellectual property and other property rights, or to defend



ourselves with regard to legal actions taken against us in a given country, may be difficult or impossible, which could adversely impact



our operations, assets or financial condition.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules&nbsp;and



regulations in many countries, including some of the emerging markets within the regions we will initially focus, are often ambiguous



or open to differing interpretation by responsible individuals and agencies at the municipal, state, regional and federal levels. The



attitudes and actions of such individuals and agencies are often difficult to predict and inconsistent.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delay



with respect to the enforcement of particular rules&nbsp;and regulations, including those relating to customs, tax, environmental and



labor, could cause serious disruption to operations abroad and negatively impact our results.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>After



our initial business combination, substantially all of our assets may be located in a foreign country and substantially all of our revenue



may be derived from our operations in such country. Accordingly, our results of operations and prospects will be subject, to a significant



extent, to the economic, political and legal policies, developments and conditions in the country in which we operate.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



economic, political and social conditions, as well as government policies, of the country in which our operations are located could affect



our business. The economies in developing markets we will initially focus on differ from the economies of most developed countries in



many respects. Such economic growth has been uneven, both geographically and among various sectors of the economy and such growth may



not be sustained in the future. If in the future such country’s economy experiences a downturn or grows at a slower rate than expected,



there may be less demand for spending in certain industries. A decrease in demand for spending in certain industries could materially



and adversely affect our ability to find an attractive target business with which to consummate our initial business combination and



if we effect our initial business combination, the ability of that target business to become profitable.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exchange



rate fluctuations and currency policies may cause a target business’ ability to succeed in the international markets to be diminished.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



the event we acquire a non-U.S. target, all revenues and income would likely be received in a foreign currency, the dollar equivalent



of our net assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value



of the currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions.



Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any target business



or, following consummation of our initial business combination, our financial condition and results of operations. Additionally, if a



currency appreciates in value against the dollar prior to the consummation of our initial business combination, the cost of a target



business as measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because



our business objective includes the possibility of acquiring one or more operating businesses with primary operations in emerging markets



we will focus on, changes in the exchange rate between the U.S. dollar and the currency of any relevant jurisdiction may affect our ability



to achieve such objective. For instance, the exchange rates between the Turkish lira or the Indian rupee and the U.S. dollar has changed



substantially in the last two decades and may fluctuate substantially in the future. If the U.S. dollar declines in value against the



relevant currency, any business combination will be more expensive and therefore more difficult to complete. Furthermore, we may incur



costs in connection with conversions between U.S. dollars and the relevant currency, which may make it more difficult to consummate a



business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 38; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because



foreign law could govern almost all of our material agreements, we may not be able to enforce our rights within such jurisdiction or



elsewhere, which could result in a significant loss of business, business opportunities or capital.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign



law could govern almost all of our material agreements. The target business may not be able to enforce any of its material agreements



or that remedies will be available outside of such foreign jurisdiction’s legal system. The system of laws and the enforcement



of existing laws and contracts in such jurisdiction may not be as certain in implementation and interpretation as in the United States.



Judiciaries in such jurisdiction may also be relatively inexperienced in enforcing corporate and commercial law, leading to a higher



than usual degree of uncertainty as to the outcome of any litigation. As a result, the inability to enforce or obtain a remedy under



any of our future agreements could result in a significant loss of business and business opportunities.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate



governance standards in foreign countries may not be as strict or developed as in the United States and such weakness may hide issues



and operational practices that are detrimental to a target business.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General



corporate governance standards in some countries are weak in that they do not prevent business practices that cause unfavorable related



party transactions, over-leveraging, improper accounting, family company interconnectivity and poor management. Local laws often do not



go far to prevent improper business practices. Therefore, shareholders may not be treated impartially and equally as a result of poor



management practices, asset shifting, conglomerate structures that result in preferential treatment to some parts of the overall company,



and cronyism. The lack of transparency and ambiguity in the regulatory process also may result in inadequate credit evaluation and weakness



that may precipitate or encourage financial crisis. In our evaluation of a business combination we will have to evaluate the corporate



governance of a target and the business environment, and in accordance with United States laws for reporting companies take steps to



implement practices that will cause compliance with all applicable rules&nbsp;and accounting practices. Notwithstanding these intended



efforts, there may be endemic practices and local laws that could add risk to an investment we ultimately make and that result in an



adverse effect on our operations and financial results.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies



in foreign countries may be subject to accounting, auditing, regulatory and financial standards and requirements that differ, in some



cases significantly, from those applicable to public companies in the United States, which may make it more difficult or complex to consummate



a business combination. In particular, the assets and profits appearing on the financial statements of a foreign company may not reflect



its financial position or results of operations in the way they would be reflected had such financial statements been prepared in accordance



with U.S. GAAP and there may be substantially less publicly available information about companies in certain jurisdictions than there



is about comparable United States companies. Moreover, foreign companies may not be subject to the same degree of regulation as are United



States companies with respect to such matters as insider trading rules, tender offer regulation, shareholder proxy requirements and the



timely disclosure of information.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal



principles relating to corporate affairs and the validity of corporate procedures, directors’ fiduciary duties and liabilities



and shareholders’ rights for foreign corporations may differ from those that may apply in the U.S., which may make the consummation



of a business combination with a foreign company more difficult. We therefore may have more difficulty in achieving our business objective.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A



slowdown in economic growth in the markets that our business target operates in may adversely affect our business, financial condition,



results of operations, the value of its equity shares and the trading price of our shares following our business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following



the business combination, our results of operations and financial condition may be dependent on, and may be adversely affected by, conditions



in financial markets in the global economy, and, particularly in the markets where the business operates. The specific economy could



be adversely affected by various factors such as political or regulatory action, including adverse changes in liberalization policies,



business corruption, social disturbances, terrorist attacks and other acts of violence or war, natural calamities, interest rates, inflation,



commodity and energy prices and various other factors which may adversely affect our business, financial condition, results of operations,



value of our equity shares and the trading price of our shares following the business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 39; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regional



hostilities, terrorist attacks, communal disturbances, civil unrest and other acts of violence or war may result in a loss of investor



confidence and a decline in the value of our equity shares and trading price of our shares following our business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terrorist



attacks, civil unrest and other acts of violence or war may negatively affect the markets in which we may operates our business following



our business combination and also adversely affect the worldwide financial markets. In addition, the countries we will focus on, have



from time to time experienced instances of civil unrest and hostilities among or between neighboring countries. Any such hostilities



and tensions may result in investor concern about stability in the region, which may adversely affect the value of our equity shares



and the trading price of our shares following our business combination. Events of this nature in the future, as well as social and civil



unrest, could influence the economy in which our business target operates, and could have an adverse effect on our business, including



the value of equity shares and the trading price of our shares following our business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any



downgrade of credit ratings of the country in which the company we acquire does business may adversely affect our ability to raise debt



financing following our business combination.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No



assurance can be given that any rating organization will not downgrade the credit ratings of the sovereign foreign currency long-term



debt of the country in which our business target operates, which reflect an assessment of the overall financial capacity of the government



of such country to pay its obligations and its ability to meet its financial commitments as they become due. Any downgrade could cause



interest rates and borrowing costs to rise, which may negatively impact both the perception of credit risk associated with our future



variable rate debt and our ability to access the debt markets on favorable terms in the future. This could have an adverse effect on



our financial condition following our business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Returns



on investment in foreign companies may be decreased by withholding and other taxes.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



investments will incur tax risk unique to investment in developing economies. Income that might otherwise not be subject to withholding



of local income tax under normal international conventions may be subject to withholding of income tax in a developing economy. Additionally,



proof of payment of withholding taxes may be required as part of the remittance procedure. Any withholding taxes paid by us on income



from our investments in such country may or may not be creditable on our income tax returns. We intend to seek to minimize any withholding



tax or local tax otherwise imposed. However, there is no assurance that the foreign tax authorities will recognize application of such



treaties to achieve a minimization of such tax. We may also elect to create foreign subsidiaries to effect the business combinations



to attempt to limit the potential tax consequences of a business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 40; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY



NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some



statements contained in this prospectus are forward-looking in nature. Our forward-looking statements include, but are not limited to,



statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future.



In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including



any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,”



“could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,”



“possible,” “potential,” “predict,” “project,” “should,” “would”



and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not



forward-looking. Forward-looking statements in this prospectus may include, for example, statements about:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    ability to complete our initial business combination;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business



    combination;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or



    in approving our initial business combination, as a result of which they would then receive expense reimbursements;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    potential ability to obtain additional financing to complete our initial business combination;</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    pool of prospective target businesses;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the



    ability of our officers and directors to generate a number of potential acquisition opportunities;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    public securities’ potential liquidity and trading;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the



    lack of a market for our securities;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the



    use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our



    financial performance following our initial public offering.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



forward-looking statements contained in this prospectus are based on our current expectations and beliefs concerning future developments



and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated.



These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions



that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.



These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors”.



Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may



vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any



forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable



securities laws.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 41; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>Item



1B. Unresolved Staff Comments</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>Item



2. Properties</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



currently maintain our executive offices at 80 Broad Street, 5<sup>th</sup> Floor, New York, NY 10004. The cost for this space is included



in the $10,000 per month fee that we will pay our sponsor for office space, administrative and support services. We consider our current



office space adequate for our current operations.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>Item



3. Legal Proceedings</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



of December&nbsp;31, 2021, there is no material litigation, arbitration or governmental proceeding currently pending against us or any



members of our management team in their capacity as such.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>Item



4. Mine Safety Disclosures</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not



Applicable</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>















<!-- Field: Page; Sequence: 42; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>PART&nbsp;II</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>ITEM



5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



units are currently traded on The Nasdaq Global Market under the symbol “ALSAU” and started trading on The Nasdaq Global



Market on December 13, 2021. The ordinary shares, rights and warrants and began separate trading on January 18, 2022, under the symbols



“ALSA,” “ALSAR” and “ALSAW” respectively.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholders



of Record</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At



December&nbsp;31, 2021 there were 11,830,000 of our units issued and outstanding by stockholders of record. Assuming all units have been separated into ordinary shares, rights and warrants, at December&nbsp;31, 2021,



there were 14,705,000 ordinary shares issued and outstanding by stockholders of record, there were 11,830,000



of our rights issued and outstanding by stockholders of record, and there were 11,830,000 warrants issued and outstanding by stockholders



of record. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners



of any of our securities whose securities are held in the names of various security brokers, dealers, and registered clearing agencies.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



have not paid any cash dividends on our shares of ordinary shares to date and do not intend to pay cash dividends prior to the completion



of an initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if



any, capital requirements and general financial condition subsequent to completion of a business combination. The payment of any dividends



subsequent to a business combination will be, subject to the laws of the Cayman Islands, within the discretion of our board of directors



at such time. It is the present intention of our board of directors to retain all earnings, if any, for use in our business operations



and, accordingly, our board of directors does not anticipate declaring any cash dividends in the foreseeable future. In addition, our



board of directors is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further,



if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to under the terms



of such indebtedness.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent



Sales of Unregistered Securities</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Securities



Authorized for Issuance Under Equity Compensation Plans</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use



of Proceeds</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on December 13,



2021. We completed our initial public offering on December 15, 2021. In our initial public offering, we sold units at an offering price



of $10.00 and consisting of one ordinary share, one right and one redeemable warrant. Each right entitles the holders thereof to receive



one seventh (1/7) of one ordinary shares upon the consumption of the initial business combination. Each warrant entitles the holder thereof



to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise of the warrants.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



connection with our initial public offering, we sold 11,500,000 units, generating gross proceeds of $115,000,000. Simultaneously with



the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement by and between the Company and our sponsor, A-Star



Management Corporation, the Company completed the private sale of an aggregate of 330,000 units (the “<span style="text-decoration: underline">Private Placement Units</span>”)



to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $3,300,000.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 43; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction



costs related to our IPO amounted to $5,669,696, consisting of $2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees



and $494,696 of other offering costs. A total of $115,000,000, comprised of $112,700,000 of the proceeds from the IPO (which amount includes



up to $2,875,000 of the underwriter’s deferred discount) and $2,300,000 of the proceeds of the sale of the Private Placement Units,



was placed in a U.S.-based trust account, established by VStock Transfer LLC, our transfer agent and maintained at Wilmington Trust,



National Association, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released



to the Company to pay its taxes, the funds held in the trust account will not be released from the trust account until the earliest of



(i)&nbsp;the completion of the Company’s initial business combination, (ii)&nbsp;the redemption of any of the Company’s public



shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles



of association to (A)&nbsp;modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it



does not complete its initial business combination within 9 months from the closing of the IPO (or up to 21 months from the closing of



the IPO if we extend the period of time to consummate a business combination), or (B)&nbsp;with respect to any other provision relating



to shareholders’ rights or pre-business combination activity, and (iii)&nbsp;the redemption of the Company’s public shares



if it is unable to complete its initial business combination within 9 months from the closing of the IPO (or up to 21 months from the



closing of the IPO if we extend the period of time to consummate a business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For



the year ended December&nbsp;31, 2021, net cash generated from the IPO and private placement units and held outside of the trust was



used in operating activities was $142,451. At December 31, 2021, the Company had working capital as $477,051, which exclude amount of $115,000,744 for marketable security held in trust account in current asset, and amount of $2,875,000 for deferred underwriting commission in current liability.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_009"></span>ITEM



6. RESERVED</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Not
applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_010"></span>ITEM



7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction



with our audited financial statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary



Data” of this Annual Report on Form&nbsp;10-K. Certain information contained in the discussion and analysis set forth below includes



forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a



result of many factors, including those set forth under “Special Note Regarding Forward-Looking Statements,” “Item



1A. Risk Factors” and elsewhere in this Annual Report on Form&nbsp;10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



are a blank check company incorporated in the Cayman Islands on March 11, 2021 formed for the purpose of effecting a merger, share exchange,



asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses. We intend to effectuate



our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Units, our shares,



debt or a combination of cash, shares and debt.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business



Combination will be successful.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results



of Operations</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception through December&nbsp;31,



2021 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target



company for a Business Combination after the Initial Public Offering. We do not expect to generate any operating revenues until after the completion of our initial Business



Combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the Initial



Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting,



accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business



Combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the year ended December&nbsp;31,

2021, we had a net loss of $52,509, which consisted of interest income on marketable securities held in the Trust Account of $749 and offset by expense of $53,258.</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 44; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity



and Capital Resources</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On



December 15, 2021, we consummated the Initial Public Offering of 11,500,000 Units, generating gross proceeds of $115,000,000. Simultaneously



with the closing of the Initial Public Offering, we consummated the sale of 330,000 Private Units to the Sponsor at a price of $10.00



per Private Unit generating gross proceeds of $3,300,000.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following



the Initial Public Offering and the sale of the Private Units, a total of $115,000,000 was placed in the Trust Account. We incurred $5,669,696



in transaction costs, including $2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees and $494,696 of other offering



costs.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the year ended December&nbsp;31,

2021, net cash used in operating activities was $142,451. Net loss of $52,509 was impacted by interest earned on investments of $749.</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At



December&nbsp;31, 2021, we had investments held in the Trust Account of $115,000,744. We intend to use substantially all of the funds



held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions,



to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share



capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the



Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions



and pursue our growth strategies.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At



December&nbsp;31, 2021, we had cash of $387,858 held outside of the Trust Account. We intend to use the funds held outside the Trust



Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel



to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate



documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an



affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Such



Working Capital Loans would be evidenced by promissory notes. If we complete a Business Combination, we may repay such notes out of the



proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working



capital held outside the Trust Account to repay such notes, but no proceeds from our Trust Account would be used for such repayment.



Up to $1,500,000 of notes may be convertible into units, at a price of $10.00 per unit, at the option of the lender. The units would



be identical to the Private Units.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



order to complete a Business Combination, the Company will need to raise additional capital through loans or additional investments from



its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not



obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion,



to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company



is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but



not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses.



The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These



conditions raise substantial doubt about the Company’s ability to continue as a going concern if a Business Combination is not



consummated.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance



Sheet Financing Arrangements</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December&nbsp;31, 2021. We



do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to



as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have



not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments



of other entities, or purchased any non-financial assets.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 45; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual



Obligations</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement



to pay the Sponsor a monthly fee of $10,000 for certain general and administrative services, including office space, utilities and administrative



services, provided to the Company. We began incurring these fees on December 15, 2021 and will continue to incur these fees monthly until



the earlier of the completion of a Business Combination  or the Company’s liquidation.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



underwriters are entitled to a deferred fee of two and one-half&nbsp;percent (2.5%) of the gross proceeds of the Initial Public Offering,



or $2,500,000. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account,



subject to the terms of the underwriting agreement.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical



Accounting Policies</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United



States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure



of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual



results could materially differ from those estimates. We have identified the following critical accounting policies:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s



specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards



Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging



(“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet



the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under



ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could



potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions



for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance



and as of each subsequent quarterly period end date while the warrants are outstanding.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For



issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component



of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants



are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.



Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary



Shares Subject to Redemption</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



account for our ordinary shares subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”)



Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability



instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption



rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within



our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our



ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain



future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as commitments and contingencies, outside



of the shareholders’ equity section of our balance sheets.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying

value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in

the carrying amount of redeemable ordinary shares are affected by charges against additional&nbsp;paid-in capital and accumulated

deficit if additional paid in capital equals to zero.</p>



<p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 46; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net



Loss Per Ordinary Share</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



statement of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner



similar to the two-class method of income (loss) per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offering



Costs Associated with the Initial Public Offering</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering

costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date

that are directly  related to the IPO. As of December 31, 2021, offering costs amounted to $5,669,696 consisting of

$2,300,000 of underwriting fees, $2,875,000  of deferred underwriting fees, and $494,696 of other offering costs. The Company

complies with the requirements of ASC 340-10-S99-1 and  SEC Staff Accounting Bulletin Topic 5A “Expenses of

Offering”. The Company allocates offering costs between public shares,  public rights and public warrants based on the

estimated fair values of public shares, public warrants,  and public rights at the date of issuance.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent



Accounting Standard</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management



does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material



effect on our financial statements.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>Item



7A. Quantitative and Qualitative Disclosures about Market Risk</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following



the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account,



have been invested in U.S. government treasury bills, notes or bonds with a maturity of 180 days or less or in certain money market funds



that invest solely in US treasuries. Due to the short-term nature of these investments, we believe there will be no associated material



exposure to interest rate risk.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_012"></span>Item



8. Financial Statements and Supplementary Data</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This



information appears following Item 15 of this Report and is included herein by reference.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_013"></span>Item



9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 47; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_014"></span>Item



9A. Controls and Procedures.</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Evaluation



of Disclosure Controls and Procedures</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure



controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed



under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the



SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated



and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely



decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and



chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of December



31, 2021, pursuant to Rule&nbsp;13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that,



as of December 31, 2021, our disclosure controls and procedures were effective.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and



procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the



disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there



are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure



controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all



our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain



assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated



goals under all potential future conditions.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management’s



Report on Internal Controls Over Financial Reporting</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This



Annual Report on Form&nbsp;10-K does not include a report of management’s assessment regarding internal control over financial



reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules&nbsp;of



the SEC for newly public companies.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes



in Internal Control over Financial Reporting</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There



has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially



affect, our internal control over financial reporting, as the circumstances that led to the restatement of our financial statements described



in this Report had not yet been identified.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_015"></span>Item



9B. Other Information</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><b><span id="item9c"></span>Item 9C. Disclosure Regarding Foreign Jurisdictions

That Prevent Inspections</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 48; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_016"></span>PART&nbsp;III</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&nbsp;10.



<i><span id="a_017"></span>DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



current directors and executive officers are as follows:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: left; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 59%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhe



    Zhang</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,



    Chief Executive Officer and Director</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guojian



    Chen</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief



    Financial Officer and Director</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Konstantin



    A. Sokolov</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaofeng



    Zhou</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huei-Ching



    Huang</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Zhe



Zhang</b> serves as our Chairman and Chief Executive Officer since April&nbsp;2021. From August&nbsp;2018 to February&nbsp;2020, Mr.&nbsp;Zhang



served as an independent director of TKK Symphony Acquisition Corporation. Since May&nbsp;2013, Dr.&nbsp;Zhang has been a Founding Partner



of SIFT Capital, an asset manager licensed by the Securities and Futures Commission (SFC) of Hong Kong and China Securities Regulatory



Commission (CSRC). Since February&nbsp;2019,&nbsp;Dr.&nbsp;Zhang has also been the CEO of Still Waters Green Technology Limited, an asset



management company based in London, specializing in the development and management of renewable energy and power generation assets. Prior



to that, from January&nbsp;2000 to April&nbsp;2013, he was an Executive Director at Goldman Sachs Beijing, where he was a member of the



Supervisory Board of Goldman’s Beijing Office and led multiple overseas acquisitions by Chinese state-owned enterprises and listed



companies. He is experienced with fund formation, equity investment and portfolio management. Before entering the private sector, Dr.&nbsp;Zhang



had spent 14 years with MOFCOM including as a diplomat stationed in Europe. He is licensed as a Responsible Officer for Asset Management



under the SFC of Hong Kong, as well as the licensed to practice as a professional respectively for securities, futures and fund management



in China. Dr.&nbsp;Zhang holds a Ph.D. degree from China University of International Business and Economics, Master degrees from both



Peking University (LL.M.) and Oxford University (Magister Juris), and a Bachelor degree from Shanghai Institute of Foreign Trade (B.A.).



He currently sits on the board of China Oxford Scholarship Fund and is involved in the process for scholarship awardee selection every



year.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Guojian



Chen</b> serves as our Chief Financial Officer and director since March&nbsp;2021. Mr.&nbsp;Chen serves as an independent director of



Venus Acquisition Corporation since February&nbsp;2021. Mr.&nbsp;Chen serves as the Secretary of Board of Beijing ChinaReel Art Exchange



Inc. a leading copyright operator focusing on high-quality video content, since May&nbsp;2020, where he is in charge of investor relations



and corporate finance matters for the company. Mr.&nbsp;Chen served as a director of Beijing Zhongqixinhe Enterprise Management Consulting



Co.,&nbsp;Ltd., a financial advisory firm with focuses on financial, real estate and TMT industry from May&nbsp;2019 to May&nbsp;2020.



Mr.&nbsp;Chen served as an analyst of Zhongrong Huitong Investment Fund Management (Zhuhai) Co., Ltd. from July&nbsp;2018 to May&nbsp;2019.



Mr.&nbsp;Chen received his Bachelor of Management degree from Renmin University of China in 2015, and Master of Finance from the University



of Chinese Academy of Sciences in June&nbsp;2018.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Xiaofeng



Zhou</b> serves as an independent director since December 2021. Ms.&nbsp;Zhou serves as the Managing Director and founder of Hainan Genyuan



Investment Corp. since October&nbsp;2020. From September&nbsp;2019 to October&nbsp;2020, Ms.&nbsp;Zhou served as Senior Strategic Consultant



for Nanjing Travel Group. Prior to that, from September&nbsp;2006 to September&nbsp;2019, Ms.&nbsp;Zhou served director, Vice President



and Secretary of the Board for Tempus International Commercial Services Corp., a company listed in Hong Kong and Shenzhen Stock market.



Ms.&nbsp;Zhou received her LL.B. degree from Shenzhen University in 2004.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Konstantin



A. Sokolov</b> serves as an independent director since December 2021. Mr.&nbsp;Sokolov is the founder and Chairman of Gotthard Investment



AG, which is a private equity firm based in Zurich, Switzerland, focusing on financial services, asset management and global real estate.



Since 2011, Gotthard Investment AG advised and managed multiple investment funds, and partnered with leading Swiss and Lichtenstein banks



to invest globally in energy and real estate assets. Prior to that, Mr.&nbsp;Sokolov served as Managing Director of Centrica plc (British



Gas and Direct Energy). Between 1997 to 2005, Mr.&nbsp;Sokolov served in senior leadership positions at Qwest Communication,&nbsp;Inc.,



a pioneer in fiber optics. Mr.&nbsp;Sokolov holds Executive MBA degree from University of Chicago in 2005 and Master of Mathematics and



Computer Science degree from St. Petersburg State University in 1997.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 49; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Huei-Ching



(Tina) Huang</b>&nbsp;serves as an independent director since December 2021. Ms.&nbsp;Huang founded and has served as director of AGC



Capital Securities Pty Ltd since April&nbsp;2014. AGC Capital is a financial advisory service company based in Sydney and licensed in



Australia. Ms.&nbsp;Huang leads AGC Capital’s operation in Australia and Asia Pacific, primarily focusing on initial public offerings,



funds management, corporate finance, mergers and acquisitions and direct investments. From February&nbsp;2021 to&nbsp;Present, Ms.&nbsp;Huang



also serve as a director of Wall St. Trust Limited based in Hong Kong, which is a licensed entity of Securities&nbsp;&amp; Futures Commission



of Hong Kong (SFC). Prior to AGC Capital, from February&nbsp;2012 to May&nbsp;2013, Ms.&nbsp;Huang worked for KPMG as a director



of Information Risk Management. Ms.&nbsp;Huang received her a LLB degree from School of Law of Soochow University in June&nbsp;1992.



We believe Ms.&nbsp;Huang is well-qualified to serve as a member of the Board because of her financial experiences in capital markets.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



officers are elected by the Board of Directors and serve at the discretion of the Board of Directors, rather than for specific terms



of office. Our Board of Directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and



articles of association as it deems appropriate. Our amended and restated memorandum and articles of association provides that our officers



may consist of a Chairman, Chief Executive Officer, President, Chief Financial Officer, Vice Presidents, Secretary, Assistant Secretaries,



Treasurer and such other offices as may be determined by the Board of Directors.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each



of our directors holds office for a two-year term. Subject to any other special rights applicable to the shareholders, any vacancies



on our Board of Directors may be filled by the affirmative vote of a majority of the directors present and voting at the meeting of our



board or by a majority of the holders of our founder shares.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director



Independence</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



NASDAQ listing standards require that a majority of our Board of Directors be independent. An “independent director” is defined



generally as a person who has no material relationship with the listed company (either directly or as a partner, shareholder or officer



of an organization that has a relationship with the company). We currently have three “independent directors” as defined



in the NASDAQ listing standards and applicable SEC rules&nbsp;prior to completion of our initial public offering. Our board has determined



that each of Messrs.&nbsp;Xiaofeng Zhou, Konstantin A. Sokolov and Huei-Ching (Tina) Huang are independent directors under applicable



SEC and NASDAQ rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Committees



of the Board of Directors</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



Board of Directors has two standing committees: an audit committee and a compensation committee. Each committee will operate under a



charter that has been approved by our board. Subject to phase-in rules&nbsp;and a limited exception, NASDAQ rules&nbsp;and Rule&nbsp;10A-3



of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors, and NASDAQ rules&nbsp;require



that the compensation committee of a listed company be comprised solely of independent directors.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



members of our audit committee are Messrs.&nbsp;Xiaofeng Zhou, Konstantin A. Sokolov and Huei-Ching (Tina) Huang. Mr. Sokolov serves



as chairman of the audit committee. Each member of the audit committee is financially literate and our Board of Directors has determined



that Mr.&nbsp;Sokolov qualifies as an “audit committee financial expert” as defined in applicable SEC rules.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



members of our Compensation Committee are Messrs.&nbsp;Xiaofeng Zhou, Konstantin A. Sokolov and Huei-Ching (Tina) Huang. Ms.&nbsp;Zhou



serves as chairman of the compensation committee.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



members of our Nominating Committee are Messrs.&nbsp;Xiaofeng Zhou, Konstantin A. Sokolov and Huei-Ching (Tina) Huang. Ms.&nbsp;Huang



serves as chairman of the Nomination committee.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 50; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&nbsp;11.



<i><span id="a_018"></span>EXECUTIVE COMPENSATION.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No



executive officer has received any cash compensation for services rendered to us during the year ended December&nbsp;31, 2021.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No



compensation or fees of any kind, including finder’s, consulting fees and other similar fees, will be paid to our founders, members



of our management team or their respective affiliates, for services rendered prior to, or in order to effectuate the consummation of,



our initial business combination (regardless of the type of transaction that it is). Directors, officers and founders will receive reimbursement



for any out-of-pocket expenses incurred by them in connection with activities on our behalf, such as identifying potential target businesses,



performing business due diligence on suitable target businesses and business combinations as well as traveling to and from the offices,



plants or similar locations of prospective target businesses to examine their operations. There is no limit on the amount of out-of-pocket



expenses reimbursable by us.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After



completion of our initial business combination, members of our management team who remain with us may be paid employment, consulting,



management or other fees from the combined company with any and all amounts being fully disclosed to stockholders, to the extent then



known, in the proxy solicitation materials furnished to our stockholders. The amount of such compensation may not be known at the time



of a stockholder meeting held to consider an initial business combination, as it will be up to the directors of the post-combination



business to determine executive and director compensation. In this event, such compensation will be publicly disclosed at the time of



its determination in an Exchange Act filing such as Current Report on Form&nbsp;8-K, as required by the SEC.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 51; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_019"></span>Item&nbsp;12.



<i>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</i></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



following table sets forth information regarding the beneficial ownership of our shares of ordinary shares as of December&nbsp;31, 2021



by:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each



    person known by us to be the beneficial owner of more than 5% of our outstanding shares of ordinary shares;</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each



    of our officers and directors; and</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all



    of our officers and directors as a group.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless



otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary



shares beneficially owned by them. The following table does not reflect beneficial ownership of the warrants and rights included in the units offered



in our initial public offering or purchased by our sponsor in connection with our initial public offering as these warrants are not exercisable



and these rights are not convertible within 60 days of December&nbsp;31, 2021 or the date of this Form&nbsp;10-K.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom">



    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Address of Beneficial Owner<sup>(1)</sup></b></span></td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>



    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount and<br> Nature of<br> Beneficial<br> Ownership<sup>(3)</sup></b></span></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>



    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate<br> Percentage of<br> Outstanding<br> Shares<sup>(3)</sup></b></span></td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-Star Management Corporation<sup>(2)</sup></span></td><td style="width: 1%">&nbsp;</td>



    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 9%; text-align: right">3,205,000</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>



    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 9%; text-align: right">21.88</td><td style="width: 1%; text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhe Zhang<sup>(2)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">3,205,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">21.88</td><td style="text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guojian Chen<sup>(4)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Konstantin A. Sokolov<sup>(4)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaofeng Zhou<sup>(4)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huei-Ching Huang<sup>(4)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Markscheid<sup>(4)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">—</td><td style="text-align: left">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">All directors and officers as a group (6 individuals)</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">3,205,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">21.88</td><td style="text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-style: italic; text-align: left">5% or greater beneficial owners</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lighthouse Investment Partners, LLC<sup>(5)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">981,585</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">6.68</td><td style="text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yakira Partners, LP<sup>(6)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">790,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">5.37</td><td style="text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weiss Asset Management LP<sup>(7)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">860,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">5.85</td><td style="text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Space Summit Capital LLC<sup>(8)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">929,634</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">8.08</td><td style="text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feis Equities LLC<sup>(9)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">985,830</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">8.57</td><td style="text-align: left">%</td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saba



Capital Management, L.P.<sup>(10)</sup></span></td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">675,245</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>



    <td style="text-align: left">&nbsp;</td><td style="text-align: right">5.7</td><td style="text-align: left">%</td></tr>



  </tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</div></div><!-- Field: /Rule-Page -->















<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less



than one percent.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise indicated, the business address of each of the individuals is 80 Broad Street,
                                            5<sup>th</sup> Floor, New York, New York 10004.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents



2,875,000 founder ordinary shares and 330,000 private placement ordinary shares held by A-Star Management Corporation, our sponsor. Mr.



Zhe Zhang, our Chairman and Chief Executive Officer, is the sole director of our sponsor, have voting and dispositive power of the ordinary



shares. The address for our sponsor is Craigmuir Chambers, PO Box 71, Road Town, Tortola, VG 1110 British Virgin Islands.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



upon 14,705,000 ordinary shares outstanding. Includes the 330,000 private placement units (and the component parts) purchased by our



sponsor simultaneously with the consummation of our initial public offering.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 52; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such



individual does not beneficially own any of our ordinary shares. However, such individual has a pecuniary interest in our ordinary shares



through his ownership of shares of our sponsor.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



on information contained in a Schedule 13G filed on February 14, 2022. Lighthouse serves as the investment manager of MAP 136, MAP 204,



and MAP 214. Because Lighthouse may be deemed to control MAP 136, MAP 204, and MAP 214, as applicable, Lighthouse may be deemed to beneficially



own, and to have the power to vote or direct the vote of, and the power to direct the disposition of the Issuer’s Shares reported



herein.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



on information contained in a Schedule 13G filed on February 9, 2022 by Yakira Partners, L.P., Yakira Enhanced Offshore Fund Ltd. and



MAP 136 Segregated Portfolio. Each such entity reported that it has shared power to vote 790,000 units and shared power to dispose of



790,000 units.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



on information contained in the Schedule 13G filed on February 7, 2022 by Weiss Asset Management, WAM GP, and Andrew Weiss. Each reporting



person has shared power to vote 860,000 ordinary shares and shared the power to dispose of 860,000 shares. The business address for each



reporting person is 222 Berkeley St., 16<sup>th</sup> Floor, Boston, Massachusetts 02116.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



on information contained in the Schedule 13G/A filed on February 3, 2022 by Space Summit Capital LLC, the reporting entity has sole power



to vote 929,634 share and sole power to dispose 929,634 shares. The business address for the reporting person is 15455 Albright Street,



Pacific Palisades, CA 90272.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



on information contained in the Schedule 13G/A filed on January 11, 2022 by Feis Equities LLC, the reporting entity has sole power to



vote 985,830 shares and sole power to dispose 985,830 shares.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="border-collapse: collapse; vertical-align: top; text-align: justify">



<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



on information contained in the Schedule 13G file on December 23, 2021 by Saba Capital Management, L.P., Boaz R. Weinstein and Saba Capital



Management GP, LLC, the reporting person has shares power to vote 675,245 shares and shared power to dispose 675,245 shares.</span></td>



</tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



founders beneficially own approximately 21.88% of the issued and outstanding ordinary shares. Because of the ownership block held by



our founders, officers and directors, such individuals may be able to effectively exercise influence over all matters requiring approval



by our stockholders, including the election of directors and approval of significant corporate transactions other than approval of our



initial business combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



sponsor, officers and directors are deemed to be our “promoters” as such term is defined under the federal securities laws.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section&nbsp;16(a)&nbsp;Beneficial



Ownership Reporting Compliance</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;16(a)&nbsp;of



the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our executive officers, directors, and persons who beneficially



own more than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission initial reports



of ownership and reports of changes in ownership of our ordinary shares and other equity securities. These executive officers, directors,



and greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of all Section&nbsp;16(a)&nbsp;forms



filed by such reporting persons.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based



solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe that, during



the fiscal year ended December&nbsp;31, 2021, our directors, executive officers, and ten percent stockholders complied with all Section&nbsp;16(a)&nbsp;filing



requirements,</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 53; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_020"></span>Item&nbsp;13.



Certain Relationships, and Related Transactions and Director Independence</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain



Relationships and Related Transactions</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April



6,&nbsp;2021, our sponsor purchased 2,875,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.01 per share.



Our sponsor owns approximately 21.88% of our issued and outstanding ordinary shares as of December&nbsp;31, 2021.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our

sponsor purchased an aggregate of 330,000 private placement units at a price of $10.00 per unit in a private placement that

was completed  simultaneously with the closing of our initial public offering. Each unit consists of one private placement

share,  one private placement  warrant and one private placement right. Each private placement warrant entitles the holder

upon exercise to purchase one-half of one ordinary share at a price of $11.50  per whole share, subject to adjustment as

provided herein. Each private placement right will be converted to one seventh (1/7) of one ordinary shares upon the

completion of its initial business combination. The private placement units (including the underlying securities) may

not,  subject to certain limited exceptions, be transferred, assigned or sold by it until 30 days after the completion of our

initial business  combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



connection with the completion of our initial public offering, we entered into an Administrative Services Agreement with our sponsor



pursuant to which we will pay a total of $10,000 per month for office space, administrative and support services to such affiliate. Upon



completion of our initial business combination or our liquidation, we will cease paying these monthly fees. Accordingly, in the event



the consummation of our initial business combination takes the maximum 21 months, our sponsor will be paid a total of $210,000 ($10,000



per month) for office space, administrative and support services and will be entitled to be reimbursed for any out-of-pocket expenses.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in



connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business



combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or



our or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling



on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



sponsor has agreed to loan us up to $300,000 to be used for a portion of the expenses of our initial public offering. As of the date



of closing our initial public offering, we had borrowed $300,000 under the promissory note with our sponsor. These loans are non-interest



bearing, unsecured and were originally due and payable in connection with our public offering (December 15, 2021). The loan repaid as



$300,000 allotted to the payment of offering expense. Related party loan balance as of December 31, 2021 was nil.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate



of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete



an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close,



we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust



account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units at a price of $10.00 per unit



(which, for example, would result in the holders being issued 150,000 ordinary shares, 150,000 rights and  150,000 warrants to purchase 75,000 shares if $1,500,000 of notes were so converted) at the option of the lender. The units would be identical to the placement units issued



to the initial holder. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements



exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as



we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to



funds in our trust account.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



holders of the founder shares, private placement units, the shares underlying the warrants underlying the unit purchase option issued



to the underwriters of our initial public offering, and units that may be issued on conversion of working capital loans (and any securities



underlying the private placement units and the working capital loans) are entitled to registration rights pursuant to a registration



rights agreement signed on the effective date of our initial public offering requiring us to register such securities for resale. The



holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities.



In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent



to our completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule&nbsp;415



under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statements</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director



Independence</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



NASDAQ listing standards require that a majority of our Board of Directors be independent. An “independent director” is defined



generally as a person who has no material relationship with the listed company (either directly or as a partner, shareholder or officer



of an organization that has a relationship with the company). We currently have three “independent directors” as defined



in the NASDAQ listing standards and applicable SEC rules&nbsp;prior to completion of our initial public offering. Our board has determined



that each of Messrs.&nbsp;Xiaofeng Zhou, Konstantin A. Sokolov and Huei-Ching (Tina) Huang are independent directors under applicable



SEC and NASDAQ rules.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>















<!-- Field: Page; Sequence: 54; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_021"></span>Item



14<i>.</i> Principal Accountant Fees and Services.</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



following is a summary of fees paid or to be paid to UHY LLP, or UHY, for services rendered.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit



Fees</i>. Audit fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and



services that are normally provided by UHY in connection with regulatory filings. The aggregate fees billed by UHY for professional services



rendered for the audit of our annual financial statements, review of the financial information included in our Forms 10-K and Form S-1 for the respective



periods and other required filings with the SEC for the year ended December&nbsp;31, 2021 is $70,500 in total. The above amounts include interim



procedures and audit fees, as well as attendance at audit committee meetings.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit-Related



Fees.</i> Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance



of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest



services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We



did not pay UHY for consultations concerning financial accounting and reporting standards for the year ended December&nbsp;31, 2021.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax



Fees</i>. We did not pay UHY for tax planning and tax advice for the year ended December&nbsp;31, 2021.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All



Other Fees</i>. We did not pay UHY for other services for the year ended December&nbsp;31, 2021.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Approval



Policy</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our



audit committee was formed upon the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve



all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board



of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve



all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject



to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to



the completion of the audit).</span></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 55; Value: 1 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_022"></span>PART&nbsp;IV</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_023"></span>Item



15<i>.</i> Exhibits, Financial Statement Schedules</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



following documents are filed as part of this Form&nbsp;10-K:</span></p></td></tr>



</tbody></table>







<p style="margin: 0">&nbsp;</p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in">&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">(1)</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Financial statements listed on the Financial Statements Table of Contents</td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></td>



    <td style="padding-bottom: 1pt; width: 1%"><b>&nbsp;</b></td>



    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_0015" tabindex="18">Report
    of Independent Registered Public Accounting Firm (Firm ID: 1195)</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-2<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements:</span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_001" tabindex="18">Balance Sheet</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002" tabindex="18">Statement of Operations</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003" tabindex="18">Statement of Changes in Stockholders’ Equity (Deficit)</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004" tabindex="18">Statement of Cash Flows</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005" tabindex="18">Notes to Financial Statements</a></span></td>



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>



  </tbody></table>















<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>















<!-- Field: Page; Sequence: 56; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="b_0015"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To the Board of Directors and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stockholders of Alpha Star Acquisition Corporation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited the accompanying balance sheet of
Alpha Star Acquisition Corporation (the Company) as of December 31, 2021, and the related statement of operations, stockholders’
equity, and cash flows as of and for the period from March 11, 2021 to December 31, 2021, and the related notes (collectively referred
to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the
financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the period from March
11, 2021 through December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Substantial Doubt about the Company’s Ability
to Continue as a Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements have been prepared
assuming the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has no revenue,
its business plan is dependent on the completion of a financing transaction and the Company’s cash and working capital as December
31, 2021 are not sufficient to complete its planned activities for the upcoming year. These conditions raise substantial doubt about the
Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s
plans regarding these matters are also described in Note 1 to the financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty. Our opinion is not modified with respect to that matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis for Opinion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations
of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal
control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal
control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">/s/ <span id="xdx_90E_edei--AuditorName_c20210311__20211231_zEQqIgoKU51k"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:AuditorName" inside-table="false" id="fact-identifier-45" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">UHY LLP</ix:nonnumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have served as the Company’s auditor since
2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_edei--AuditorLocation_c20210311__20211231_zUxR7Qd2TY0k"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:AuditorLocation" inside-table="false" id="fact-identifier-46" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Irvine, California</ix:nonnumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">March 29, 2022<span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;<span id="xdx_90C_edei--AuditorFirmId_c20210311__20211231_ziKTakwl1qB6" style="display: none"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="dei:AuditorFirmId" inside-table="false" id="fact-identifier-47" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1195</ix:nonnumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>















<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_001"></span>Alpha



Star Acquisition Corporation</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance



Sheet</b></span></p>















<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></p>







<table cellpadding="0" cellspacing="0" id="xdx_30F_111_z3UDj1Jj2XE6" summary="xdx: Statement - Balance Sheet" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom; background-color: White">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td id="xdx_490_20211231_zONSvrWLrEQ3" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>

<tr style="vertical-align: bottom">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></td>



    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>As of <br>



    December&nbsp;31,</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></td></tr>



  <tr style="vertical-align: bottom">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2021</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></td></tr>



  <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zSUiR4MqPGk4" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: bottom; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_z5M7BhCXWfgl" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current



    assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_401_ecustom--CashHeldInEscrow_i02I_maCz953_zeTYzZuZQHte" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash



    in escrow</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:CashHeldInEscrow" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-48" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">387,858</ix:nonfraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_407_eus-gaap--PrepaidInsurance_i02I_maCz953_znYTNlyHp5y2" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid



    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:PrepaidInsurance" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-49" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">142,192</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40E_eus-gaap--AssetsHeldInTrustCurrent_i02I_maCz953_zLM4pXswAzId" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable



    securities held in trust account</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:AssetsHeldInTrustCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-50" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,744</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40F_eus-gaap--AssetsCurrent_i01TI_mtCz953_maCz40b_zu6FXIDyH0mb" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total



    current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:AssetsCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-51" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,530,794</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_404_eus-gaap--Assets_iTI_mtCz40b_zgoE3EjU1cM8" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total



    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:Assets" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-52" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,530,794</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z54MzS0B0mae" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Liabilities



    and stockholders’ equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_407_eus-gaap--LiabilitiesCurrentAbstract_i01B_zCiIdR1O7GQ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current



    liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCzsab_z2O5WRCXVcUd" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued



    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:AccruedLiabilitiesCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-53" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,999</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_400_eus-gaap--DeferredCompensationLiabilityCurrent_i02I_maCzsab_zHPFPs10FMF" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Deferred



    underwriting commissions</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-54" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_401_eus-gaap--LiabilitiesCurrent_i01TI_mtCzsab_maCz1Nb_zhpN9XcNyFo9" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total



    current liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:LiabilitiesCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-55" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,927,999</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40A_eus-gaap--Liabilities_i01TI_mtCz1Nb_maCznUl_zMYLiU9KAfq5" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total



    liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:Liabilities" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-56" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,927,999</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_405_eus-gaap--CommitmentsAndContingencies_i01I_zrCA0cx5TUO7" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commitments



    and contingencies</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maCznUl_zGDzwU8iJZ33" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ordinary



    shares subject to possible redemption, <span id="xdx_903_eus-gaap--TemporaryEquitySharesAuthorized_c20211231_pdd" title="Odinary shares subject to possible redemption"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-57" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span> shares at redemption value of $<span id="xdx_902_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20211231_zHn06H4bs0v1" title="Odinary shares subject to possible redemption, Per Share"><span><ix:nonfraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="true" id="fact-identifier-58" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span> per share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-59" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B_zLhFmkBTTJG" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stockholders’ equity (deficit):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40D_eus-gaap--CommonStockValue_i02I_maCzx7c_z9YUrEe5G3Vf" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ordinary



    shares, par value $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_zldhEMD6FhN9" title="Common stock, par value"><span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="true" id="fact-identifier-60" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.001</ix:nonfraction></span></span>, authorized <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20211231_pdd" title="Common stock, shares authorized"><span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-61" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">50,000,000</ix:nonfraction></span></span> shares; <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20211231_zE3voSLzSeU1" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zirQoJuJvYE1" title="Common stock, shares outstanding"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-62" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-63" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,205,000</ix:nonfraction></span></ix:nonfraction></span></span></span> shares issued and outstanding at December 31, 2021, excluding <span id="xdx_90A_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20211231_zuU2O4Q78iQ8" title="Odinary shares subject to possible redemption"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-64" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span>



    shares subject to possible redemption</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:CommonStockValue" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-65" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,205</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_maCzx7c_zyzEF99bx5s3" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional



    paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0105"><span><ix:nonfraction name="us-gaap:AdditionalPaidInCapital" contextref="AsOf2021-12-31" id="fact-identifier-66" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0105" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isstandardonly="true" iscustomonly="false">–</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40C_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzx7c_zAgicNK7ktne" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated



    deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-67" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,400,410</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_401_eus-gaap--StockholdersEquity_i01TI_mtCzx7c_maCznUl_zfzjVahhlwVc" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total

    stockholders’ deficit</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-68" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,397,205</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCznUl_zG3DV5Xjd4Ta" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total

liabilities and stockholders’ deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-69" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,530,794</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  </tbody></table>











<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>























<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The



accompanying notes are an integral part of the financial statements.</i></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>















<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></p>















<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_002"></span>Alpha



Star Acquisition Corporation</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement



of Operations</b></span></p>















<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" id="xdx_30B_113_zxMHjzzsMmqe" summary="xdx: Statement - Statement of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom; background-color: White">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td id="xdx_498_20210311__20211231_z3KF01aWKUJ7" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>

<tr style="vertical-align: bottom">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>For



                                            the period from March 11, 2021 (inception) to</b></span></p>



                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>December&nbsp;31,



                                            <br>



                                            2021</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_msCzZTu_zMuUl9UMlwoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Formation



    and operational costs</span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:GeneralAndAdministrativeExpense" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-70" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">53,258</ix:nonfraction></span></span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iNT_di_mtCzZTu_maCzq4w_zB201cPiLcul" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss



    from operation costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:OperatingIncomeLoss" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-71" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">53,258</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>







  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zYY0sO8Zcqc8" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_403_eus-gaap--InterestIncomeOperating_i01_maCzWIq_zIufHD01DXH3" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Interest



    income</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:InterestIncomeOperating" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-72" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">749</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_405_eus-gaap--NonoperatingIncomeExpense_iT_mtCzWIq_maCzq4w_zRTuQwTkQom1" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total



    other income</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:NonoperatingIncomeExpense" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-73" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">749</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzq4w_maCzMsn_zwGdHNYzrVB1" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss



    before income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-74" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,509</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_msCzMsn_zUG2lBtFBzyg" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Income



    tax (benefit) expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0125"><span><ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2021-03-11to2021-12-31" id="fact-identifier-75" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0125" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isstandardonly="true" iscustomonly="false">–</ix:nonfraction></span></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_iT_mtCzMsn_zoeSlUrY8CPe" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net



    loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-76" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,509</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40A_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToRedemption_zdFpF6lEdDQ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic



    and diluted weighted average shares outstanding - ordinary shares subject to redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToRedemption" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-77" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">660,473</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40D_ecustom--BasicAndDilutedNetLossPerShare_z8pKpLlExQW4" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic



    and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:BasicAndDilutedNetLossPerShare" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="true" id="fact-identifier-78" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">24.46</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_407_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingNonRedeemableCommonStock_zd0NrrcRnVe5" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic



    and diluted weighted average shares outstanding - non redeemable ordinary shares</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:BasicAndDilutedWeightedAverageSharesOutstandingNonRedeemableCommonStock" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-79" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,893,953</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40C_ecustom--BasicAndDilutedNetLossPerShareNonRedeemableCommonStock_zdEvtKZ2hYt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic



    and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:BasicAndDilutedNetLossPerShareNonRedeemableCommonStock" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares" inside-table="true" id="fact-identifier-80" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5.60</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  </tbody></table>











<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The



accompanying notes are an integral part of the financial statements.</i></span></p>















<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_003"></span>Alpha



Star Acquisition Corporation</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement

of Stockholder’s Deficit</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For



the period from March 11, 2021 (inception) to December 31, 2021</b></span></p>















<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></p>







<table cellpadding="0" cellspacing="0" id="xdx_30B_114_zPKgAUwqLQNc" summary="xdx: Statement - Statement of Stockholder's Equity (Deficit)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom; background-color: White">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 40%">&nbsp;</td><td style="width: 1%">&nbsp;</td>

    <td style="text-align: left; width: 1%">&nbsp;</td><td style="text-align: right; width: 9%">&nbsp;</td><td style="text-align: left; width: 1%">&nbsp;</td><td style="width: 1%">&nbsp;</td>

    <td style="text-align: left; width: 1%">&nbsp;</td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_custom--OrdinarySharesMember_zYoSzkATXnF1" style="text-align: right; width: 9%">&nbsp;</td><td style="text-align: left; width: 1%">&nbsp;</td><td style="width: 1%">&nbsp;</td>

    <td style="text-align: left; width: 1%">&nbsp;</td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zREJkb871Ra2" style="text-align: right; width: 9%">&nbsp;</td><td style="text-align: left; width: 1%">&nbsp;</td><td style="width: 1%">&nbsp;</td>

    <td style="text-align: left; width: 1%">&nbsp;</td><td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zBxGq77EJKI4" style="text-align: right; width: 9%">&nbsp;</td><td style="text-align: left; width: 1%">&nbsp;</td><td style="width: 1%">&nbsp;</td>

    <td style="text-align: left; width: 1%">&nbsp;</td><td id="xdx_4B1_zOvcpEMGi2Sc" style="text-align: right; width: 9%">&nbsp;</td><td style="text-align: left; width: 1%">&nbsp;</td></tr>

<tr style="vertical-align: bottom">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Paid-in</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Stockholders’</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">capital</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">deficit</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">deficit</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_43F_c20210311__20211231_eus-gaap--StockholdersEquity_iS_zvvxQ8fx0Vz1" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance



    at March 11, 2021 (inception)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20210311__20211231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zy1swlBL9lod" title="Beginning balance, Shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0142"><span><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2021-03-10_custom_OrdinarySharesMember" id="fact-identifier-81" unitref="Shares" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0142" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0137"><span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-03-10_custom_OrdinarySharesMember" id="fact-identifier-82" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0137" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0138"><span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-03-10_us-gaap_AdditionalPaidInCapitalMember" id="fact-identifier-83" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0138" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0139"><span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-03-10_us-gaap_RetainedEarningsMember" id="fact-identifier-84" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0139" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0140"><span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-03-10" id="fact-identifier-85" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0140" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>









  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zO0t9I3kkok3" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance



    of founder shares to sponsor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210311__20211231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zn3AOCxkwTC2" title="Issuance of founder shares to sponsor, Shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-86" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-87" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-88" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,125</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0146"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" id="fact-identifier-89" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0146" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-90" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_405_ecustom--SalesOfCommonStockAndOverallotment_zBUAPlJwB8x8" style="vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sales of ordinary shares and over-allotment</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td id="xdx_98D_ecustom--SalesOfCommonStockAndOverallotmentShares_c20210311__20211231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zxSB2UBkOtSk" title="Sales of ordinary shares and over-allotment, Shares" style="text-align: right"><span><ix:nonfraction name="alsa:SalesOfCommonStockAndOverallotmentShares" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-91" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">11,500,000</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span><ix:nonfraction name="alsa:SalesOfCommonStockAndOverallotment" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-92" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">11,500</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span><ix:nonfraction name="alsa:SalesOfCommonStockAndOverallotment" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-93" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">114,988,500</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0153"><span><ix:nonfraction name="alsa:SalesOfCommonStockAndOverallotment" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" id="fact-identifier-94" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0153" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span><ix:nonfraction name="alsa:SalesOfCommonStockAndOverallotment" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-95" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">115,000,000</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td></tr>

  <tr id="xdx_40F_ecustom--UnderwritersCompensation_zPPXwlvieS8i" style="vertical-align: bottom; background-color: White">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Underwriters’ compensation</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">-&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0158"><span><ix:nonfraction name="alsa:UnderwritersCompensation" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" id="fact-identifier-96" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0158" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:UnderwritersCompensation" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-97" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5,175,000</ix:nonfraction></span></td><td style="text-align: left">)&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0160"><span><ix:nonfraction name="alsa:UnderwritersCompensation" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" id="fact-identifier-98" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0160" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">&nbsp;</ix:nonfraction></span></span>-</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:UnderwritersCompensation" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-99" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5,175,000</ix:nonfraction></span></td><td style="text-align: left">)&nbsp;</td></tr>

  <tr id="xdx_409_ecustom--OfferingCosts_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Offering



    costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0163"><span><ix:nonfraction name="alsa:OfferingCosts" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" id="fact-identifier-100" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0163" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:OfferingCosts" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-101" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">494,696</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0165"><span><ix:nonfraction name="alsa:OfferingCosts" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" id="fact-identifier-102" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0165" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:OfferingCosts" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-103" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">494,696</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_404_ecustom--SaleOfSharesToSponsorInPrivatePlacement_i_pp0p0" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sale



    of shares to sponsor in private placement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td id="xdx_986_ecustom--SaleOfSharesToSponsorInPrivatePlacementShares_c20210311__20211231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zyUvN0f3zrlf" title="Sale of shares to sponsor in private placement, Shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:SaleOfSharesToSponsorInPrivatePlacementShares" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-104" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">330,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:SaleOfSharesToSponsorInPrivatePlacement" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-105" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">330</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:SaleOfSharesToSponsorInPrivatePlacement" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-106" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,299,670</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0170"><span><ix:nonfraction name="alsa:SaleOfSharesToSponsorInPrivatePlacement" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" id="fact-identifier-107" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0170" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:SaleOfSharesToSponsorInPrivatePlacement" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-108" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,300,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>







  <tr id="xdx_408_ecustom--CommonStockSubjectToPossibleRedemption_zl5qJ3D42ih2" style="vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ordinary shares subject to possible redemption</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td id="xdx_984_ecustom--CommonStockSubjectToPossibleRedemptionShares_c20210311__20211231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zEZMzVut2d86" title="Ordinary shares subject to possible redemption, Shares" style="text-align: right">(<span><ix:nonfraction name="alsa:CommonStockSubjectToPossibleRedemptionShares" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="Shares" inside-table="true" id="fact-identifier-109" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">11,500,000</ix:nonfraction></span></td><td style="text-align: left">)&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:CommonStockSubjectToPossibleRedemption" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-110" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">11,500</ix:nonfraction></span></td><td style="text-align: left">)&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:CommonStockSubjectToPossibleRedemption" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-111" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">100,066,549</ix:nonfraction></span></td><td style="text-align: left">)&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0177"><span><ix:nonfraction name="alsa:CommonStockSubjectToPossibleRedemption" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" id="fact-identifier-112" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0177" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:CommonStockSubjectToPossibleRedemption" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-113" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">100,078,049</ix:nonfraction></span></td><td style="text-align: left">)&nbsp;</td></tr>

    <tr id="xdx_40F_ecustom--AllocationOfOfferingCostsRelatedToRedeemableShares_i_pp0p0" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Allocation



    of offering costs related to redeemable shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0182"><span><ix:nonfraction name="alsa:AllocationOfOfferingCostsRelatedToRedeemableShares" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" id="fact-identifier-114" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0182" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:AllocationOfOfferingCostsRelatedToRedeemableShares" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-115" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">4,934,018</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0184"><span><ix:nonfraction name="alsa:AllocationOfOfferingCostsRelatedToRedeemableShares" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" id="fact-identifier-116" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0184" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">-</ix:nonfraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:AllocationOfOfferingCostsRelatedToRedeemableShares" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-117" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">4,934,018</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>

<tr id="xdx_40D_ecustom--AccretionForRedeemableSharesToRedemptionValue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">













    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accretion



    for redeemable shares to redemption value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:AccretionForRedeemableSharesToRedemptionValue" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-118" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">17,508,069</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:AccretionForRedeemableSharesToRedemptionValue" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-119" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,347,901</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:AccretionForRedeemableSharesToRedemptionValue" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-120" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">19,855,970</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net



    loss</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0192"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-03-112021-12-31_custom_OrdinarySharesMember" id="fact-identifier-121" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0192" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0193"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-03-112021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="fact-identifier-122" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0193" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-03-112021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-123" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,509</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-124" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,509</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_439_c20210311__20211231_eus-gaap--StockholdersEquity_iE_zVB3mvlFRKYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance



    at December 31, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20210311__20211231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zYXyhPUHQish" title="Ending balance, Shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-125" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,205,000</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_custom_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-126" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,205</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0198"><span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="fact-identifier-127" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0198" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-128" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,400,410</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-129" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,397,205</ix:nonfraction></span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  </tbody></table>











<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The



accompanying notes are an integral part of the financial statements.</i></span></p>











<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>















<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page -->







<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_004"></span>Alpha



Star Acquisition Corporation</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement



of Cash Flows</b></span></p>















<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>



<p style="margin: 0"></p><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>







<table cellpadding="0" cellspacing="0" id="xdx_30D_112_zGTyWFvfmYW7" summary="xdx: Statement - Statement of Cash Flow" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom; background-color: White">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td id="xdx_49F_20210311__20211231_zOOyhdZjfBtl" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>

<tr style="vertical-align: bottom">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>For the<br>



period from<br>



March&nbsp;11, 2021<br>



(inception) to<br>



December&nbsp;31,<br>



    2021</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zftfNCIMJCDi" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: bottom; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash



    flows from operating activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&nbsp;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_405_eus-gaap--NetIncomeLoss_i01_maCzJSg_zVhwz5B3Y88j" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net



    loss</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-130" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,509</ix:nonfraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_404_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zG9FGlfgSH3h" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments

to reconcile net income (loss) to net cash used in operating activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_402_ecustom--InterestEarnedInTrustAccount_i02N_di_msCzJSg_zZA5pD4SHyP" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest



    earned in trust account</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:InterestEarnedInTrustAccount" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-131" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">749</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_40F_eus-gaap--AdjustmentForAmortization_i02_maCzJSg_zX47vbQ3ptki" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization of prepaid expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:AdjustmentForAmortization" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-132" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">7,808</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zBV3BjzZLSZe" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net



    changes in operating assets &amp; liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_di_msCzJSg_zDtXqmW0DH0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid



    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-133" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">150,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i02_maCzJSg_zVzyFBL0bQ88" style="vertical-align: bottom; background-color: White">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued



    expenses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-134" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,999</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzJSg_maCzYeU_zIIHEK042DI5" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net



    cash used in operating activities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-135" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">142,451</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zrdgEHaP0CK8" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash



    flows from investing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40C_ecustom--InvestmentOfCashInTrustAccount_i01N_di_msCzlRP_zQj2FwaI5ZGb" style="vertical-align: bottom; background-color: White">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investment



    of cash in trust account</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:InvestmentOfCashInTrustAccount" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-136" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">115,000,000</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtCzlRP_maCzYeU_zQIr4xvEnSD1" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net



    cash used in investing activities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-137" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,000</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zq5vM9qXWb9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash



    flows from financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCzrCe_zyWdSyKfTPN2" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds



    from issuance of founder shares to sponsor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-138" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40D_eus-gaap--ProceedsFromLoans_i01_maCzrCe_z5u36GXewW84" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&nbsp;Proceeds from sponsor loan</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span><ix:nonfraction name="us-gaap:ProceedsFromLoans" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-139" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">300,000</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--PaymentsForLoans_i01N_di_msCzrCe_z4ctP6p3R3L8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&nbsp;Payment of sponsor loan</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="us-gaap:PaymentsForLoans" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-140" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">300,000</ix:nonfraction></span></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_i01_maCzrCe_zdQZIR8qw747" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds



    from sale of private placement unit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-141" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,300,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_i01_maCzrCe_z44PKxlIZtdh" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds



    from sale of units</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-142" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,000</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_402_ecustom--PaymentOfOfferingCosts_i01N_di_msCzrCe_zRbfsca7kdH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Payment



    of offering costs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:PaymentOfOfferingCosts" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-143" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,794,691</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtCzrCe_maCzYeU_zKIjIBS82P0a" style="vertical-align: bottom; background-color: White">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net



    cash provided by financing activities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-144" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,530,309</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCzYeU_zGPvHRRcG0Fb" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net



    increase in cash and cash equivalents</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-145" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">387,858</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_407_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iS_zdClrLSyKS0d" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash



    and cash equivalents at beginning of period</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0246"><span><ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2021-03-10" id="fact-identifier-146" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0246" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">–</ix:nonfraction></span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_407_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iE_zghWe2r3aFYj" style="vertical-align: bottom; background-color: White">



    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash



    and cash equivalents at end of period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-147" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">387,858</ix:nonfraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40A_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zS65QmantuZ7" style="vertical-align: bottom; background-color: White">



    <td colspan="5" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Supplemental



    disclosure of non-cash investing and financing Activities:</span></td></tr>



  <tr id="xdx_40F_ecustom--DeferedUnderwiringCompensation_i01_zCYcLCTQWzVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> Defer underwiring compensation</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:DeferedUnderwiringCompensation" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-148" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,875,000</ix:nonfraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



    <tr id="xdx_40F_ecustom--OrdinaryStockSubjectToPossibleRedemption_i01_zo0LxFpX15ne" style="vertical-align: bottom; background-color: White">

    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"> Ordinary
    stock subject to possible redemption</td><td style="padding-bottom: 2.5pt">&nbsp;</td>

    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonfraction name="alsa:OrdinaryStockSubjectToPossibleRedemption" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-149" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">100,078,049</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>

<tr id="xdx_408_ecustom--ReclassificationOfOfferingCostsRelatedToPublicShares_i01_zpqCpvrLgOac" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Reclassification

    of offering costs related to public shares </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:ReclassificationOfOfferingCostsRelatedToPublicShares" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-150" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">4,934,018</ix:nonfraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             <tr id="xdx_40D_ecustom--SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionAgainstAdditionalPaidincapitalApicAndAccumulatedDeficit_i01_zjU4J4570tJ2" style="vertical-align: bottom; background-color: White">

    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Subsequent measurement of ordinary shares subject to redemption against additional paid-in-capital (“APIC”) and accumulated deficit</td><td style="padding-bottom: 2.5pt">&nbsp;</td>

    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonfraction name="alsa:SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionAgainstAdditionalPaidincapitalApicAndAccumulatedDeficit" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-151" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">19,855,970</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>

</tbody></table>



<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The



accompanying notes are an integral part of the financial statements.</i></span></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_005"></span>ALPHA



STAR ACQUISITION CORPORATION</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES



TO THE FINANCIAL STATEMENT</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-152" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z5rM7nlRYxYe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



1 – <span id="xdx_825_zzsi7mveVuV1">Description of Organization and Business Operations</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization



and General</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha



Star Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on March&nbsp;11,



2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization



or similar business combination with one or more businesses (“Business Combination”). The Company has selected December 31



as its fiscal year-end.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although



the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company



intends to focus on businesses that have a connection to the Asian market. The Company is an early stage and emerging growth company



and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company’s sponsor is A-Star Management Corporation, a British Virgin Islands incorporated company (the “Sponsor”).



At December 31, 2021, the Company had not yet commenced any operations. All activity through December 31, 2021 relates to the Company’s



formation and initial public offering (“IPO”). The Company will not generate any operating revenues until after the completion



of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds



derived from the Proposed Offering.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company will have 9 months from the closing of the IPO (or up to 21 months from the closing of our initial public offering if we extend the period of time to consummate a business combination) to consummate a Business Combination (the “Combination Period”). If the Company fails to consummate a Business



Combination within the Combination Period, it will trigger its automatic winding up, liquidation and subsequent dissolution pursuant



to the terms of the Company’s amended and restated memorandum and articles of association. As a result, this has the same effect



as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be



required from the Company’s shareholders to commence such a voluntary winding up, liquidation and subsequent dissolution.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The

Company’s IPO was declared effective on December 13, 2021. On December&nbsp;15, 2021, the

Company consummated  the IPO of&nbsp;<span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z50DMe0STeC8" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-153" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span>&nbsp;units

which includes an additional&nbsp;<span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_pdd" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-154" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,500,000</ix:nonfraction></span></span>&nbsp;units

as a result of the underwriters’  fully exercise of the over-allotment, at $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_c20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units per share"><span><ix:nonfraction name="us-gaap:SaleOfStockPricePerShare" contextref="AsOf2021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-155" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span>&nbsp;per

Unit, generating gross proceeds of $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Sale of units in initial public offering aggragate amount"><span><ix:nonfraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextref="From2021-12-012021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-156" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,000</ix:nonfraction></span></span>,

which is described in Note  3.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently



with the closing of the IPO, the Company consummated the sale of&nbsp;<span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-157" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">330,000</ix:nonfraction></span></span> units (the “Private Placement”)



at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_c20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Sale of units per share"><span><ix:nonfraction name="us-gaap:SaleOfStockPricePerShare" contextref="AsOf2021-12-15_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-158" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span>&nbsp;per Private Unit in a private placement to A-Star Management Corporation, generating



gross proceeds of $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Sale of units in initial public offering aggragate amount"><span><ix:nonfraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextref="From2021-12-012021-12-15_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-159" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,300,000</ix:nonfraction></span></span>, which is described in Note 4.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The



Trust Account</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



of December 15, 2021, a total of $<span id="xdx_90D_ecustom--ProceedsFromIpoAndPrivatePlacement_pp0p0_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyr6ZYO9x6vj" title="Proceeds from IPO and Private Placement"><span><ix:nonfraction name="alsa:ProceedsFromIpoAndPrivatePlacement" contextref="From2021-12-012021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-160" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">115,682,250</ix:nonfraction></span></span> of the net proceeds from the IPO and the Private Placement transaction completed with the



Sponsor was deposited in a trust account established for the benefit of the Company’s public shareholders with Wilmington Trust,



National Association acting as trustee. The amount exceeding $115,000,000, $<span id="xdx_906_ecustom--EscrowCashTransfered_iI_pp0p0_c20211215_zGdqNPugK908" title="Escrow cash transfered"><span><ix:nonfraction name="alsa:EscrowCashTransfered" contextref="AsOf2021-12-15" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-161" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">682,254</ix:nonfraction></span></span> had been transfer to the Company’s



escrow cash account as its working capital. At December 31, 2021, the Company had working capital as $<span id="xdx_905_ecustom--WorkingCapital_iI_pp0p0_c20211231_z9jNGsToZug6" title="Working Capital"><span><ix:nonfraction name="alsa:WorkingCapital" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-162" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">477,051</ix:nonfraction></span></span>, which exclude amount of $<span id="xdx_906_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231_zkt1qU6Zbk1k" title="Marketable security held in trust account"><span><ix:nonfraction name="us-gaap:MarketableSecuritiesCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-163" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,744</ix:nonfraction></span></span> for marketable security held in trust account in current asset, and amount of $<span id="xdx_906_eus-gaap--DeferredCompensationLiabilityCurrent_iI_c20211231_zf5SOqSv2PKl" title="Deferred underwriting commission"><span><ix:nonfraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-164" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></span> for deferred underwriting commission in current liability.



</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



funds held in the Trust Account will be invested only in United States government treasury bills, bonds or notes having a maturity of



180 days or less, or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company



Act of 1940 and that invest solely in United States government treasuries. Except with respect to interest earned on the funds held in



the Trust Account that may be released to the Company to pay its income or other tax obligations, the proceeds will not be released from



the Trust Account until the earlier of the completion of a Business Combination or the Company’s liquidation.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_231_ziekWFnIRGwe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity



and Going Concern</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As



of December 31, 2021, the Company had cash $<span id="xdx_90A_ecustom--CashHeldInEscrow_c20211231_pp0p0" title="Cash in escrow"><span><ix:nonfraction name="alsa:CashHeldInEscrow" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-165" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">387,858</ix:nonfraction></span></span>&nbsp;in its escrow account, and working capital as $<span id="xdx_900_ecustom--WorkingCapital_iI_pp0p0_c20211231_zVuqCd5nVqJ7" title="Working Capital"><span><ix:nonfraction name="alsa:WorkingCapital" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-166" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">477,051</ix:nonfraction></span></span>, which excludes amount of $<span id="xdx_906_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231_zGal2EQo7MR3"><span><ix:nonfraction name="us-gaap:MarketableSecuritiesCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-167" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,744</ix:nonfraction></span></span> for marketable security held in trust account in current asset, and amount of $<span id="xdx_906_eus-gaap--DeferredCompensationLiabilityCurrent_iI_c20211231_zrVJScDV7WKi"><span><ix:nonfraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-168" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></span> for deferred underwriting commission in current liability.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company’s liquidity needs to date have been satisfied through a payment of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210311__20211231_zrqirnqhTNL2" title="Issuance of Founder Shares to Sponsor"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-169" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25,000</ix:nonfraction></span></span>&nbsp;from the Sponsor to cover certain expenses



on behalf of the Company in exchange for the issuance of the Founder Shares and the proceeds from the consummation of the Private Placement



not held in the Trust Account to provide working capital needed to identify and seek to consummate a Business Combination.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain



of the Company’s officers and directors may, but are not obligated to, provide the Company related party loans. As of December



31, 2021, the Company had&nbsp;no&nbsp;borrowings under the related party loans.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If



the Company’s estimate of the costs of identifying a target business, undertaking due diligence and negotiating a Business Combination



are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate our business prior to



our initial Business Combination. Moreover, the Company may need to obtain additional financing either to complete its Business Combination



or because the Company has become obligated to redeem a significant number of its Public Shares upon completion of its Business Combination,



in which case the Company may issue additional securities or incur debt in connection with such Business Combination. In addition, we



have until September 15, 2023 (the “Liquidation Date”) to consummate a business combination. </span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In



connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”)



205-40, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined



that if the Company is unable to complete a Business Combination by the Liquidation Date, then the Company may cease all operations except



for the purpose of liquidating. The uncertainty surrounding the date for mandatory liquidation and subsequent dissolution raise substantial



doubt about the Company’s ability to continue as a going concern. Management expects to close the Business Combination prior to



the Liquidation Date. If the Company is unable to close the Business Combination or raise additional capital, it may be required to take



additional measures to conserve liquidity, which could include, but not necessarily include or be limited to, curtailing operations,



suspending the pursuit of a potential transaction and reducing overhead expenses. The Company cannot provide any assurance that new financing



will be available to it on commercially acceptable terms or if at all. These conditions raise substantial doubt about the Company’s



ability to continue as a going concern through the Liquidation Date if a Business Combination is not consummated. These financial statements



do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be



necessary should the Company be unable to continue as a going concern.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management



believes that, on December 31, 2021, the company has insufficient working capital to cover its short term operating needs. The Company



has no revenue before the Business Combination. Its business plan is dependent on the completion of a financing transaction and the Company’s



cash and working capital as December 31, 2021 are not sufficient to complete its planned activities for the upcoming year. These factors raise substantial doubt about the Company's ability to continue as a going concern one year from the date the financial statement is issued.</span></p>







<ix:exclude><p id="xdx_233_zUASmid1p7t7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p></ix:exclude>















<ix:exclude><!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_239_ztdfRqaCc7dg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-170" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zV2Lzn7rTbTa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



2 – <span id="xdx_82F_z44S9wD52Oo6">Summary of Significant Accounting Policies</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-171" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zms1HKrqtU0e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zkjNLoLTl783">Basis



of Presentation</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



accompanying financial statement of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted



in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission



(“SEC”).</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="alsa:EmergingGrowthCompanyPolicyTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-172" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true"><p id="xdx_843_ecustom--EmergingGrowthCompanyPolicyTextBlock_zYeDyEGm6Ugg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zZTl4UKHfVyi">Emerging



Growth Company</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company is an emerging growth company as defined by Section 2(a) of the JOBS Act and it may take advantage of certain exemptions from



various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but no



limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced



disclosures obligations regarding executive compensation in its periodic reports and proxy statements, and exceptions from the requirements



of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payment not previously



approved.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,



Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting



standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do



not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting



standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements



that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out



of such extended transition period which means that when a standard is issued or revised, and it has different application dates for



public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies



adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which



is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult



or impossible because of the potential differences in accounting standards used.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:UseOfEstimates" inside-table="false" id="fact-identifier-173" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_843_eus-gaap--UseOfEstimates_zfU3KR9XXaMb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z47MZ8nhsVr9">Use



of Estimates</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



preparation of financial statement in conformity with GAAP requires the Company’s management to make estimates and assumptions



that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial



statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making



estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of



a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating



its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates



included in these financial statements is the determination of the fair value of the warrant and forward contract derivative liabilities.



Accordingly, the actual results could differ significantly from those estimates.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-174" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjjaUwGZ7g55" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zKYkXGkhiiNe">Cash



and Cash Equivalents</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.



The Company had $<span id="xdx_909_eus-gaap--Cash_iI_c20211231_z1bcnI2qUm97" title="Cash"><span><ix:nonfraction name="us-gaap:Cash" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-175" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">387,858</ix:nonfraction></span></span> in cash and did <span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_zKLsJVcdsJCe" title="Cash equivalents"><span><ix:nonfraction name="us-gaap:CashEquivalentsAtCarryingValue" contextref="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-176" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">no</ix:nonfraction></span></span>t have any cash equivalents as of December 31, 2021.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" inside-table="false" id="fact-identifier-177" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zA2foQ2FKza" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zSoLvbthTCWc">Concentration



of Credit Risk</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial



instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution



which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_902_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_pp0p0_c20210311__20211231_zr91mzKWRyh1" title="Federal depository insurance coverage"><span><ix:nonfraction name="us-gaap:FederalDepositInsuranceCorporationPremiumExpense" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-178" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">250,000</ix:nonfraction></span></span>. As of December 31, 2021, the Company had not experienced



losses on this account.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<ix:exclude><!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_235_zMc0n7YzfSg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>







</ix:nonnumeric></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:MarketableSecuritiesPolicy" inside-table="false" id="fact-identifier-179" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_842_eus-gaap--MarketableSecuritiesPolicy_zPYx6wxavsFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zrymgwHINgci">Marketable



Securities Held in Trust Account</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. At December 31, 2021, the Company had $<span id="xdx_909_eus-gaap--MarketableSecurities_iI_pp0p0_c20211231_zkz4KlYLwzk6" title="Marketable securities held in trust account"><span><ix:nonfraction name="us-gaap:MarketableSecurities" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-180" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,744</ix:nonfraction></span></span> cash



in marketable securities held in the trust account.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="alsa:OfferingCostsAssociatedWithTheInitialPublicOfferingPoliciesTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-181" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true"><p id="xdx_842_ecustom--OfferingCostsAssociatedWithTheInitialPublicOfferingPoliciesTextBlock_zwSbRE7vxu3i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zXEW9WYlvSme">Offering



Costs Associated with the Initial Public Offering</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering

costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date

that are directly  related to the IPO. As of December 31, 2021, offering costs amounted to $<span id="xdx_901_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20210311__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2oQwmKk7ZO8" title="Offering costs"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextref="From2021-03-112021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-182" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">5,669,696</ix:nonfraction></span></span>

consisting of $<span id="xdx_900_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20210311__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Underwriting fees"><span><ix:nonfraction name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" contextref="From2021-03-112021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-183" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,300,000</ix:nonfraction></span></span>

of underwriting fees, $<span id="xdx_90A_ecustom--DeferredUnderwritingFees_pp0p0_c20210311__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zCRmvQUz1mV7" title="Deferred underwriting fees"><span><ix:nonfraction name="alsa:DeferredUnderwritingFees" contextref="From2021-03-112021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-184" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,875,000</ix:nonfraction></span></span>

of deferred underwriting fees, and $<span id="xdx_90A_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_pp0p0_c20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z57iPhrIoEV6" title="Other offering costs"><span><ix:nonfraction name="us-gaap:OtherOwnershipInterestsOfferingCosts" contextref="AsOf2021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-185" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">494,696</ix:nonfraction></span></span>

of other offering costs. The Company complies with the requirements of ASC 340-10-S99-1 and  SEC Staff Accounting Bulletin

Topic 5A – “Expenses of Offering”. The Company allocates offering costs between public  shares, public

rights and public warrants based on the estimated fair values of public shares, public warrants, and public rights at

the date of  issuance.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="alsa:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-186" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true"><p id="xdx_84F_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zyMhegg3ghEa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zJhVbDT5Ayw9">Ordinary



Shares Subject to Possible Redemption</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The

Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting

Standards Codification  (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares

subject to mandatory redemption is  classified as a liability instrument and is measured at fair value. Conditionally

redeemable ordinary shares (including ordinary shares  that feature redemption rights that is either within the control of

the holder or subject to redemption upon the occurrence of uncertain  events not solely within the Company’s control)

is classified as temporary equity. At all other times, ordinary shares are  classified  as shareholders’ equity. The

Company’s ordinary shares features certain redemption rights that are considered to be outside  of the Company’s

control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible  redemption is

presented at redemption value as temporary equity, outside of the shareholders’ equity section of the

Company’s  balance sheet.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All



of the&nbsp;<span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7q3Xo1ninqh" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-187" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span>&nbsp;shares of ordinary shares sold as part of the Units in the IPO contain a redemption feature



which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote



or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Certificate



of Incorporation. Accordingly, all of the <span id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20211231_zA0QiRqZggs6" title="Odinary shares subject to possible redemption"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-188" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span> shares of ordinary shares are presented as temporary equity.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases

or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional&nbsp;paid-in capital and

accumulated deficit if additional paid in capital equals to zero.</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" inside-table="false" id="fact-identifier-189" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zShCc1tGqrt1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zKr3628J0eg4">Fair



Value of Financial Instruments</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to the short-term



nature.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-190" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zWan3aWLpat8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zmMHhAzvfum9">Net



Income (Loss) per Share</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



calculation of diluted income (loss) per ordinary shares does not consider the effect of the warrants issued in connection with the (i)&nbsp;Initial



Public Offering, and (ii)&nbsp;the private placement since the exercise of the warrants is contingent upon the occurrence of future events.



The warrants are exercisable to purchase&nbsp;<span id="xdx_904_ecustom--WarrantsExercisable_c20210311__20211231_zDPOBEu26pSh" title="Warrants exercisable"><span><ix:nonfraction name="alsa:WarrantsExercisable" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-191" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5,915,000</ix:nonfraction></span></span>&nbsp;shares of ordinary shares in the aggregate. As of December&nbsp;31, 2021, the



Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares



and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary shares  is the same as basic net income



(loss) per ordinary shares for the periods presented.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<ix:exclude><!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_232_zz2LdQsoTTN3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



net income (loss) per share presented in the statement of operations is based on the following:</span></p>











<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-192" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><table cellpadding="0" cellspacing="0" id="xdx_898_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zvTRnJIjUy3a" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom">

    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b style="display: none">Schedule

    of statement of operations</b></td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>

    <td colspan="2" style="font-weight: bold; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>

  <tr style="vertical-align: bottom">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the<br>

period from<br>

March&nbsp;11, 2021<br>

(inception) to<br>

December&nbsp;31,<br>



    2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net



    (loss) income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_c20210311__20211231_zFSeXCkwzoKd" title="Net (loss) income" style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-193" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">52,509</ix:nonfraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Accretion of temporary equity to redemption value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--AccretionOfTemporaryEquityToRedemptionValue_c20210311__20211231_zmEdtEv73tp7" title="Accretion of temporary equity to redemption value" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:AccretionOfTemporaryEquityToRedemptionValue" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-194" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">19,855,970</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss including accretion of temporary equity to redemption value</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NetLossIncludingAccretionOfTemporaryEquityToRedemptionValue_c20210311__20211231_zD1iufnLPG8f" title="Net loss including accretion of temporary equity to redemption value" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:NetLossIncludingAccretionOfTemporaryEquityToRedemptionValue" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-195" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">19,908,479</ix:nonfraction></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  </tbody></table>











</ix:nonnumeric></span><p id="xdx_8A5_zkqKmI3k60jc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-196" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQyEb3fsd0pd" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom; background-color: White">

    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b><span id="xdx_8B7_zCGxPnvcYVxf" style="display: none">Schedule of basic and diluted

    net income (loss) per share</span></b></td><td>&nbsp;</td>

    <td colspan="2" id="xdx_498_20210311_20211231_us-gaap--StatementClassOfStockAxis_custom--NonRedeemableSharesMember" style="text-align: center">&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td>

    <td colspan="2" id="xdx_498_20210311_20211231_us-gaap--StatementClassOfStockAxis_custom--RedeemableSharesMember" style="text-align: center">&nbsp;</td><td>&nbsp;</td></tr>

  <tr style="vertical-align: bottom">



    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the<br>

period from<br>

March&nbsp;11, 2021<br>

(inception) to<br>

December&nbsp;31,<br>



    2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom">



    <td style="vertical-align: bottom; text-align: left"></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-redeemable shares</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Redeemable shares</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic



    and Diluted net income (loss) per share:</span></td><td style="font-weight: bold">&nbsp;</td>



    <td colspan="2" style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>



    <td colspan="2" style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold">&nbsp;</td></tr>



  <tr id="xdx_409_ecustom--Numerators_i" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Numerators:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_40B_ecustom--AllocationOfNetLossesIncludedAccretion_zZ3aCmfqPrs6" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Allocation



    of net losses included accretion</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:AllocationOfNetLossesIncludedAccretion" contextref="From2021-03-112021-12-31_custom_NonRedeemableSharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-197" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">16,209,143</ix:nonfraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:AllocationOfNetLossesIncludedAccretion" contextref="From2021-03-112021-12-31_custom_RedeemableSharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-198" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,699,335</ix:nonfraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>



  <tr id="xdx_40E_eus-gaap--TemporaryEquityAccretionOfDividends_zSN6vjpDM8na" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Accretion



    of temporary equity to redemption value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:TemporaryEquityAccretionOfDividends" contextref="From2021-03-112021-12-31_custom_RedeemableSharesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-199" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">19,855,970</ix:nonfraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_404_ecustom--AllocationOfNetIncomeLoss_zrSg28hvJzoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Allocation



    of net income (loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:AllocationOfNetIncomeLoss" contextref="From2021-03-112021-12-31_custom_NonRedeemableSharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-200" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">16,209,143</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:AllocationOfNetIncomeLoss" contextref="From2021-03-112021-12-31_custom_RedeemableSharesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-201" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">16,156,634</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_405_ecustom--Denominators_i" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Denominators:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_406_ecustom--WeightedaverageSharesOutstanding_zRgClTnZoo03" style="vertical-align: bottom; background-color: White">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average



    shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:WeightedaverageSharesOutstanding" contextref="From2021-03-112021-12-31_custom_NonRedeemableSharesMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-202" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,893,953</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:WeightedaverageSharesOutstanding" contextref="From2021-03-112021-12-31_custom_RedeemableSharesMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="true" id="fact-identifier-203" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">660,473</ix:nonfraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr id="xdx_406_ecustom--BasicAndDilutedNetIncomeLossPerShare_zQ861pzoVZO9" style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic



    and diluted net income (loss) per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<span><ix:nonfraction name="alsa:BasicAndDilutedNetIncomeLossPerShare" contextref="From2021-03-112021-12-31_custom_NonRedeemableSharesMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares" inside-table="true" id="fact-identifier-204" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5.60</ix:nonfraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="alsa:BasicAndDilutedNetIncomeLossPerShare" contextref="From2021-03-112021-12-31_custom_RedeemableSharesMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="true" id="fact-identifier-205" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">24.46</ix:nonfraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  </tbody></table>







</ix:nonnumeric></span><p id="xdx_8AB_zQZaaXNC9SPh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-206" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zPiH0HBk4PUe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zpeap1nzGU84">Income



Taxes</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax



assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities



and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation



allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC



740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes



a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected



to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination



by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim



period, disclosure and transition. The Company has identified the Cayman Islands as its only “major” tax jurisdiction,



as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring



recognition in the Company’s financial statement. Since the Company was incorporated on March 11, 2021, the evaluation was performed



for the period ended December 31, 2021 which will be the only period subject to examination. The Company believes that its income tax



positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes



to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items



as a component of income tax expense.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



provision for income taxes was deemed to be immaterial for the period from March 11, 2021 (inception) through December 31, 2021.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</p>



</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="alsa:WarrantsPoliciesTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-207" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true"><p id="xdx_84C_ecustom--WarrantsPoliciesTextBlock_zgOc9yMpWGjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zKdMsP1Vlhk2">Warrants</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The

Company evaluates the Public and Private Warrants as either equity-classified&nbsp;or liability-classified&nbsp;instruments based on

an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”)

Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815,

Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments

pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for

equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other

conditions for equity classification. Pursuant to such evaluation, both Public and Private Warrants will be classified in stockholders’

equity.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<ix:exclude><!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_230_zaKM4RiiN6Bb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-208" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z70GU2FPBt2b" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zR43pout5QKk">Recently



Issued Accounting Standards</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In



August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06,&nbsp;Debt



— Debt with Conversion and Other Options (Subtopic&nbsp;470-20)&nbsp;and Derivatives and Hedging — Contracts in Entity’s



Own Equity (Subtopic&nbsp;815-40) (“ASU&nbsp;2020-06”) to simplify accounting for certain financial instruments. ASU&nbsp;2020-06&nbsp;eliminates



the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies



the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard



also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s



own equity. ASU&nbsp;2020-06 amends the diluted earnings per share guidance, including the requirement to use the&nbsp;if-converted&nbsp;method



for all convertible instruments. ASU&nbsp;2020-06 is effective January&nbsp;1, 2022 and should be applied on a full or modified retrospective



basis, with early adoption permitted beginning on January&nbsp;1, 2021. The Company is currently assessing the impact, if any, that ASU&nbsp;2020-06&nbsp;would



have on its financial position, results of operations or cash flows.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management



does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material



effect on the Company’s financial statements.</span></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span></ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="alsa:InitialPublicOfferingTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-209" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true"><p id="xdx_806_ecustom--InitialPublicOfferingTextBlock_zOIVg9UBTAwf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



3 – <span id="xdx_822_z2UK3S3nhmT2">Initial Public Offering</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On



December 15, 2021, the Company consummated the initial public offering and sale of <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTdTlM8yqsza" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-210" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span> units (including the issuance of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_z8Z8YyqEqDOd" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-211" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,500,000</ix:nonfraction></span></span> units as a result of the underwriters’



fully exercise of the over-allotment) at a price of $<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_c20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zte4opWbJSyd" title="Sale of units per share"><span><ix:nonfraction name="us-gaap:SaleOfStockPricePerShare" contextref="AsOf2021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-212" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span> per Unit, generating gross proceeds of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3H3BLZlln68" title="Sale of units in initial public offering aggragate amount"><span><ix:nonfraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextref="From2021-12-012021-12-15_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-213" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,000</ix:nonfraction></span></span>. Each



Unit consists of one ordinary share, one redeemable warrant (each a “Warrant”, and, collectively, the “Warrants”),



and one right to receive one-seventh (1/7) of an ordinary share upon the consummation of a Business Combination. Each two redeemable



warrants entitle the holder thereof to purchase one ordinary share, and each seven rights entitle the holder thereof to receive one ordinary



share at the closing of a Business Combination. No fractional shares issued upon separation of the Units, and only whole Warrants will



trade.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company granted the underwriters a 45-day option from the date of the IPO to purchase up to an additional <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_z0uSsWr1kwBg"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-214" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,500,000</ix:nonfraction></span></span> units to cover



over-allotments. On December 15, 2021, the underwriters exercised the over-allotment option in full to purchase <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zCnjNfKciyf7" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-215" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,500,000</ix:nonfraction></span></span> Public Units,



at a purchase price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zsopM94Jc1H2" title="Sale of units per share"><span><ix:nonfraction name="us-gaap:SaleOfStockPricePerShare" contextref="AsOf2021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-216" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span> per Public Unit, generating gross proceeds to the Company of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zL8d0Y7ZBU99" title="Sale of units in initial public offering aggragate amount"><span><ix:nonfraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextref="From2021-12-012021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-217" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">15,000,000</ix:nonfraction></span></span>.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At

December 31, 2021, the ordinary share reflected in the balance sheet are reconciled in the following tables:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="alsa:ScheduleOfOrdianarySharesSubjectToPossibleRedemptionTableTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-218" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true"><table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfOrdianarySharesSubjectToPossibleRedemptionTableTextBlock_zGJQSACqLhe6" summary="xdx: Disclosure - Initial Public Offering (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; border-collapse: collapse; width: 100%">

  <tbody><tr style="vertical-align: bottom; background-color: White">

    <td style="text-indent: -0.125in; padding-left: 0.125in"><span id="xdx_8BE_zfgMh2dkot6a" style="display: none">Schedule of ordinary shares subject to possible redemption</span></td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td id="xdx_49E_20210311__20211231_zcuvGPu3uiV1" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>

<tr id="xdx_40F_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Gross proceeds from public shares</td><td style="width: 1%">&nbsp;</td>

    <td style="width: 1%; text-align: left">&nbsp;$</td><td style="width: 9%; text-align: right"><span><ix:nonfraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-219" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,000</ix:nonfraction></span></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>

  <tr style="vertical-align: bottom; background-color: White">

    <td style="text-indent: -0.125in; padding-left: 0.125in">Less:</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>

  <tr id="xdx_40D_ecustom--ProceedsAllocatedPublicRights_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds allocated to pubic rights</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:ProceedsAllocatedPublicRights" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-220" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">11,780,488</ix:nonfraction></span></td><td style="text-align: left">)</td></tr>

  <tr id="xdx_409_ecustom--ProceedsAllocatedPublicWarrants_i_pp0p0" style="vertical-align: bottom; background-color: White">

    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds allocated to pubic warrants</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:ProceedsAllocatedPublicWarrants" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-221" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,141,463</ix:nonfraction></span></td><td style="text-align: left">)</td></tr>

  <tr id="xdx_40A_ecustom--AllocationOfOfferingCostsRelatedToOrdinaryShares_zN2uiZzKDySd" style="vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Allocation of offering costs related to ordinary shares</td><td style="padding-bottom: 1pt">&nbsp;</td>

    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<span><ix:nonfraction name="alsa:AllocationOfOfferingCostsRelatedToOrdinaryShares" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-222" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">4,934,018</ix:nonfraction></span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>

  <tr id="xdx_402_ecustom--Total_zd1DP6101eQk" style="vertical-align: bottom; background-color: White">

    <td style="text-indent: -0.125in; padding-left: 0.125in">&nbsp;<b style="color: White">Total</b></td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<span><ix:nonfraction name="alsa:Total" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD" inside-table="true" id="fact-identifier-223" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">19,855,970</ix:nonfraction></span></td><td style="text-align: left">)</td></tr>

  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="text-indent: -0.125in; padding-left: 0.125in">Plus:</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>

  <tr id="xdx_40F_ecustom--AccretionsOfCarryingValueToRedemptionValue_i_pp0p0" style="vertical-align: bottom; background-color: White">

    <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt">&nbsp;</td>

    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonfraction name="alsa:AccretionsOfCarryingValueToRedemptionValue" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-224" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">19,855,970</ix:nonfraction></span></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>

  <tr id="xdx_402_ecustom--OrdinarySharesSubjectToPossibleRedemption_zWEe7x3z9Pnl" style="vertical-align: bottom; background-color: rgb(204,238,255)">

    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ordinary shares subject to possible redemption</td><td>&nbsp;</td>

    <td style="text-align: left">&nbsp;$</td><td style="text-align: right"><span><ix:nonfraction name="alsa:OrdinarySharesSubjectToPossibleRedemption" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="true" id="fact-identifier-225" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">115,000,000</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td></tr>

  </tbody></table></ix:nonnumeric></span>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="alsa:PrivatePlacementTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-226" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true"><p id="xdx_80A_ecustom--PrivatePlacementTextBlock_zxyfNIKcOrxd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



4 – <span id="xdx_82A_zAY5qN75v6Ea">Private Placement</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently



with the consummation of the IPO, A-Star Management Corporation, the Sponsor, purchased an aggregate of <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zJNeW8euGQKk" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-227" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">330,000</ix:nonfraction></span> </span>units at a price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5N2RdJh0g6c" title="Sale of units per share"><span><ix:nonfraction name="us-gaap:SaleOfStockPricePerShare" contextref="AsOf2021-12-15_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-228" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span> per Private



Unit for an aggregate purchase price of $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zvvnqxCnHXdc" title="Sale of units in initial public offering aggragate amount"><span><ix:nonfraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextref="From2021-12-012021-12-15_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-229" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,300,000</ix:nonfraction></span></span> in a private placement. The Private Units are identical to the public Units except



with respect to certain registration rights and transfer restrictions. The proceeds from the Private Units were added to the proceeds



from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period,



the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements



of applicable law), and the Private Units and all underlying securities will expire worthless.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-230" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zH8ZjShuy2Me" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



5 – <span id="xdx_82F_zObmdOpJ5eG9">Related Party Transactions</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Founder



Shares</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On



March 11,&nbsp;2021, the Company issued one ordinary share to the Sponsor for no consideration. On April&nbsp;6, 2021, the Company cancelled



the one share for no consideration and the Sponsor purchased <span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodShares_c20210401__20210406__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zXxUHbq9hZJ1" title="Number of shares forfeited"><span><ix:nonfraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextref="From2021-04-012021-04-06_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-231" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></span> ordinary shares for an aggregate price of $<span id="xdx_904_eus-gaap--StockRepurchasedAndRetiredDuringPeriodValue_c20210401__20210406__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z7IP3YYLje3h" title="Value of shares forfeited"><span><ix:nonfraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="From2021-04-012021-04-06_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-232" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25,000</ix:nonfraction></span></span>.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210401__20210406__us-gaap--RelatedPartyTransactionAxis__custom--FounderMember_zQIb4TCKHtid"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextref="From2021-04-012021-04-06_custom_FounderMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-233" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">founder shares (for purposes hereof referred
to as the “Founder Shares”) include an aggregate of up to <span id="xdx_904_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20210401__20210406__us-gaap--RelatedPartyTransactionAxis__custom--FounderMember_zTORfqeJwM4i"><span><ix:nonfraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextref="From2021-04-012021-04-06_custom_FounderMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-234" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">375,000</ix:nonfraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares subject to forfeiture by the Sponsor to
the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own
20% of the Company’s issued and outstanding shares after the Proposed Offering. On December 15, 2021, the underwriters exercised
the over-allotment option in full, so there are no Founder Shares subject to forfeiture as of December 31, 2021.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<ix:exclude><!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_238_zDUsDs78sOdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor and each Insider agrees that

it, he or she shall not (a)&nbsp;Transfer 50% of their Founder Shares until the earlier of (A)&nbsp;six months after the consummation

of the Company’s initial Business Combination or (B)&nbsp;the date on which the closing price of the Ordinary Shares equals

or exceeds $12.50 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations,

recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial

Business Combination or (b)&nbsp;Transfer the remaining 50% of their Founder Shares until six months after the date of the consummation

of the Company’s initial Business Combination, or earlier in either case, if subsequent to the Company’s initial Business

Combination the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results

in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property

(the “<b><i>Founder Shares Lock-up Period</i></b>”).</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administrative



Services Agreement</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company entered into an administrative services agreement, commencing on December 13, 2021, through the earlier of the Company’s



consummation of a Business Combination or its liquidation, to pay to the Sponsor a total of $<span id="xdx_90A_eus-gaap--RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_pp0p0_c20210311__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z7SNrg6KevD7" title="Related party service fee"><span><ix:nonfraction name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" contextref="From2021-03-112021-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-235" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,000</ix:nonfraction></span></span>&nbsp;per month for office space,



secretarial and administrative services provided to members of the Company’s management team. For the period from March 11, 2021 (inception) through December&nbsp;31,



2021, the Company incurred $<span id="xdx_904_eus-gaap--AdministrativeFeesExpense_pp0p0_c20210311__20211231_zUqlzzazPO51"><span><ix:nonfraction name="us-gaap:AdministrativeFeesExpense" contextref="From2021-03-11to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-236" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">6,129</ix:nonfraction></span></span>&nbsp;in fees for these services.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sponsor



Promissory Note — Related Party</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On



March&nbsp;26, 2021, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an



aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20210326__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zlC2xprZ3djb" title="Principal amount"><span><ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount" contextref="AsOf2021-03-26_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-237" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">300,000</ix:nonfraction></span></span> (the “Promissory Note”). The Promissory Note is non-interest bearing and payable on



the earlier of (i)&nbsp;December&nbsp;31, 2021 or (ii)&nbsp;the consummation of the Proposed Offering. The loan repaid as $<span id="xdx_908_eus-gaap--RepaymentsOfDebt_c20210311__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zphc7MG9qPIg" title="Loan repaid"><span><ix:nonfraction name="us-gaap:RepaymentsOfDebt" contextref="From2021-03-112021-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-238" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">300,000</ix:nonfraction></span></span> allotted



to the payment of offering expense. Sponsor promissory note balance as of December 31, 2021 was nil. <span id="xdx_90C_eus-gaap--DueToRelatedPartiesCurrent_iI_c20211231_zOFbP7aaqUCk" title="Related party loan balance" style="display: none"><span><ix:nonfraction name="us-gaap:DueToRelatedPartiesCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-239" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0</ix:nonfraction></span></span></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-240" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zDFqoNVo4Mxg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



6 – <span id="xdx_826_zACK3mavIFvd">Commitments and Contingencies</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks



and Uncertainties</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management



continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could



have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific



impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments



that might result from the outcome of this uncertainty.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underwriters



Agreement</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company granted the underwriters, a 45-day option to purchase up to 1,500,000 Units (over and above the 10,000,000 units referred to



above) solely to cover over-allotments at $10.00 per Unit. On December 15, 2021, the underwriters exercised the over-allotment option



in full to purchase <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211201__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zkteJviqwCY9" title="Sale of units in initial public offering"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-12-012021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-241" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,500,000</ix:nonfraction></span></span> Units at a purchase price of $<span id="xdx_908_eus-gaap--SharePrice_iI_c20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zog0f6qzjmv9" title="Share Price"><span><ix:nonfraction name="us-gaap:SharePrice" contextref="AsOf2021-12-15_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-242" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span> per Unit.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On



December 15, 2021, the Company paid a cash underwriting commission of <span id="xdx_904_ecustom--PercentageOfCashUnderwritingCommission_dp_c20210311__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7c9f60Erbc3" title="Percentage of cash underwritng commission"><span><ix:nonfraction name="alsa:PercentageOfCashUnderwritingCommission" contextref="From2021-03-112021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure" inside-table="false" id="fact-identifier-243" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2.0</ix:nonfraction></span></span>% of the gross proceeds of the IPO, or $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210311__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Proceeds from Initial Public Offering"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextref="From2021-03-112021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-244" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,300,000</ix:nonfraction></span></span>.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



underwriters are entitled to a deferred underwriting commission of <span id="xdx_908_ecustom--PercentageOfUnderwritingDeferredCommission_dp_c20210311__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVoZmVK47JY7" title="Percentage of underwriting deferred Commission"><span><ix:nonfraction name="alsa:PercentageOfUnderwritingDeferredCommission" contextref="From2021-03-112021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure" inside-table="false" id="fact-identifier-245" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2.5</ix:nonfraction></span></span>% of the gross proceeds of the IPO, or $<span id="xdx_90B_ecustom--GrossProceedsFromInitialPublicOffering_pp0p0_c20210311__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zt4ZH3XkKGya" title="Gross proceeds from Initial Public Offering"><span><ix:nonfraction name="alsa:GrossProceedsFromInitialPublicOffering" contextref="From2021-03-112021-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-246" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,875,000</ix:nonfraction></span></span>, which will be



paid from the funds held in the Trust Account upon completion of the Company’s initial Business Combination subject to the terms



of the underwriting agreement. As of December 31, 2021, the Company has the deferred underwriting commissions $<span id="xdx_909_eus-gaap--DeferredCompensationLiabilityCurrent_iI_pp0p0_c20211231_zUnBjTaYff0h" title="Deferred underwriting commissions"><span><ix:nonfraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="false" id="fact-identifier-247" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></span> as current



liabilities.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration



Rights</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



holders of the Founder Shares will be entitled to registration rights pursuant to a registration rights agreement to be signed prior



to or on the effective date of the Proposed Offering. The holders of these securities are entitled to make up to three demands, excluding



short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration



rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the



Company to register for resale such securities pursuant to Rule&nbsp;415 under the Securities Act. The Company will bear the expenses



incurred in connection with the filing of any such registration statements.</span></p>







<ix:exclude><p id="xdx_231_zNr8dIhgCejk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p></ix:exclude>















<ix:exclude><!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_234_z5uuIXgWpFgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-248" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_805_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zrkGCBO7XWGk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note

7 – <span id="xdx_825_zILfEsA88KQ5">Stockholders’ Deficit</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary



Shares</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



Company is authorized to issue <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zh3ecgOVMSsc" title="Common stock, shares authorized"><span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-249" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">50,000,000</ix:nonfraction></span></span> ordinary shares, with a par value of $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_zTQvDURuwJy4" title="Common stock, par value per share"><span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-250" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.001</ix:nonfraction></span></span> per share. <span id="xdx_90D_eus-gaap--CommonStockVotingRights_c20210311__20211231_zfeqWTil5Ck2" title="Common stock, voting rights"><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" name="us-gaap:CommonStockVotingRights" inside-table="false" id="fact-identifier-251" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Holders of the ordinary shares are entitled



to one vote for each ordinary share.</ix:nonnumeric></span> </span>At December 31, 2021, there were <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20211231_zbBc2ZlBKWG7" title="Common Stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zXhIZwxuogRh" title="Common stock, shares outstanding"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-252" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-253" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,205,000</ix:nonfraction></span></ix:nonfraction></span></span></span> ordinary shares issued and outstanding, excluding <span id="xdx_90B_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20211231_zMbveMuRVcS4" title="Odinary shares subject to possible redemption"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-254" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span>



shares subject to possible redemption. The Sponsor has agreed to forfeit <span id="xdx_903_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20210311__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zvisQFg3bux9" title="Number of shares forfeited"><span><ix:nonfraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextref="From2021-03-112021-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-255" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">375,000</ix:nonfraction></span></span> ordinary shares to the extent that the over-allotment



option is not exercised in full by the underwriters. On December 15, 2021, the underwriters fully exercised the over-allotment option,



as such there are no ordinary shares subject to forfeiture.&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Public  Warrants</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Initial Public Offering, the Company
sold <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210311__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z1SbpoOme2j1" title="Sale of units"><span><ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextref="From2021-03-112021-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-256" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span> Units at a price of $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0bjyH0TXeO2" title="Share Price"><span><ix:nonfraction name="us-gaap:SaleOfStockPricePerShare" contextref="AsOf2021-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-257" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></span> per Unit for a total of $<span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210311__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTNbYQMOkQ8i" title="Proceeds from sale of stock"><span><ix:nonfraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextref="From2021-03-112021-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD" inside-table="false" id="fact-identifier-258" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,000</ix:nonfraction></span></span>. The total amounts of ordinary shares subject to possible redemption is <span id="xdx_90B_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20211231_zMdo2TkETnz9" title="Shares subject to possible redemption"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares" inside-table="false" id="fact-identifier-259" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11,500,000</ix:nonfraction></span></span>. Each Unit consists of
one ordinary share, one right to acquire one-seventh (1/7) of an ordinary share, and one redeemable warrant (“Public Warrant”)
to purchase one-half of one ordinary share at a price of $11.50 per share, subject to adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each warrant entitles the holder to purchase one-half
ordinary share at a price of $<span id="xdx_907_eus-gaap--SharePrice_iI_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zCjmhPAO0We6" title="Share Price"><span><ix:nonfraction name="us-gaap:SharePrice" contextref="AsOf2021-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-260" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">11.50</ix:nonfraction></span></span> per share commencing 30 days after the completion of its initial business combination and expiring
five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants
will trade. The Company may redeem the warrants at a price of $<span id="xdx_904_ecustom--ClassOfWarrantsOrRightsRedemptionPricePerShare_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_pdd" title="Class of warrants or rights redemption price per share"><span><ix:nonfraction name="alsa:ClassOfWarrantsOrRightsRedemptionPricePerShare" contextref="AsOf2021-12-31_custom_PrivateWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-261" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">0.01</ix:nonfraction></span></span> per warrant upon 30 days’ notice, only in the event that the last
sale price of the ordinary shares is at least $18.00 per share for any 20 trading days within a 30-trading day period ending on the third
day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus
in effect with respect to the ordinary shares underlying such warrants during the<span id="xdx_902_ecustom--MinimumNoticePeriodToBeGivenToWarrantHoldersPriorToRedemption_dtD_c20210311__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_zsia2byKSEx5" title="Minimum notice period to be given to warrant holders prior to redemption"> <span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_PrivateWarrantsMember" format="ixt-sec:durday" name="alsa:MinimumNoticePeriodToBeGivenToWarrantHoldersPriorToRedemption" inside-table="false" id="fact-identifier-262" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">30</ix:nonnumeric></span></span> day redemption period. If a registration statement
is not effective within <span id="xdx_90D_ecustom--ClassOfWarrantsOrRightsPeriodWithinWhichTheRegistrationShallBeEffectiveFromTheConsummationOfBusinessCombination_dtD_c20210311__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_zqSA6FFw4yp5" title="Class of warrants or rights period within the registration shall be effective from the consummation of business combination"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_PrivateWarrantsMember" format="ixt-sec:durday" name="alsa:ClassOfWarrantsOrRightsPeriodWithinWhichTheRegistrationShallBeEffectiveFromTheConsummationOfBusinessCombination" inside-table="false" id="fact-identifier-263" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">60</ix:nonnumeric></span> </span>days following the consummation of a business combination, warrant holders may, until such time as there is
an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement,
exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if (a) the Company issues additional ordinary shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $<span id="xdx_901_ecustom--VolumeWeightedAveragePricePerShare_c20210311__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_pdd" title="Volume weighted average price per share"><span><ix:nonfraction name="alsa:VolumeWeightedAveragePricePerShare" contextref="From2021-03-112021-12-31_custom_PrivateWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-264" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">9.20</ix:nonfraction></span></span> per share (with such issue price or effective issue price to be determined in good faith by our board of
directors), (b) the aggregate gross proceeds from such issuances represent more than <span id="xdx_908_ecustom--PercentageOfFundsRaisedToBeUsedForConsummatingBusinessCombination_dp_c20210311__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_zULLcjlHvdUd" title="Percentage of funds raised to be used for consummating business combination"><span><ix:nonfraction name="alsa:PercentageOfFundsRaisedToBeUsedForConsummatingBusinessCombination" contextref="From2021-03-112021-12-31_custom_PrivateWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure" inside-table="false" id="fact-identifier-265" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">60</ix:nonfraction></span></span>% of the total equity proceeds, and interest thereon,
available for the funding of our initial business combination, and (c) the volume weighted average trading price of the ordinary shares
during the <span id="xdx_908_ecustom--NumberOfTradingDaysForDeterminingTheVolumeWeightedAveragePriceOfShare_dtD_c20210311__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_zBABtSFJnln5" title="Number of consecutive trading days for determining the volume weighted average price of share"><span><ix:nonnumeric contextref="From2021-03-112021-12-31_custom_PrivateWarrantsMember" format="ixt-sec:durday" name="alsa:NumberOfTradingDaysForDeterminingTheVolumeWeightedAveragePriceOfShare" inside-table="false" id="fact-identifier-266" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">20</ix:nonnumeric></span> </span>trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination
(such price, the “Market Value”) is below $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_pdd" title="Shares issued price per share"><span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" contextref="AsOf2021-12-31_custom_PrivateWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares" inside-table="false" id="fact-identifier-267" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">9.20</ix:nonfraction></span></span> per share, the exercise price of the warrants will be adjusted (to the nearest
cent) to be equal to <span id="xdx_906_ecustom--ClassOfWarrantsOrRightsExercisePricePercentage_iI_dp_c20211231__custom--WarrantRedemptionExercisePricePercentageAxis__custom--WarrantRedemptionExercisePricePercentageOneMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zlf86i9FG9yc" title="Class of warrants or rights exercise price percentage"><span><ix:nonfraction name="alsa:ClassOfWarrantsOrRightsExercisePricePercentage" contextref="AsOf2021-12-31_custom_WarrantRedemptionExercisePricePercentageOneMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure" inside-table="false" id="fact-identifier-268" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">115</ix:nonfraction></span></span>% of the Market Value, and the last sales price of the ordinary shares that triggers the Company's right to redeem
the Warrants will be adjusted (to the nearest cent) to be equal to <span id="xdx_906_ecustom--ClassOfWarrantsOrRightsExercisePricePercentage_iI_dp_c20211231__custom--WarrantRedemptionExercisePricePercentageAxis__custom--WarrantRedemptionExercisePricePercentageTwoMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTXgy5qreSE7" title="Class of warrants or rights exercise price percentage"><span><ix:nonfraction name="alsa:ClassOfWarrantsOrRightsExercisePricePercentage" contextref="AsOf2021-12-31_custom_WarrantRedemptionExercisePricePercentageTwoMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure" inside-table="false" id="fact-identifier-269" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">180</ix:nonfraction></span></span>% of the Market Value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Private warrants</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The private warrants have terms and provisions that are identical to those
of the warrants being sold as part of the units in this offering.</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p><p style="margin: 0pt 0; text-align: justify">Except

in cases where the Company is not the surviving Company in a business combination, the holders of the rights will automatically

receive&nbsp;1/7&nbsp;of a share of ordinary shares upon consummation of the Company’s initial business combination. In

the event the Company will not be the surviving company upon completion of the initial business combination, each holder of a

right will be required to affirmatively convert his, her or its rights in order to receive the 1/7 of a share underlying each

right upon consummation of the business combination. As of December 31, 2021,&nbsp;no&nbsp;rights had been issued.</p>







<ix:exclude><p id="xdx_23F_zaa9gCHU7sSk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p></ix:exclude>















<ix:exclude><!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page --></ix:exclude>







<ix:exclude><p id="xdx_239_zJau0oORM1C3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p></ix:exclude>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-270" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_806_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zvJGXhulMzUi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



8 – <span id="xdx_82D_zO25TSRSDP2e">Fair Value Measurements</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The

Company complies with ASC 820, “Fair Value Measurements”, for its financial assets and liabilities that are

re-measured and  reported at fair value at each reporting period, and&nbsp;non-financial assets and liabilities that are

re-measured and reported at fair  value at least annually. ASC 820 determines fair value to be the price that would be

received to sell an asset or would be paid to transfer  a liability (i.e., the exit price) in an orderly transaction between

market participants at the measurement date.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The



following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used



in order to value the assets and liabilities:</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif">



    <td style="width: 0.25in">&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&nbsp;1:</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted



    prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions



    for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif">



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif">



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&nbsp;2:</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable



    inputs other than Level&nbsp;1 inputs. Examples of Level&nbsp;2 inputs include quoted prices in active markets for similar assets



    or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif">



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif">



    <td>&nbsp;</td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level&nbsp;3:</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable



    inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At

December 31, 2021, assets held in the trust account were entirely comprised of marketable securities.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The

following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December

31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p>















<p style="margin: 0">&nbsp;</p>







<span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-271" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z7r7Qn1wsdMf" summary="xdx: Disclosure - Fair Value Measurements (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">



  <tbody><tr style="vertical-align: bottom">

    <td style="vertical-align: bottom; font-weight: bold; text-align: left"><span id="xdx_8B2_z2Sas3ctXYc" style="display: none">Schedule of fair value, assets and liabilities measured on recurring basis</span></td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>

    <td colspan="2" style="font-weight: bold; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>

    <td colspan="2" style="font-weight: bold; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>

    <td colspan="2" style="font-weight: bold; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>

  <tr style="vertical-align: bottom">



    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quoted



    Prices in<br> Active Markets<br> (Level 1)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Significant



    Other<br> Observable Inputs<br> (Level 2)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Significant



    Other<br> Unobservable Inputs<br> (Level 3)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">



    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable



    Securities held in Trust Account</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--MarketableSecurities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpHeJMSSYYZ2" title="Marketable Securities held in Trust Account" style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><ix:nonfraction name="us-gaap:MarketableSecurities" contextref="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD" inside-table="true" id="fact-identifier-272" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">115,000,744</ix:nonfraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--MarketableSecurities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZvpg1c0d4Yg" title="Marketable Securities held in Trust Account" style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0513"><span><ix:nonfraction name="us-gaap:MarketableSecurities" contextref="AsOf2021-12-31_us-gaap_FairValueInputsLevel2Member" id="fact-identifier-273" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0513" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--MarketableSecurities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrcwt6IUOgWc" title="Marketable Securities held in Trust Account" style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515"><span><ix:nonfraction name="us-gaap:MarketableSecurities" contextref="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member" id="fact-identifier-274" unitref="USD" xs:nil="true" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="xdx2ixbrl0515" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">-</ix:nonfraction></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td></tr>



  </tbody></table></ix:nonnumeric></span>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







</ix:nonnumeric></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric contextref="From2021-03-11to2021-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock" inside-table="false" text-block-taxonomy="true" id="fact-identifier-275" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_z89MK2jG4bBi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note



9 – <span id="xdx_821_zEM3LKpqqu4">Subsequent Events</span></b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The

Company evaluated subsequent events and transactions that occurred after the balance sheet date up to March 29, 2022 </span>the

date the financial statement was available to be issued. Based upon the review, the Company did not identify any subsequent events

that would have required adjustment or disclosure in the financial statement.</p>







</ix:nonnumeric></span><p id="xdx_819_zqrxqpMBdJEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"></td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%"></td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"></div>
    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&nbsp;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; vertical-align: top">



<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></td></tr></tbody></table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We



here by file as part of this Report the exhibits listed in the attached Exhibit&nbsp;Index. Exhibits which are incorporated herein by



reference can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington,



D.C. 20549. Copies of such material can also be obtained from the Public Reference Section&nbsp;of the SEC, 100 F Street, N.E., Washington,



D.C. 20549, at prescribed rates or on the SEC website at www.sec.gov.<sup>(1)</sup></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&nbsp;No.</b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1865111/000110465921149985/tm2135327d1_ex1-1.htm" tabindex="18">Underwriting Agreement, date December 13, 2021, by and among the Company, Ladenburg Thalmann&nbsp;&amp; Co. Inc. <sup>(1)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1865111/000110465921149985/tm2135327d1_ex3-1.htm" tabindex="18">Amended and Restated Memorandum and Articles of Association. <sup>(1)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1865111/000110465921149985/tm2135327d1_ex4-1.htm" tabindex="18">Warrant Agreement, dated December 3, 2021, by and between the Company and Vstock Transfer LLC, as warrant agent. <sup>(1)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex4-2.htm" tabindex="18">Description
    of Registrant’s Securities <sup>(3)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1865111/000110465921149985/tm2135327d1_ex10-1.htm" tabindex="18">Letter Agreement, dated December 3, 2021, by and among the Company, its officers, directors and A-Star Management Corporation. <sup>(1)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex10-2.htm" tabindex="18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administrative
    Services Agreement, dated July&nbsp;23, 2021, by and among the Company and A-Star Management Corporation.<sup>&nbsp;(3)</sup></span></a></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1865111/000110465921149985/tm2135327d1_ex10-2.htm" tabindex="18">Investment Management Trust Agreement, December 9, 2021, by and between the Company and Wilmington Trust, National Association, and Vstock Transfer, as trustee. <sup>(1)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1865111/000110465921149985/tm2135327d1_ex10-3.htm" tabindex="18">Registration Rights Agreement, dated December 13, 2021, by and among the Company, M-Star Management Corporation and the holders party thereto. <sup>(1)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex10-5.htm" tabindex="18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
    Placement Units Purchase Agreement, December 13, 2021, by and between the Company and A-Star Management Corporation. <sup>(3)</sup></span></a></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1865111/000110465921086903/tm2119933d1_ex10-5.htm" tabindex="18">Securities Subscription Agreement, dated March 26, 2021, between the Registrant and A-Star Management Corporation. <sup>(2)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex21.htm" tabindex="18">List of subsidiaries. <sup>(3)</sup></a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex31-1.htm" tabindex="18">Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)*</a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex31-2.htm" tabindex="18">Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) *</a></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></p>



    </td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex32-1.htm" tabindex="18">Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**</a></span></p>



    </td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1865111/000182912622006943/alphastaracq_ex32-2.htm" tabindex="18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**</span></a></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS
</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL



    Instance Document*</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH
</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL



    Schema Document*</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL
</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL



    Calculation Linkbase Document*</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF
</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL



    Definition Linkbase Document*</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB
</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL



    Label Linkbase Document*</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE
</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL



    Presentation Linkbase Document*</span></td></tr>



  </tbody></table>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></div></div><!-- Field: /Rule-Page -->















<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed



    as an Exhibit&nbsp;to the Registrant’s Form&nbsp;8-K as filed with the Commission on December 15, 2021.</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed



    as an exhibit to the Registrant’s Form&nbsp;S-1 as filed with the Commission on June 29, 2021.</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field



                                            as an Exhibit&nbsp;to this Form&nbsp;10-K.</span></p></td></tr>



</tbody></table>







<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></p></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed



                                            herewith.</span></p></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">**</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished



    herewith.</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_024"></span>ITEM



16. Form&nbsp;10-K Summary</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>











<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 71; Options: NewSection; Value: 53 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>



    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>



    <!-- Field: /Page -->







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Signatures</b></span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant



to the requirements of Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934, the Registrant has duly caused this Report



to be signed on its behalf by the undersigned, thereunto duly authorized as of March 29, 2022.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHA STAR ACQUISITION CORPORATION</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/



    Zhe Zhang</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhe



    Zhang</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief



    Executive Officer</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal



    Executive Officer)</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>







<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant



to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the



registrant and in the capacities and on the dates indicated.</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">



  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capacity</b></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/



    Zhe Zhang</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Chairman



    of the Board, Chief Executive Officer</span></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhe



    Zhang</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>(Principal



    Executive Officer)</i></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    29, 2022</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/



    Guojian Chen</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief



Financial Officer</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guojian



    Chen</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal



    Financial Officer)</i></span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    29, 2022</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Konstantin



    Sokolov </span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director



    </span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Konstantin



    Sokolov</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    29, 2022</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Xiaofeng



    Zhou </span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaofeng



    Zhou</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    29, 2022</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Huei-Ching



    Huang </span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td></tr>



  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huei-Ching



    Huang</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>



    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    29, 2022</span></td></tr>



  </tbody></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>















<!-- Field: Page; Sequence: 72; Value: 53 -->



    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>



    <!-- Field: /Page -->

















<!-- 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 -->


</body>
</html>